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Foreword 
Due to the emergence of shortages concerning natural resources and the globalization of pro-
duction, sustainability has become vital in business decisions. Meanwhile, sustainability man-
agement has become an independent field of research in business science and in the decision 
processes of companies. The research and teaching of the Chair of Environmental Manage-
ment and Accounting of the Technische Universität Dresden focus on the economic and envi-
ronmental efficiency (e
3
) in organizations. Strategies for practical use are developed based on 
scientific concepts. In recent years the importance of the natural environment in the economic 
sciences has been increasing continuously. 
The research program of the Chair of Environmental Management and Accounting at the 
Technische Universität Dresden is reflected in the composition of the teachings. In this way 
the knowledge gained from the theoretical and practical research flows directly into each of 
the lectures. The current scientific series “Dresdner Beiträge zur Lehre der Betrieblichen 
Umweltökonomie” aims to support this integration process. Contents of the scientific series 
are predominantly theses selected from the Chair of Environmental Management and Ac-
counting through which the reader may gain an insight into the key activities of the chair as 
well as a clear understanding of the work content. 
The scientific series was composed by Dr. Susann Silbermann and the coordination of the 
present series was carried out by Dipl.-Kffr. Kristin Stechemesser. 
This paper explores the extent to which corporations currently increase the voluntary disclo-
sures in triple bottom line (TBL) reports. Although research already has provided substantial 
contributions as to why and how firms apply TBL reporting, there remains limited under-
standing of the motivations for and against making voluntary disclosures. Drawing from liter-
ature in environmental management and accounting as well as international auditing, this 
work focuses on guidance, boundary-setting and external assurance for TBL reports. An in-
ductive case study approach is applied to investigate the credibility of TBL reporting by con-
trasting the competing predictions from legitimacy theory and voluntary disclosure theory on 
voluntary disclosures. A set of firm and industry specific factors are identified that are ex-
pected to determine a firm’s level and extent of reporting. The sample comprises nine US and 
EU red biotechnology corporations which aligned their TBL reporting to the GRI reporting 
standards in at least part of their TBL reports that were published between 2000 and 2009. An 
initial attempt is made to systematically investigate the credibility of TBL reporting to devel-
op the model of voluntary disclosures.  
The empirical findings of this case study suggest that current guidance, boundary-setting and 
assurance for TBL reports are not sufficient to in-crease the credibility, comparability and 
reliability of reporting. Voluntary disclosure theory can serve to provide economic motiva-
tions, while legitimacy theory is helpful to provide a legitimating motivation. The findings 
support the notion that the economics-based factors better explain the secrecy strategy of 
providing mainly soft disclosures.  
The increase of disclosure levels maybe is considered sufficient to respond to public pressure. 
This work concludes by suggesting some directions of research in the areas of boundary-
setting and assurance that have academic and practical implications. 
Edeltraud Günther
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1 Introduction 
“Sustainability can be a 2 + 2 = 5 (or even 50) game. To achieve outstanding triple bottom line perfor-
mance, new types of economic, social, and environmental partnership are needed.”
 1
 
Within this publication the term “triple bottom line” (TBL) is used to refer to the corporate 
reporting or performance with respect to the economic, environmental and social dimensions 
of corporate responsibility. TBL describes the impacts of business activity on the economic, 
social and natural capitals which need to be maintained in order to ensure the survival our so-
ciety.
2
 Corporations are able to solve dilemmas impeding sustainable development by engag-
ing as political actors who takes responsibility for the way they behave in the usual business 
activity as well as in new governance processes.
3
 This includes new forms of communication 
with their stakeholders
4
, for instance by the means of voluntary disclosures on their TBL per-
formance. But are such disclosures indeed used in an accountable and credible manner? Re-
searchers concerned with organizations and the promotion of sustainable development already 
have provided substantial contributions to this question. They have investigated why some 
firms publish a TBL report and over time increase the level and extent of their voluntary dis-
closures, while others in apparently similar circumstances do not opt to publish a report or re-
duce the disclosures after an initial decision for reporting was made. Some researchers have 
examined the effect of public perceptions and pressure on the corporate behavior to voluntari-
ly publish TBL reports. Others investigated the effect of managerial and commercial strategies 
on voluntary disclosures. Understanding the motivations for and against publishing TBL re-
ports is critical as this could help to establish appropriate rules to foster societies, including 
business organizations, which are oriented towards sustainable development.  
Several studies have identified motivations for voluntary disclosures, including stakeholder 
pressure and competitive advantage. Many scholars examined the effect of public perceptions 
and pressure
5
, others focused on firm and industry specific characteristics
6
. The legitimacy of 
voluntary disclosures in general has been widely discussed, whereas the boundary-setting and 
external assurance of TBL reports up to now have obtained limited attention in academic lit-
erature although they are useful to get an idea of the reach of voluntary disclosures. A number 
of descriptive analyses, regression analyses already exists on boundary-setting
7
, external as-
surance
8
 and the determination of country and industry specific factors
9
. However, except for 
KOLK, A. (2010) these empirical works were not connecting the empirical results to theory. 
Hence, this work draws on the above evolving streams of literature in environmental man-
                                                 
1  ELKINGTON, J. (1998), p. 37. 
2  Cf. WORLD COMMISSION ON ENVIRONMENT AND DEVELOPMENT (1987), w/o p. 
3  Cf. PALAZZO, G.; SCHERER, A. G. (2006), p. 73, SCHERER, A. G.; PALAZZO, G.; BAUMANN, D. (2006), p. 520. 
4  Cf. PIES, I.; HIELSCHER, S.; BECKMANN, M. (2009), pp. 385ff. 
5  Cf. PATTEN, D. M. (1991), pp. 297ff; PATTEN, D. M. (2002a), pp. 152ff; DEEGAN, C. (2000), pp. 101ff; DEEGAN, 
C. (2002a), pp. 312ff; CHO, C. H. (2009), pp. 33ff.  
6  Cf. ADAMS, C. A.; HILL, W. Y.; ROBERTS, C. B. (1998), pp. 1ff; CORMIER, D. (2001), pp. 587ff; CAMPBELL, D. 
(2003a), pp. 357ff. 
7  Cf. VELEVA, V. et al. (2003), pp. 107ff; ARCHEL, P. (2008), pp. 106ff;  
8  Cf. O'DWYER, B.; OWEN, D. L. (2005), pp. 205ff; DEEGAN, C. (2006a), pp. 2ff; DEEGAN, C. (2006b), pp. 329ff; 
MOCK, T. J. (2007), pp. 67ff; PEREGO, P. (2009), pp. 412ff; KOLK, A. (2010), pp. 182ff. 
9  Cf. DURNEV, A. (2005), pp. 1461ff; CHOI, J. H. (2007), pp. 13ff; MOCK, T. J. (2007), pp. 67ff; PEREGO, P. (2009), 
pp. 412ff; KOLK, A. (2010), pp. 182ff. 
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agement and accounting as well as international auditing to which it seeks to contribute. First, 
it provides exploratory insights in the adoption of TBL guidance for setting boundaries and 
adopting assurance for TBL reports. Second, it adds to prior research by developing a model 
that identifies different motivations and the corresponding outcomes in terms of voluntary 
disclosures. 
The objective of this work is to investigate the credibility of TBL reporting by contrasting the 
two competing predictions from legitimacy theory and voluntary disclosure theory on volun-
tary disclosures. On this account, this work examines the extent to which corporations apply 
guidance for setting boundaries and adopting external assurance for TBL reports. A set of firm 
and industry specific factors are discussed that are expected to significantly predict the corpo-
rate reporting characteristics. The sample comprises nine red biotechnology corporations from 
the United States (US) and Europe which aligned their TBL reporting to the Global Reporting 
Initiative (GRI) reporting standards in at least part of the TBL reports published between 2000 
and 2009. An initial attempt is made to systematically connect the motivations of the compet-
ing theories to develop the model of voluntary disclosures. 
This work is an attempt to advance the understanding of why firms adopt a certain level of 
voluntary disclosures. A rich model of voluntary disclosures requires considering the motiva-
tions and underlying factors. This work attempts to inform the normative and empirical litera-
ture on legitimacy by developing theory that helps to explain and predict voluntary disclo-
sures in corporate TBL reports. 
As depicted in figure 1 this work is organized as follows. Chapter 2 provides an overview of 
the normative discussion on sustainable business, including the concepts of sustainable devel-
opment, corporate citizenship and corporate responsibilities. Moreover the recent develop-
ments in the area of voluntary disclosures and available studies that have examined boundary-
setting and external assurance statements are presented. In chapter 3, the red biotechnology 
industry and its characteristics are analyzed. The next chapter presents in detail the research 
interest, the sampling, sample data and analysis methods. Chapter 5 comprises the empirical 
results which will be discussed in detail and related to firm and industry specific factors in 
chapter 6. The work concludes with remarks and suggestions for future research. 
Sustainable Business through Voluntary Disclosures:  
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Figure 1: Structure of the work 
(Own illustration.) 
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2 Theoretical Foundations 
This chapter presents the main theories and empirical works which are relevant for this work. 
First, some fundamental theoretical concepts on sustainable business are discussed to pave the 
way for the theories on voluntary disclosures as well as related preliminary empirical litera-
ture which provide the setting for this work. 
2.1 Concepts on Sustainable Business 
In this subchapter the interrelated concepts of sustainable development, corporate citizenship 
and corporate responsibilities are presented to discuss the role organizations increasingly are 
demanded to take for the promotion of sustainable development. As will be detailed below, 
“sustainable business” is characterized by acting as a good corporate citizen who does busi-
ness by sustaining the economic, environmental and social capitals of society guided by legal, 
moral and political requirements. Figure 2 demonstrates the relationship among the three con-
cepts. 
 
Figure 2: The relation of the concepts on sustainable business 
(Own illustration.) 
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2.1.1 The Concept of Sustainable Development 
The past decades have been characterized by an ongoing trend of globalization and deterrito-
rialization that uncouples social connections and regional territories.
10
 As global actors, corpo-
rations often intensify ethical dilemma situations for instance by diluting competitiveness, so-
cial, moral or democratic rights in countries with weaker legal systems.
11
  
The current free-market economy causes forced and urged growth
12
 which implies 
“to increase naturally in size by the addition of material through assimilation or accretion. 
[] When something grows it gets bigger.”
13
 
This concept of growth poses massive threats to society and environment
14
 and causes the de-
pletion of global resources at a furious pace as the calculations of the Global Footprint Net-
work show. Annually they determine at which day of the year the amount of resources used to 
cover human demand and absorb carbon dioxide emissions exceeds the amount of the planet’s 
resources.
15
 In 1990, the World Overshoot Day was the 7
th
 of December, whereas in 2010 this 
was the already case on 21
th
 of August.
16
 The global economy cannot continue to grow, but to 
develop.
 17
 The concept of sustainable development could provide an opportune measure to al-
low the progress and survival of the global society.
18
 Contrary to growth, development implies 
“to expand or realize the potentialities of; to bring gradually to a fuller, greater, or better 
state. [] When something develops it gets different.”
 19
 
Basing on the above considerations “sustainable development” is understood as 
“‘development without growth’ – i. e., qualitative improvement of a physical economic 
base that is maintained in a steady state by a throughput of matter-energy that is within 
the regenerative and assimilative capacities of the ecosystem.”
 20 
 
The political definition understands “sustainable development” as a 
“development that meets the needs of the present without compromising the ability of fu-
ture generations to meet their own needs. It contains within it two key concepts: the con-
cept of 'needs', in particular the essential needs of the world's poor, to which overriding 
priority should be given; and the idea of limitations imposed by the state of technology 
and social organization on the environment's ability to meet present and future needs.
 21
 
The latter definition does not only require inter-generational justice towards future genera-
tions, but also intra-generational justice in terms of a fairer distribution of welfare between in-
                                                 
10  Cf. CRANE, A.; MATTEN, D.; MOON, J. (2010), pp. 17ff; SCHOLTE, J. A. (2000), pp. 46ff. 
11  Cf. DESJARDINS, J. (1998), p. 826; CRANE, A.; MATTEN, D.; MOON, J. (2010), pp. 17ff; HOMANN, K.; LÜTGE, 
C. (2005), pp. 114ff. 
12  Cf. KOSCH, S. (2009), w/o p. 
13  DALY, H. E. (1993), p. 267. 
14  Cf. WORLD COMMISSION ON ENVIRONMENT AND DEVELOPMENT (1987), w/o p. 
15  Cf. GLOBAL FOOTPRINT NETWORK (2010), w/o p. 
16  Cf. GLOBAL FOOTPRINT NETWORK (2010), w/o p. 
17  Cf. DALY, H. E. (1993), p. 267. 
18  Cf. WORLD COMMISSION ON ENVIRONMENT AND DEVELOPMENT (1987), w/o p. 
19  DALY, H. E. (1993), p. 267. 
20  DALY, H. E. (1993), p. 267. 
21  WORLD COMMISSION ON ENVIRONMENT AND DEVELOPMENT (1987), w/o p. 
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dustrial and developing countries.
22
 Thus, organizations are to be held responsible to at least 
preserve the community’s economic, social (including human and intellectual) and natural 
capital
23
 to address the challenge of sustainable development. The concept of capital is a met-
aphor for the resources which a firm combines to produce products and services.
24
 The eco-
nomic, social and natural capital is often collectively referred to by the term “triple bottom 
line” (TBL)
25
. 
2.1.2 The Concepts of Corporate Citizenship and Corporate Responsibilities 
There is ongoing discussion if corporations can be considered as corporate citizens. Citizen-
ship can be seen as a metaphor to express the private self-interest of corporations to do busi-
ness that is accountable to their relevant stakeholders, i. e.  
“any group or individual who can affect or is affected by the achievement of an organiza-
tion’s purpose”
26
. 
Thus, corporations as citizens are required to respect certain criteria, conditions and obliga-
tions
27
. Most importantly they shall be required to take their role in the promotion of sustaina-
ble development by acting as a good corporate citizen who does business by sustaining the 
economic, environmental and social capitals. 
The terminology “corporate citizenship” first appeared in the 1980s in the US business area, 
since the 1990s there is an increasing body of academic work dedicated to this subject, inter 
alia, the concept was applied in the context of globalization.
28
 Different understandings of the 
concept of corporate citizenship exist, which are very close or even equivalent to the idea of 
corporate responsibilities.
29
 This work adopts the extended, political view of corporate citi-
zenship which instead specifies that corporations metaphorically participate and engage in so-
ciety like citizens.
30
 It is argued that there must be symmetry between rights and obligations, 
i. e. corporations are to take the political role in protecting, enabling and implementing citi-
zenship rights.
31
 The implications of this political role are detailed below. 
The terminology “corporate social responsibilities” (CSR) has evolved since the 1950s, ever 
since there have been broad controversies over the political and social legitimacy of CSR be-
tween the representatives of the free market model and the social market model.
32
 Advocates 
of free markets defend the pursuit of economic growth while respecting legal and moral re-
sponsibilities and see a trade-off between CSR and profits
33
, whereas advocates of social 
                                                 
22  Cf. HART, S. L. (1995), p. 997. 
23  Cf. COSTANZA, R. et al. (1997), p. 254; NAHAPIET, J.; GHOSHAL, S. (1998), pp. 245ff; ADLER, P. S. (2002), p. 22. 
24  Cf. COSTANZA, R. et al. (1997), p. 254; ADLER, P. S. (2002), p. 22. 
25  Cf. ELKINGTON, J. (1998), pp. 37ff. 
26  FREEMAN, R. E. (1984), p. 53. 
27  Cf. MOON, J.; CRANE, A.; MATTEN, D. (2005), pp. 443ff. 
28  Cf. CRANE, A.; MATTEN, D.; MOON, J. (2010), p. 65; GARRIGA, E.; MELÉ, D. (2004), p. 57. 
29  Cf. CRANE, A.; MATTEN, D.; MOON, J. (2010), pp. 67ff. 
30  Cf. CRANE, A.; MATTEN, D.; MOON, J. (2010), pp. 70f. 
31  Cf. MATTEN, D.; CRANE, A. (2005), p. 173; VAN OOSTERHOUT, J. (2005), pp. 678f; SCHERER, A. G.; 
PALAZZO, G.; BAUMANN, D. (2006), p. 515. 
32  Cf. LEE, M. -. P. (2008), p. 58. 
33  Cf. JENSEN, M. C. (2001), p. 10; VANBERG, V. J. (2007), p. 214. 
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markets argue that also ethical and social aspects are to be accounted for
34
. A broadly applied 
categorization of CSR includes economic, legal, ethical and discretionary/ philanthropic di-
mensions
35
. Furthermore, CSR was integrated with other concepts from stakeholder theory or 
business ethics to introduce a stakeholder dimension.
36
 The following widely cited defini-
tion
37
 already covers the three sustainable development dimensions: 
CSR is a “concept whereby companies integrate social and environmental concerns in 
their business operations and in their interaction with their stakeholders on a voluntary 
basis”
38
. 
In the following, the relevance of different corporate responsibilities is discussed to determine 
what a sustainable business could be like. It will be argued that doing sustainable business 
should include acting as a good corporate citizen, i. e. sustaining the economic, environmental 
and social capitals of society guided by legal, moral and political requirements. 
It is unquestioned that corporations are obliged to perform their business conform to legal and 
regulatory requirements in the countries where they operate.
39
 But there are two main devel-
opments which suggest that minimum compliance is not sufficient.
40
 In many countries gov-
ernments alone are not able to maintain an efficient institutional framework with appropriate 
legal obligations, regulation and control to protect the health and environment of their citizens 
as well as the citizens themselves.
41
 Globalization with its complex and far-reaching risks 
poses even greater challenges as well-functioning international institutions are far from being 
implemented.
42
 As a consequence, by simply complying legal and regulatory requirements the 
criterion of at least preserving the community’s capital was and is increasingly at risk as some 
examples will show. Excessive expectations of return, e. g. by tying the manager’s remunera-
tion to stock options
43
, bring strong incentives for short-term profitability. This comes at the 
expense of middle- and long-term goals which may reduce the economic capital by reducing 
the company value. Multinational corporations have the potential to play governments of dif-
ferent countries off against each other in a “race to the bottom” by moving continually to “low 
cost” regions
44
. Hence, by obeying to minimum legal and regulatory standards, the short-term 
economic capital may be maximized, but the long-term economic, natural and social capitals 
are exploited. 
Business ethicists argue that corporations are licensed to fulfill moral requirements as they 
possess mechanisms such as an “internal decision structure” influencing the corporate inten-
tionality
45
 as well as an “organizational culture” influencing the behavior and decisions made 
                                                 
34  Cf. CARROLL, A. B. (1991), p. 41; PORTER, M. E.; KRAMER, M. R. (2006), pp. 89ff; VANBERG, V. J. (2007), 
p. 214. 
35  Cf. CARROLL, A. B. (1979), pp. 499f. 
36  Cf. DAHLSRUD, A. (2008), pp. 41f. 
37  Cf. DAHLSRUD, A. (2008), p. 7. 
38   COMMISSION OF THE EUROPEAN COMMUNITIES (2001), p. 6. 
39  Cf. FRIEDMAN, M. (1970), p. 1ff; CARROLL, A. B. (1991), p. 40. 
40  Cf. CARROLL, A. B. (1991), p. 40. 
41  Cf. BECK, U. (1992), pp. 19ff; HANDY, C. (2002), p. 53; BISHOP, J. D. (2008), p. 205. 
42  Cf. e. g. MATTEN, D.; CRANE, A. (2005), p. 172; CRANE, A.; MATTEN, D.; MOON, J. (2010), p. 18ff. 
43  Cf. HANDY, C. (2002), p. 50. 
44  Cf. e. g. CRANE, A.; MATTEN, D. (2010), pp. 18 & 69. 
45  Cf. FRENCH, P. A. (1979), pp. 211f. 
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by the individuals of a corporation
46
. Corporate codes of conduct and their reflection in indi-
vidual agreements of objectives are useful means to assure the moral requirements of the in-
dividuals within the corporation.
47
 Thus, corporations could contribute to the sustainable use 
of the community’s capital by respecting moral norms, values and beliefs rather than solely 
complying with the “moral minimum” of avoiding harm.
48
 Although critics may argue that 
moral behavior is a new way of cultural imperialism
49
 it rather should be understood as a 
global conception with scientific rather than ideological answers to what is right and wrong
50
. 
Knowing and understanding scientifically the corporations’ impacts on the community’s capi-
tal can help taking moral decisions within the course of business. 
By participating and engaging in society like citizens to address the above difficulties as de-
manded increasingly by stakeholders, corporations take a political role without being elected 
democratically.
51
 In response to this legitimation gap, business ethicists argue that corpora-
tions submit themselves to democratic control through their stakeholders to become legiti-
mized for taking this role.
52
  
“[B]eing not only part of the problem, but also perhaps part of the solution”
53
,  
corporations can do so by taking responsibility for the way they act in their usual business ac-
tivity (to obtain within-game legitimacy) as well as in new governance processes (ordo-
legitimacy).
54
 Within-game legitimacy can be achieved by pro-actively communicating and 
collaborating with the relevant stakeholders. Written communication, in particular TBL re-
porting comprises e. g. transparent auditing and reporting on self-commitments to sustainable 
development, collaboration enables stakeholders to examine if the community’s capital is 
abused by the way business is run.
55
 In return, communication and collaboration can legiti-
mize corporations to engage in new governance processes of rule-finding and rule-setting 
which in turn provide them with ordo-legitimacy. By pro-actively participating in the rule-
finding discourse (i. e. taking discourse responsibility) and rule-setting process (i. e. taking 
governance responsibility) corporations can contribute with their knowledge and resources to 
improve the deficient institutional framework.
56
 In short, by engaging as a political actor, cor-
porations are able to solve dilemmas impeding sustainable development. Corporations may be 
motivated to do so if they see an opportunity to improve the sustainable use of the communi-
ty’s capital, but feel unable to tackle the dilemma alone.
57
 
                                                 
46  Cf. MOORE, G. (1999), p. 333. 
47  Cf. BOATRIGHT, J. R. (1999), pp. 583ff; HOMANN, K.; LÜTGE, C. (2005), p. 84; WICKS, A. C. (1996), pp. 99ff. 
48  Cf. BOWIE, N. (1991), p. 56; LOGSDON, J. M.; WOOD, D. J. (2002), p. 165; MATTEN, D.; CRANE, A. (2005), 
p. 173f. 
49  Cf. TOMLINSON, J. (2001), pp. 103ff; LOGSDON, J. M.; WOOD, D. J. (2002), p. 180. 
50  Cf. HARRIS, S. (2010), w/o p. 
51  Cf. BECK, U. (1992), pp. 202ff; CRANE, A.; MATTEN, D.; MOON, J. (2010), pp. 70f. 
52  Cf. BECK, U. (1992), pp. 202ff; SCHERER, A. G.; PALAZZO, G.; BAUMANN, D. (2006), pp. 519f; ULRICH, P. 
(2008), p. 107; BLED, A. J. (2009), p. 157. 
53  KOLK, A. (2010), p. 119. 
54  Cf. PALAZZO, G.; SCHERER, A. G. (2006), p. 73, SCHERER, A. G.; PALAZZO, G.; BAUMANN, D. (2006), p. 520; 
PIES, I.; HIELSCHER, S.; BECKMANN, M. (2009), pp. 385ff. 
55  Cf. PALAZZO, G.; SCHERER, A. G. (2006), p. 73, SCHERER, A. G.; PALAZZO, G.; BAUMANN, D. (2006), p. 520. 
56  Cf. e. g. SCHERER, A. G.; PALAZZO, G.; BAUMANN, D. (2006), p. 520; VANBERG, V. J. (2007), p. 203; PIES, I.; 
HIELSCHER, S.; BECKMANN, M. (2009), pp. 385ff. 
57  Cf. PIES, I.; HIELSCHER, S.; BECKMANN, M. (2009), pp. 388ff. 
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Under the premise of sustainable development corporations should have an interest in provid-
ing goods and services
58
 while ensuring the long-term well-being of the community and thus 
the own corporation by preserving at least the economic, natural and social capitals of the 
community. The economic capital can be preserved by efficiently using the factors of produc-
tion and adapting production to their assumed future market developments
59
. Moreover, cor-
porations are to provide consistent, i. e. long-term, profitability and maintain their competitive 
position.
60
 With concerted investments in the corporate environment the social and natural 
capitals can be preserved. Rather than donating imprudently or mitigating value chain im-
pacts, corporations should analyze carefully their surroundings, i. e. competitive context, and 
identify critical impacts on society and environment in order to find reduction opportunities. 
Impacts may be reduced e. g. by enhancing labor or living conditions or by improving the sus-
tainable use of natural resources. Such strategic adaptations do not necessarily only incur 
costs but can have the potential for cost reductions or product differentiations, thus increasing 
the economic capital, too.
61
 In this way, corporations are able to reinforce their strategy of 
sustained preservation of their economic, social and natural capitals. Rather than simply align-
ing common interest with profit interest
62
, or as would be another extreme, questioning profit 
interest per se
63
, the focus is on minimizing conflicts between them.
64
 Concerted sustainable 
development investments according to the business impact thus do not aim at overburdening 
corporations. 
When accepting the promotion of sustainable development as indispensable for business ac-
tivities, then it is not sufficient for corporations to take economic responsibility while obeying 
to legal requirements
65
. Hence, a “sustainable business” is characterized by acting as a good 
corporate citizen who does business by taking economic, social and environmental responsi-
bilities guided by legal, moral and political requirements.  
This rather normative discussion of sustainable development, corporate citizenship and corpo-
rate responsibilities forms the basis for the empirical analysis of this work. It will be exam-
ined if voluntary disclosures on guidance, boundary-setting and external assurance are indeed 
adding to the credibility of corporate TBL reporting. If so, reporting may make corporations 
democratically accountable to their stakeholders and bring within-game legitimacy for taking 
the political role discussed above. Building on these normative concepts on sustainable busi-
ness, the following subchapter introduces the relevant theories on voluntary disclosures.  
                                                 
58  Cf. CARROLL, A. B. (1979), p. 500. 
59  Cf. e. g.VON MISES, L. (1951), pp. 11f; VON MISES, L. (1961), p. 134; ULRICH, P. (2008), p. 107. 
60  Cf. e. g. FRIEDMAN, M. (1970), pp. 1ff; CARROLL, A. B. (1991), p. 40; JENSEN, M. C. (2001), p. 9. 
61  Cf. PORTER, M. E.; KRAMER, M. R. (2002), pp. 7ff; PORTER, M. E.; KRAMER, M. R. (2006), pp. 89ff. 
62  Cf. PORTER, M. E.; KRAMER, M. R. (2002), pp. 8ff; PORTER, M. E.; KRAMER, M. R. (2006), pp. 89ff. 
63  Cf. VANBERG, V. J. (2007), p. 214. 
64  Note: The author re-interpretates the view of reinforcing strategy from alignment with profit-interest (as suggested by 
PORTER, M. E.; KRAMER, M. R. (2002), pp. 8ff; PORTER, M. E.; KRAMER, M. R. (2006), pp. 89ff) to minimizing 
conflicts between economic, social, and environmental considerations. 
65  Cf. FRIEDMAN, M. (1970), pp. 1ff. 
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2.2 Theories on Voluntary Disclosures 
While there remain controversies about the political role of corporations and legitimacy de-
mands
66
 this chapter presents two theories with competing predictions about voluntary disclo-
sures in corporate reports which can help to shed light into this discussion. Legitimacy theory 
suggests that firms have incentives to disclose information in all the three dimensions of their 
TBL performance due to public pressure in order to get public acceptance.
67
 Voluntary disclo-
sure theory suggests that firms have incentives to disclose TBL information due to adverse se-
lection problems in order to get public acceptance.
68
 Figures 3 and 4 illustrate these basic ide-
as. Finally, the studies available in environmental management and accounting as well as in-
ternational auditing are discussed that have examined the boundaries set and external assur-
ance adopted for TBL reporting. 
 
Figure 3: The basic idea of legitimacy theory 
(Own illustration.) 
 
Figure 4: The basic idea of voluntary disclosure theory 
(Own illustration.) 
                                                 
66  Cf. WOOD, D. J. (1991), p. 701. 
67  Cf. PATTEN, D. M. (2002b), p. 767. 
68  Cf. DYE, R. A. (1985), pp. 124ff; VERRECCHIA, R. E. (1983), pp. 181ff. 
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2.2.1 Legitimacy Theory 
Legitimacy theory belongs to the socio-political theories and is closely associated to the con-
cepts of corporate citizenship and corporate responsibilities discussed above. Economic ac-
tivity that is aligned to the social and environmental dimensions of sustainable business and 
consistent with the legal, moral and political requirements is preferable to economic activity 
which is not. In general, legitimacy can be defined as follows: 
“Legitimacy is a generalized perception or assumption that the actions of an entity are de-
sirable, proper, or appropriate within some socially constructed system of norms, values, 
beliefs, and definitions.”
69
 
The concept of legitimacy is based on a hypothetical social contract which builds on the fol-
lowing principles of justice:
70
 
"First: each person is to have an equal right to the most extensive scheme of equal basic 
liberties BISHOP, J. D. (2008)BISHOP, J. D. (2008)BISHOP, J. D. (2008)BISHOP, J. D. 
(2008)BISHOP, J. D. (2008)BISHOP, J. D. (2008)compatible with a similar scheme of 
liberties for others. Second: social and economic inequalities are to be arranged so that 
they are both (a) reasonably expected to be to everyone’s advantage and (b) attached to 
positions and offices open to all.”
71
 
A social contract may be perceived to be violated which can threaten the survival of a firm by 
a legitimation crisis resulting from increased institutional pressures as some examples will 
show. Governments, legislators and regulators have the potential to enforce political demands 
while societal and media demands are increasingly influencing norms, values and attitudes of 
consumers, employees and the management. Investors and analysts can impact economic per-
formance and thus drive voluntary disclosures by determining where to invest and which cor-
porations to include in sustainability indices. Stakeholders may perceive competitors and 
business partners from the value chain to be more legitimate which can drive the reporting 
behavior as well.
72
 
Legitimacy is not a static attribute of firms but can be granted at one time, then questioned, 
even lost and later again recovered.
73
 To justify its right of existence
74
 firms either choose 
strategies to gain, maintain or repair legitimacy.
75
 While markets can bring economic legiti-
macy by evaluating profits, social legitimacy results from public policy and thus public pres-
sure.
76
 Hence, legitimacy theory predicts that voluntary disclosure is a function of stakeholder 
pressure.
77
 
As figure 5 demonstrates, a firm may choose a different approach to legitimacy depending on 
the understanding of the own corporate responsibilities.  
                                                 
69  SUCHMAN, M. C. (1995), p. 574. 
70  Cf. BISHOP, J. D. (2008), pp. 192ff. 
71  RAWLS, J. (1999), p. 53. 
72  Cf. DIMAGGIO, P. J.; POWELL, W. W. (1983), pp. 150ff; KOLK, A.; WALHAIN, S.; VAN, D. W. (2001), p. 27; 
KOLK, A. (2003), p. 228. 
73  Cf. BRETON, G.; CÔTÉ, L. (2006), p. 514. 
74  Cf. DIMAGGIO, P. J.; POWELL, W. W. (1983), p. 155. 
75  Cf. SUCHMAN, M. C. (1995), pp. 586ff. 
76  Cf. PATTEN, D. M. (1991), p. 299; PATTEN, D. M. (1992), p. 472. 
77  Cf. PATTEN, D. M. (2002b), p. 767. 
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Figure 5: Legitimacy approaches 
(Own illustration.) 
Pragmatic legitimacy provides limited potential to improve legitimacy as it is based on the 
firms’ self-interest and direct influence and manipulation options.
78
 Cognitive legitimacy still 
brings limited potential to increase legitimacy as it aims at instrumentally manipulating and 
using symbols to gain public support.
79
 For instance, corporations which sense high public 
pressure may be motivated to increase their voluntary disclosures 
 to educate and inform about (actual) changes in TBL performance,  
 to change perceptions of TBL performance,  
 to manipulate perceptions by drawing attention to good TBL performance issues and 
diverting from other aspects of concern, or 
 to change expectations of TBL performance.80 
Only moral legitimacy has the potential to improve legitimacy due to its rule-based, commu-
nicative and collaborative approach without any interest in manipulation.
81
 
In subchapter 4.1 the line of reasoning of legitimacy theory is detailed for firms with low as 
well as high public pressure.  
                                                 
78  Cf. SUCHMAN, M. C. (1995), pp. 578f. 
79  Cf. SUCHMAN, M. C. (1995), pp. 582ff. 
80  Cf. LINDBLOM, C. K. (1994), p. n/a, quoted from GRAY, R. (1995), p. 54. 
81  Cf. SUCHMAN, M. C. (1995), pp. 579ff. 
• free market model 
• economic responsibility 
• legal and moral requirements 
Pragmatic legitimacy 
(institutional approach) 
• social market model 
• economic, environmental and social 
responsibilities 
• legal and moral requirements  
Cognitive legitimacy 
(strategic approach) 
• global market model 
• economic, environmental and social 
responsibilities 
• legal, moral and political requirements 
Moral legitimacy 
(communicative approach) 
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2.2.2 Voluntary Disclosure Theory 
Voluntary disclosure theory is an economics based theory and closely associated to the con-
cepts of information asymmetry and adverse selection. Management generally has full 
knowledge of favorable and unfavorable information with respect to the firm’s TBL perfor-
mance, whereas their stakeholders’ knowledge is subject to the information the management 
is willing to provide them with, i. e. information asymmetry is present. This may incentivize 
an industry to reduce the average quality of TBL performance and instead focus on better 
marketing techniques which may convince stakeholders that the TBL performance is still bet-
ter than it really is. Thus, it is difficult to distinguish firms with good and bad TBL perfor-
mance, a typical case of the adverse selection problem. It may even be the case that poor per-
formers are more likely to be preferred by stakeholders due to their marketing strategies. To 
reduce this adverse selection problem a good performing firm may choose to increase the lev-
el of their TBL reporting and thereby differentiate from their peer firms.
82
 
Stakeholders do not have the same information as managers do, but the company value is sub-
ject to their expectations. In the event of existing proprietary costs (i. e. costs broadly related 
to disclosure) and withheld information, they cannot know if the information withheld in-
cludes favorable or unfavorable information. For this reason they cannot correctly infer if the 
firm’s TBL performance is overstated or not. Moreover, managers have to find a trade-off be-
tween the benefits and costs of voluntary disclosures in TBL reports. With increasing proprie-
tary costs, they have increasing incentives to withhold unfavorable information as they can 
increasingly hope that the withheld information is interpreted favorably by stakeholders. It 
can be derived that the level of voluntary disclosures is negatively related to proprietary costs 
and positively associated to the favorableness of news.
83
 
In subchapter 4.1 the line of reasoning of voluntary disclosure theory is detailed for firms with 
little as well as substantial unfavorable information. This work is an attempt to advance the 
understanding of why firms adopt a certain level of voluntary disclosures. By determining the 
factors that drive voluntary disclosures the arguments of both theories discussed above can be 
contrasted. It will be argued in subchapter 4.1 that both theories refer to cognitive legitimacy 
in the case of poor performers and only have a limited potential to add to the credibility, 
transparency and value of voluntary disclosures. The aim of this work is to inform the norma-
tive and empirical literature on legitimacy by developing theory that helps to explain and pre-
dict voluntary disclosures in corporate TBL reports. In the final chapter of this work it will be 
argued that both arguments are not necessarily contradictory but rather can complement each 
other.  
Next, the studies available in environmental management and accounting as well as interna-
tional auditing are discussed that have examined the boundaries set and assurance adopted for 
TBL reporting. 
  
                                                 
82  Cf. AKERLOF, G. A. (1970), pp. 488ff; CLARKSON, P. M. et al. (2008), pp. 308f. 
83  Cf. DYE, R. A. (1985), pp. 124ff; VERRECCHIA, R. E. (1983), pp. 181ff. 
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2.2.3 Supporting Research on Voluntary Disclosures 
Within this publication, the terminologies “TBL reporting” and in some cases also “TBL per-
formance” are used to refer to the corporate reporting or performance with respect to the eco-
nomic, environmental and social dimensions of the corporate responsibilities. TBL reporting 
includes measuring and disclosing the economic, environmental and social dimensions of the 
corporate responsibilities in order to be accountable to corporate stakeholders towards the aim 
of sustainable development.
 84
 Such reports often inappropriately are labeled as sustainability 
reports to suggest “true” sustainability although they represent merely a picture of the sustain-
able development dimensions.
85
 Over the past decades, TBL reporting increased steadily, es-
pecially in large and environmentally sensitive industries. There exists substantial research on 
the legitimacy of TBL reporting. Many scholars examined the effect of public perceptions and 
pressure on voluntary disclosures, for instance due to media attention, criticism, regulation or 
disasters and other events.
86
 Others focused on corporate and industry specific characteristics 
such as profits, size, industry, country, ownership status
87
 A number of researchers explored 
the strategies of gaining, maintaining and repairing legitimacy.
 88
 The extents and trends of 
TBL reporting, including underlying motivations and factors, have been analyzed by using 
various methods, such as surveys
89
, content analyses
90
 or combinations of case studies and 
content analyses
91
. Initially the legitimacy hypothesis was rejected
92
, in later research support 
for the type and motivation of disclosures was found
93
. In particular, support was found for 
annual report environmental disclosures
94
, management support
95
, large companies, compa-
nies exposed to pressure and environmental sensitive companies
96
 or societal/ media expecta-
tions
97
. Hence, the legitimacy of voluntary disclosures in general has been widely discussed, 
whereas the boundary-setting and external assurance of TBL reports up to now have obtained 
limited attention in academic literature, although they are useful to get an idea of the reach of 
Voluntary disclosures. 
The reporting boundary should include the upstream and downstream value chain entities 
with significant actual and potential sustainability impacts and/ or those over which the corpo-
ration exercises significant financial or operational control or influence.
98
 While it is central to 
                                                 
84  Cf. GLOBAL REPORTING INITIATIVE (2006), p. 3. 
85  Cf. O'DWYER, B.; OWEN, D. L. (2005), p. 215; 
86  Cf. for instance PATTEN, D. M. (1991), pp. 297ff; PATTEN, D. M. (2002a), pp. 152ff; DEEGAN, C. (2000), pp. 101ff; 
DEEGAN, C. (2002a), pp. 312ff; CHO, C. H. (2009), pp. 33ff. 
87  Cf. ADAMS, C. A.; HILL, W. Y.; ROBERTS, C. B. (1998), pp. 1ff; CORMIER, D. (2001), pp. 587ff; CAMPBELL, D. 
(2003a), pp. 357ff. 
88  Cf. O’DONOVAN, G. (2002), pp. 344ff; OGDEN, S.; CLARKE, J. (2005), pp. 313ff; AERTS, W.; CORMIER, D.; 
MAGNAN, M. (2006), pp. 299ff. 
89  Cf. CLARKE, J. (1999), pp. 5ff. 
90  Cf. AHMAD, N. N. N. (2004), pp. 44ff.; DE VILLIERS, C.; VAN STADEN, C. J. (2006), pp. 763ff; AERTS, W.; 
CORMIER, D. (2009), pp. 1ff. 
91  Cf. GUTHRIE, J. (1989), pp. 342ff; CAMPBELL, D. J. (2000), pp. 80ff; DEEGAN, C. (2002a), pp. 312ff; CAMPBELL, 
D. (2003a), pp. 357ff; CAMPBELL, D. (2003b), pp. 558ff. 
92  Cf. GUTHRIE, J. (1989), pp. 342ff. 
93  Cf. CAMPBELL, D. (2003b), pp. 558ff; AHMAD, N. N. N. (2004), pp. 44ff; TILLING, M. V. (2010), pp. 55ff. 
94  Cf. AERTS, W.; CORMIER, D. (2009), pp. 1ff. 
95  Cf. CAMPBELL, D. J. (2000), pp. 80ff. 
96  Cf. CLARKE, J. (1999), pp. 5ff; CAMPBELL, D. (2003a), pp. 357ff; CAMPBELL, D. (2003b), pp. 558ff. 
97  Cf. DEEGAN, C. (2002a), pp. 312ff; DE VILLIERS, C.; VAN STADEN, C. J. (2006), pp. 763ff. 
98  Cf. GLOBAL REPORTING INITIATIVE (2005), pp. 4f; GLOBAL REPORTING INITIATIVE (2006), p. 17. 
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determine the extent and type of TBL reporting
99
, the author was aware of only study directly 
associated to boundary-setting. ARCHEL, P. (2008) examined the relationship between 
boundary setting and organizational accountability to discuss if organizations chose sufficient 
organizational and operational boundaries. Moreover, they analyzed if direct impacts were 
misleadingly reported as indirect impacts. 57 reports which were “in accordance” with the 
GRI guidelines 2002
100
 were analyzed up to 2005 using content analysis. Organizational and 
operational boundaries were distinguished. Organizational boundaries included scope 1 enti-
ties based on financial control and were operationalized through reporting boundaries, bound-
ary limitations, basis for reporting on entities which are not 100 % owned, description of enti-
ties which are not 100 % owned, description of major products and services and the extent of 
outsourcing. Operational boundaries encompass organizational boundaries, but in addition al-
so scope 2 and scope 3 entities and were operationalized by additional performance indicators 
derived from GRI
101
. The results show that the organizations, although they were among the 
best TBL reporters, did not define and disclose on broad boundaries and that their mean 
boundary values were quite low. They could also show that especially core performance indi-
cators were misleadingly reported as indirect impacts. They concluded that the firms used 
boundary-setting strategically to conceal non-disclosure and dismiss their indirect impacts.
102
 
Interestingly, VELEVA, V. et al. (2003) examined the use of sustainability indicators in volun-
tary environmental disclosures to shed light into the state of the art of developing more sus-
tainable production systems. They differentiated the indicators into the following five levels 
which indirectly also indicated the boundary of reporting: company compliance/ conformance 
indicators, company material use and performance indicators, company effect indicators, sup-
ply chain and product life-cycle indicators and sustainable systems indicators. The sample in-
cluded six companies from the pharmaceuticals industry, of which three were GRI pilots 
(American Home Products, Astra-Zeneca, Bristol-Myers Squibb) and three non-pilot compa-
nies (Novartis, Pfizer, Roche Holding). Except for American Home Products the sample com-
panies are included as well in this work. The results suggest that most indicators addressed 
performance or eco-efficiency, a few indicators considered environmental effects and only the 
GRI pilots were beginning to address and report on supply-chain and product life-cycle ef-
fects, whereas no company was addressing sustainable systems indicators.
103
 
An external assurance engagement is a central means to give credibility to effective TBL re-
porting and aims at evaluating and concluding on the nature, extent and quality of information 
disclosed on a subject matter against certain criteria to increase confidence.
104
 However, the 
terminologies “audit”, “verification” and “validation” often are used interchangeably although 
they have different meanings.
105
 For reasons of consistency, the terminologies “assurance” (to 
refer to this kind of engagement), “assurance statements” (to describe the statements exam-
ined) and “assurance provider” or “assurors” (to refer to the preparers of such statements) are 
used within this publication. Over the past decade, the number of companies that voluntarily 
                                                 
99  Cf. ARCHEL, P. (2008), pp. 107f. 
100  Cf. GLOBAL REPORTING INITIATIVE (2002), pp. 1ff. 
101  Cf. GLOBAL REPORTING INITIATIVE (2002), pp. 1ff. 
102  Cf. ARCHEL, P. (2008), pp. 106ff. 
103  Cf. VELEVA, V. et al. (2003), pp. 107ff. 
104  Cf. ACCOUNTABILITY (2008), pp. 6 & 8. 
105  Cf. O'DWYER, B.; OWEN, D. L. (2005), p. 206. 
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include a third-party statement in their TBL reports has increased significantly. In 1999, 19 % 
of the Fortune Global 250 companies which issued a TBL report enclosed such a statement, 
while in 2008 this was the case for 40 %.
106
 In particular the pharmaceuticals industry was 
with 50 % assurance among the five leading industries in the Fortune Global 250 index (see 
table 1Table 1).
107
 
Table 1: Share of the reporting companies adopting external assurance 
 2002 2008 
Mining 50 % 100 % 
Utilities 25 % 75 % 
Oil & gas 42 % 59 % 
Pharmaceuticals 43 % (2nd) 50 % (4th) 
Chemicals & synthetics 33 % 50 % 
(Source: KPMG GLOBAL SUSTAINABILITY SERVICES (2002), p. 19; KPMG SUSTAINABILITY SERVICES (2008), p. 59.) 
A number of descriptive analyses and a few regression analyses on the legitimacy of assur-
ance statements already exist. In general, the authors focused on the level and extent of such 
statements as well as the nature of the assurance provider. 
BALL, A.; OWEN, D. L.; GRAY, R. (2000) content analyzed the assurance statements of 79 
leading environmental reporters which were awarded by the Association of Chartered Certi-
fied Accountants (ACCA) for the years 1992 to 2008. They found that half of the assurance 
providers lacked independence from the reporting company. While only some assurance 
statements included environmental performance and reporting quality, the main focus was ra-
ther on environmental management. The authors concluded that assurance was used as a man-
agerial tool and that management exerted substantive control over the assurance process. 
Thus, assurance did merely improve the value to stakeholders by enhancing transparency and 
accountability.
108
 
As part of her dissertation KAMP-ROELAND, N. (2002) examined the content of assurance 
statement accompanying environmental reports and developed an assurance framework for 
environmental reports. To this purpose, she content analyzed the assurance statements which 
accompanied European environmental reports in 1994 and 1995. She found significant incon-
sistencies concerning the subject matter, assurance scope, objectives and criteria, level of as-
surance, assurance procedures and wording of assurance opinions.
109
 
O'DWYER, B.; OWEN, DAVID L. (2005) advanced the work by BALL, A.; OWEN, D. L.; 
GRAY, R. (2000) and investigated the extent to which the accountability and transparency of 
TBL reports can be enhanced by report assurance. Basing on guidelines developed by Ac-
countAbility
110
, the Federation of European Accountants - Fédération des Experts Comptables 
                                                 
106  Cf. KPMG GLOBAL SUSTAINABILITY SERVICES (2002), p. 18; KPMG SUSTAINABILITY SERVICES (2008), 
p. 56. 
107  Cf. KPMG GLOBAL SUSTAINABILITY SERVICES (2002), p. 19; KPMG SUSTAINABILITY SERVICES (2008), 
p. 59. 
108  Cf. BALL, A.; OWEN, D. L.; GRAY, R. (2000), pp. 1ff. 
109  Cf. ACCOUNTABILITY (1999), pp. 1ff. 
110  Cf. ACCOUNTABILITY (1999), pp. 1ff; ACCOUNTABILITY (2003), pp. 1ff. 
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Européens (FEE)
111
 and the GRI
112
 the authors developed an evaluating framework to shed 
light into the nature of the assurance provider and the assurance process, the undertaken work 
and its scope, the use of assurance principles, criteria or standards and finally the form of 
opinions stated. For this purpose, they content analyzed 41 reports of assumingly best-practice 
companies which were shortlisted for the ACCA Sustainability Reporting Awards in 2002. In 
line with BALL, A.; OWEN, D. L.; GRAY, R. (2000) the authors especially questioned the 
independence of assurance because only in less than half of the assurance statements disclo-
sures were made on the public relationship of assurance providers. The authors moreover 
concluded that the assurance process was controlled strongly by management and that stake-
holder neither participated in the process nor did their constituencies were addressed in the as-
surance statements. Second, definitions, methodologies and contents varied among the com-
panies due to the absence of a generally accepted standard. Moreover, they found that con-
sultant and accountant assurors had different assurance approaches. Accountants on the one 
hand only gave cautious, low-level assurance. Consultants on the other hand were more likely 
to evaluate TBL reports and provide higher levels of assurance, but were more exposed to 
concerns of independency criticism. Thus, the authors showed that assurance by itself not 
necessarily increases accountability and transparency of TBL reports.
113
 
In DEEGAN, C. (2006a) and DEEGAN, C. (2006b) TBL report assurance statements were 
examined to see if the key elements suggested by GRI
114
 and FEE
115
 were complied with. 
They constructed a database to include 170 European (including UK) respectively 
33 Australian corporate TBL reports with external assurance statements for the years 2000 to 
2003. The assurance statements were content analyzed for the categories assurance provider, 
assurance title, addressee, responsibilities, objectives, coverage, criteria, procedures (includ-
ing nature, timing and extent), standards, use of experts, restrictions, wording of conclusion, 
praise and recommendations by the assurance provider. In both papers, the authors concluded 
consistent with KAMP-ROELAND, N. (2002) that the content of assurance statements was 
substantially variable and ambiguous. Moreover, they questioned the added value of assur-
ance statements to TBL reporting as the assurance process, the review and the conclusions 
drawn were not transparent to readers. They called for clear guidance and regulation.
116
 
The influence of country (e. g. legal environment) and industry specific factors on the adop-
tion of report assurance was analyzed by a number of researchers; some of them will be pre-
sented in detail below.
117
 
MOCK, T. J. (2007) used multivariate statistics to analyze the assurance statements of TBL 
reports issued between 2002 and 2004 by 130 international companies to identify the relation-
ships between the four big accountants and the characteristics of assurance statements. Their 
intention was to examine the assurance levels and interrelation of some assurance statements 
                                                 
111  Cf. FÉDÉRATION DES EXPERTS COMPTABLES EUROPÉENS (2002), pp. 1ff. 
112  Cf. GLOBAL REPORTING INITIATIVE (2002), pp. 1ff. 
113  Cf. O'DWYER, B.; OWEN, D. L. (2005), pp. 205ff. 
114  Cf. GLOBAL REPORTING INITIATIVE (2002), pp. 1ff. 
115  Cf. FÉDÉRATION DES EXPERTS COMPTABLES EUROPÉENS (2002), pp. 1ff. 
116  Cf. DEEGAN, C. (2006a), pp. 2ff; DEEGAN, C. (2006b), pp. 329ff. 
117  Cf. DURNEV, A. (2005), pp. 1461ff; CHOI, J. H. (2007), pp. 13ff; MOCK, T. J. (2007), pp. 67ff; PEREGO, P. (2009), 
pp. 412ff; KOLK, A. (2010), pp. 182ff. 
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characteristics. Moreover, they investigated how country and industry specific as well as other 
factors affect the characteristics. Bivariate associations were investigated between the de-
pendent variable, assurance provider, and the independent variables positive assurance, sus-
tainability dimensions, assertions, symbols used, restricted usage, recommendation, proce-
dures used and frameworks used. They found that positive assurance, symbols used, recom-
mendations as well as frameworks used are significant predictors of the four big accountants. 
Moreover, they identified different characteristics which affect the level of assurance and are 
significantly associated with the assurance provider. The authors concluded that the four big 
accountants had a higher level of TBL accounting expertise in comparison with other types of 
assurance providers such as consultants but failed to contrast the results of accountants to 
such of consultants.
118
 
PEREGO, P. (2009) refined the work by MOCK, T. J. (2007) by applying the framework 
elaborated by O'DWYER, B.; OWEN, DAVID L. (2005) to examine the relationship between 
assurance providers and the extent of assurance statements. He intended to find causes and 
consequences of choosing different assurance providers. For this purpose, he content analyzed 
69 assurance statements that were available within a sample of 136 companies short-listed for 
the ACCA Sustainability Reporting Award in 2005. In a second step, he applied ordered probit 
regression to measure the assurance quality for the categories assurance procedures, reporting 
format and recommendations/ opinions. Results suggest that companies are more likely to 
choose a big accountant for assurance in countries that have a weaker legal systems. The four 
big accountants positively affect the assurance quality in the categories of assurance proce-
dures and reporting format, while for non-accountants a positive relation was found concern-
ing the quality of recommendations/ opinions.
119
 
Most recently, KOLK, A. (2010) examined which country and industry specific factors are as-
sociated with the voluntary assurance of TBL reports. To this end, they a applied pooled lo-
gistic regression analysis to a sample of 212 companies which were listed in the Fortune 
Global 250 in the years 1999, 2002 and 2005. The following variables were regressed on the 
dependent variable, assurance statement: the independent variables legal origin, enforcement 
and responsibility index as well as some control variables (firm size, capital intensity, some 
environmentally sensitive industries) and additional variables (sustainability report, account-
ant, litigation). They concluded that companies are more likely to include assurance state-
ments in countries were stakeholder orientation is stronger, government enforcement is weak-
er and sustainable practices are better established by institutional and market mechanisms. In 
addition, they found that the four big accountants are more likely to be contracted in countries 
with a lower level of litigation and a higher shareholder orientation.
120
 
Other studies conducted interviews or experiments to explore drivers and hurdles to assurance 
of TBL reports.  
JONES, M. J.; SOLOMON, JILL F. (2010) explored the perception of the necessity for assur-
ance to build credibility and trust through semi-structured interviews with managers from 20 
                                                 
118  Cf. MOCK, T. J. (2007), pp. 67ff. 
119  Cf. PEREGO, P. (2009), pp. 412ff. 
120  Cf. KOLK, A. (2010), pp. 182ff. 
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UK companies in 2004. They obtained mixed results as 50 % of the managers answered in fa-
vor of assurance necessity to build credibility and trust while the others solely relied on inter-
nal assurance as a managerial tool. Costs in terms of time and money, insufficient develop-
ment of TBL reporting, the assurance complexity, assurance roots from financial auditing and 
the questioned independence of assurance providers were the main hurdles identified.
121
 
KURUPPU, S.; MILNE, MARKUS J. (2010) performed hypothetical experiments and a sur-
vey among students to examine if the presence of assurance statements affects the stakeholder 
relationships of firms. Results were very mixed, thus it could not be shown or neglected that 
assurance increases the credibility of TBL reporting.
122
 
In summary, the existing studies expressed substantial criticism with respect to the legitimacy 
of voluntary disclosures. In some instances different results were obtained, which may be due 
to different research designs, including for instance different sample industries and countries. 
This work builds on this preliminary literature and aims at contributing to theory by perform-
ing a detailed case study to develop the model of the legitimacy of voluntary disclosures. 
Moreover, this works connects the empirical results to the theories on voluntary disclosures, 
legitimacy theory and voluntary disclosure theory. Before presenting the research design of 
this work, the following section serves to identify the industry-specific factors of the sample 
corporations considered. 
  
                                                 
121  Cf. JONES, M. J.; SOLOMON, J. F. (2010), pp. 20ff. 
122  Cf. KURUPPU, S.; MILNE, M. J. (2010), pp. 1ff. 
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3 Industry Context: Red Biotechnologies 
This work examines the legitimation efforts of the main global pharmaceutical corporations 
which include a red biotechnology business segment. On this account, this section gives an 
overview of the red biotechnology industry and its strengths, weaknesses, threats and oppor-
tunities are presented. Biotechnology is an umbrella term for a great variety of products and 
processes and is broadly defined as the  
“application of science and technology to living organisms, as well as parts, products and 
models thereof, to alter living or non-living materials for the production of knowledge, 
goods and services”.
123
 
To distinguish the variety of different technologies which are referred to collectively as bio-
technologies, the following fields of application were introduced: 
 red biotechnologies refer to the area of medicine,  
 white biotechnologies cover industrial applications and  
 green biotechnologies include agricultural biotechnologies.124 
While red and white biotechnologies are broadly supported, green biotechnologies especially 
in Europe face strong criticism.
125
 
Despite the general economic downturn of the global economy in 2009, the global biotech-
nology market grew by 4 % and reached a value of about 200 billion USD. The market seg-
mentation by type and market value is presented in table 2. As red biotechnologies represent 
the major share of the market, the focus of this work will be on this field of application. The 
world’s leading red biotechnology corporations include Merck KGaA, Novartis AG, Pfizer 
Inc. and AstraZeneca PLC. 
Table 2: Market segmentation by type and market value 
 Share (in %) 
Medical/ Healthcare 66.2% 
Service provider 13.9% 
Food & Agriculture 11.5% 
Environment & Industrial processing 4.2% 
Technology service 4.1% 
Total 100 % 
(Source: DATAMONITOR (2010e), p. 10.) 
The market segmentation by region and market value is given in table 3. While the rapid mar-
ket growth should adhere new players into the market, competition from new entrants is con-
sidered as moderate as the players typically are small and medium companies.
126
 
                                                 
123  ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT (2005), p. 9. 
124  Cf. EUROPEAN COMMISSION (2006), p. 3. 
125  Cf. EUROPEAN COMMISSION (2006), p. 3. 
126  Cf. DATAMONITOR (2010e), pp. 7ff. 
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Table 3: Market segmentation by region and market value 
 Share (in %) 
Americas 48.4 % 
Asia-Pacific 26.4 % 
Europe 25.2 % 
Total 100 % 
(Source: DATAMONITOR (2010e), p. 11.) 
The following SWOT analysis helps to understand the strengths, weaknesses, opportunities 
and threats of the red biotechnology industry, whereby strengths and weaknesses are derived 
from a company analysis and opportunities and threats from an analysis of the industry’s envi-
ronment.
127
 Table 12 in the annex demonstrates firm-level strengths and opportunities as well 
as weaknesses and threats which were derived from Datamonitor.
128
 Building on this infor-
mation, a proper content analysis of the risk factors identified in the latest available 10k or 
20F annual reports is performed. The results of both are summarized in the industry-level 
SWOT analysis in table 4 below.  
Table 4: Industry-level SWOT analysis 
Aspects Strength Weakness Opportunity Threat 
Product portfolio x x   
Competition    x 
Value chain dependence x x   
Investment & analysis x   x 
Product development x x    
Human resources x x   
Product control    x 
Legislation & regulation   x x 
Litigations & investigations    x 
Customer acceptance   x x 
Reputation    x 
(Derived from: DATAMONITOR (2010a), DATAMONITOR (2010b), DATAMONITOR (2010c), DATAMONITOR (2010d), 
DATAMONITOR (2010f), DATAMONITOR (2010g), DATAMONITOR (2010i), p. 5ff. and proper content analysis of corpo-
rate economic and TBL reports.) 
Typically, the red biotechnology corporations have a broad product portfolio and strong mar-
ket position in at least one market segment. Moreover, they avail themselves substantially of 
the options of outsourcing, restructuring as well as mergers and acquisitions (M&A). While 
this strengthens the operating profit margins, there are also risks of overdependence on key 
products (e. g. specialty pharmaceuticals, vaccines) or key customers. M&A contain the pos-
sibility to strengthen diversification, but overstated diversification can lead to a higher risk or 
reduced strategic and financial flexibility. There is also a tradeoff towards research and devel-
opment (R&D) as innovation may be diluted. Besides, competition from other segments, e. g. 
biosimilars, generics, low-cost remedies or counterfeits, poses additional threats. Due to out-
                                                 
127  Cf. KLEMPIEN, D. (2011), w/o p. 
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sourcing and restructuring, the industry is characterized by a strong dependence on its value 
chain. While this may strengthen the financial position, the reliance on third parties increases 
weaknesses in terms of supply interruptions and delays as well as the management of quality, 
safety or environment. The financial position of the corporations can be strengthened by the 
cost reducing potentials of outsourcing and restructuring. Although the 2009 growth rate was 
about 4 %
129
, the majority of the corporations considered potential threats from the global 
economic downturn. Financial obligations can result from extensive M&A investments, pen-
sion liabilities as well as interest and exchange rates.  
The industry is also strong in product development, including R&D and patenting. Both are 
essential to guarantee a strong R&D pipeline and market exclusivity. But due to fast changing, 
incremental technological changes
130
 and the possible overdependence of the revenue from 
patented products, the corporations hold also the risks of R&D pipeline attritions or failures, 
costs for research studies and clinical trials as well as losses of patent exclusivity. Besides, the 
approval of generics or other low-cost remedies pose threats as well. Resulting from the high 
level of R&D, the employee’s expertise is of importance to the red biotechnology corpora-
tions. They tend to improve their knowledge stocks through M&A or clustering
131
.  
The industry faces strong threats from product control by government and purchasers, for in-
stance in terms of prices, safety and efficacy or marketing and sales practices. Besides, gov-
ernments can refuse the approval of new products. The past decades have also seen substantial 
tightening with respect to the legislation and regulation of taxation, healthcare, competition, 
accounting rules and trade restrictions. For instance, the industry continuingly gets govern-
mental subsidies and grants
132
, but they increasingly face demands that high-cost products are 
replaced by generics and low-cost remedies. Other threats are perceived resulting from the 
expiry or infringement of patents and other intellectual property, liability and compliance 
costs as well as antitrust litigation. 
Customers can consider red biotechnology products as innovative solutions to address the 
challenges of society or be seriously concerned about the side effects of such solutions on sus-
tainable development, e. g. through increased contamination, hazardous materials, genetic 
modification or animal testing. Reputation can be threatened, for instance, if critical health, 
safety & environment (HSE) issues reduce the general public acceptance
133
. Figure 6 presents 
the above aspects from right to left in decreasing order of occurrence in the annual reports of 
the analyzed corporations to get an idea of which factors they considered as especially risky.  
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131  Cf. MCCANN, B. T.; FOLTA, T. B. (2011), pp. 107ff. 
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Figure 4: Risk factors in the pharmaceuticals industry 
(Own illustration.) 
It can be stated that in particular aspects are mentioned that can be controlled by the corpora-
tion, such as product portfolio or development, or by the government and regulators, i. e. leg-
islation and regulation, product control and litigations and investigations. Customer disap-
proval, scarcity of human resources and reputation risks are stated to a much lesser extent. 
Hence, in contrast to its green counterpart, the red biotechnology industry perceives less soci-
etal controversies and moral debates although they as well have substantial impacts on all the 
dimensions of sustainable development. The main pressures are perceived from the legislatory 
and regulatory, financial as well as competitive environment. 
The results of the above SWOT analysis will be related to the results for guidance, boundary 
setting and assurance to get an idea of the drivers and barriers of TBL reporting. Before turn-
ing to the analysis of results the following section specifies the research design of this work. 
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4 Research Design 
Within this section the research interest (subchapter 4.1) and research methods (subchap-
ter 4.2) are described. First, the motivations, aim and purpose for this work are derived from 
preliminary literature. Subchapter 4.1 continues by contrasting the predictions of legitimacy 
theory and voluntary disclosure theory for voluntary disclosures to develop the research ques-
tions and present the preliminary model of the legitimacy of TBL reporting. In subchapter 4.2 
the proceeding of this work is specified by describing the sampling method, the data collec-
tion process and the data analysis methods. 
4.1 Research Interest 
This work is guided by the normative discussion how corporations can become democratical-
ly accountable to their stakeholders to gain legitimacy for the political role they are taking in a 
global community. It was concluded in subchapter 2.1 that a “sustainable business” is charac-
terized by acting as a good corporate citizen who does business by taking economic, social 
and environmental responsibilities guided by legal, moral and political requirements in order 
to ensure the long-term survival of the community and corporations. When following the ar-
gument that corporations are political actors, a legitimation gap becomes evident, both in 
terms of democratic accountability and the growing demands of commitments to sustainable 
development. As discussed, corporations can become legitimized by the way they behave in 
the usual course of business (to obtain within-game legitimacy) as well as in the new govern-
ance processes (ordo-legitimacy).
134
 The focus of this work is limited to the first type. Corpo-
rations can get for instance within-game legitimacy by means of transparent reporting and au-
diting.
135
 This can, inter alia, be achieved by applying guidance, setting reporting boundaries 
and adopting external assurance for corporate reports. Hence, the purpose of this work is to 
examine if voluntary disclosures on guidance, boundary-setting and external assurance can 
add to the credibility of corporate TBL reporting. If so, reporting might make corporations 
democratically accountable to their stakeholders and bring within-game legitimacy for taking 
the political role discussed above. Moreover, this works aims at refining the model that ex-
plains the level and extent of voluntary disclosures in TBL reports by identifying underlying 
country and industry specific factors which drive reporting.  
In contrast to these theoretical considerations, there is skepticism on the corporate legitimacy 
as firms exaggerate their behavior in their voluntary disclosures and thus merely add account-
ability or credibility to TBL reporting.
136
 Moreover, due to challenges to build a report which 
truly reflects all the relevant impacts and to substantial inconsistencies in the verification ap-
proach, the value of reporting is questioned.
137
 Hence, there are increasing calls for accounta-
bility by improving the comparability and verifiability of reporting.
138
  
As subchapter 2.2.3 suggests, the legitimacy of voluntary disclosures in TBL reports in gen-
eral has been widely discussed, whereas boundary-setting and external assurance up to now 
                                                 
134  Cf. CRANE, A.; MATTEN, D. (2010), pp. 70ff; SCHERER, A. G.; PALAZZO, G. (2007), pp. 1108f. 
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p. 39. 
138  Cf. KOLK, A. (1999), p. 235; KOLK, A.; WALHAIN, S.; VAN, D. W. (2001), p. 27; KOLK, A. (2008), pp. 1f. 
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have obtained limited attention in academic literature although they are useful to get an idea 
of the reach of voluntary disclosures. TBL reporting includes measuring and disclosing on the 
economic, environmental and social dimensions of the corporate responsibilities to be ac-
countable to the corporate stakeholders towards the aim of sustainable development.
139
 Over 
the past decades TBL reporting increased steadily, especially in large and environmentally 
sensitive industries. Mandatory annual reports are assured together with the financial report 
information which added much to the credibility of financial reporting.
140
 TBL reporting, 
however, remains underdeveloped with substantial differences in reporting formats, typology 
and metrics of performance indicators due to its voluntary nature.
141
 Yet, over the past decade, 
a tendency towards standardization increased in terms of reporting and assurance standards as 
well as certifications of programs or products to guide standardization. Within this publica-
tion, the terminology “guidance” is used to refer to these three standardization approaches. 
TBL reporting standards serve for balanced and reasonable reporting on TBL performance, 
including positive and negative incidences.
142
 TBL assurance standards provide a means to 
evaluate and hold corporations to account for their management, reporting and performance of 
TBL issues.
143
 The application and certification of international standards help to reduce risks, 
facilitate assurance and improve corporate management systems, such as International Organ-
ization for Standardization (ISO) 9000 series for quality management, Eco-Management and 
Audit Scheme (EMAS) or ISO 14000 series for environmental management as well as Occu-
pational Health and Safety Assessment Series (OHSAS) 18001.
144
 
TBL reporting standards contain standardizations for the operational boundaries of TBL re-
porting.
145
 The reporting boundary should include the upstream and downstream value chain 
entities with significant actual and potential sustainability impacts and/ or those over which 
the corporation exercises significant financial or operational control or influence.
146
 Opera-
tional boundaries are central to determine the extent and type of reporting and empirical stud-
ies show that entities generally are not included with respect to their significance in terms of 
control/ influence and impacts.
147
 This work aims at considering the reporting section where 
the corporations explain which entities are included with respect to the decision tree in terms 
of control/ influence and impacts. The approach differs from the prior study which analyzed 
the boundaries in terms of the output, measured by performance indicators.
148
 Building on 
both approaches, an interesting future development would be to empirically examine the rela-
tion of boundary-setting and TBL performance over the value chain. 
TBL reporting and assurance standards provide detailed frameworks for third-party assurance 
of TBL reports. Assurance is considered as a central means to respond to demands from man-
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141  Cf. JENKINS, H. (2006), p. 274. 
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143  Cf. ACCOUNTABILITY (2008), p. 6. 
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agement and stakeholders for reliable and credible information, managing threats to sustaina-
ble development and demonstrate consistency, quality and credibility of TBL reporting.
149
 
As outlined in subchapter 2.2.3, a number of detailed descriptive studies already exist on the 
nature and purpose of the assurance process as well as the qualifications of assurance provid-
ers, whereas only two studies were identified with respect to boundary-setting. As to external 
assurance, some researchers also performed regressions to factors that influence the scope of 
engagement. However, except for KOLK, A. (2010) these empirical works were not connect-
ing the empirical results properly to theory. For this reason, this work takes a case study ap-
proach to investigate the credibility of TBL reporting by contrasting the two competing pre-
dictions from legitimacy theory and voluntary disclosure theory on voluntary disclosures on 
the guidance applied, boundaries set and assurance adopted. Table 5 summarizes the argumen-
tations of legitimacy theory and voluntary disclosure theory which will be detailed below. 
Table 5: Comparison of legitimacy theory and voluntary disclosure theory 
 Legitimacy theory Voluntary disclosure theory 
Assumption 
Firms with low public 
pressure 
Firms with high public 
pressure 
Adverse selection Secrecy 
Legitimation strategy 
Gain/ maintain public 
acceptance 
Repair public ac-
ceptance 
Maintain/ improve 
public awareness 
Maintain public 
awareness 
Legitimation strategy 
Increase hard & soft 
disclosures 
Increase soft disclo-
sures 
Increase disclosure 
level 
Maintain/ reduce dis-
closure level 
Legitimation approach Moral legitimacy Cognitive legitimacy Cognitive legitimacy Cognitive legitimacy 
Disclosure  
strategy 
Legitimation strategy Managerial & commercial strategy 
Acquiesce/ compli-
ance or compromise 
Conceal and dismiss 
Acquiesce/ compli-
ance or compromise 
Conceal and dismiss 
Credibility Possible Limited Possible Limited 
(Own illustration.) 
Legitimacy theory suggests that firms have incentives to disclose information voluntarily to 
increase public acceptance.
150
 On the one hand, firms whose legitimacy is not threatened by 
public pressure may have an interest to gain or maintain public acceptance by using voluntary 
disclosures truthfully as legitimation tool. They include, hard disclosures, i. e. manifest fig-
ures which are difficult to mimic by competitors, and soft disclosures, i. e. in particular narra-
tive information which is easy to mimic.
151
 Such disclosures are made to acquiesce or comply 
with stakeholder demands
152
 and add to the value of voluntary disclosures by increasing pub-
lic acceptance, thereby enhancing its transparency, accountability, credibility and moral legit-
imacy
153
. Firms whose legitimacy is threatened by high public pressure, on the other hand, 
might feel the need to repair the public perception by pretending to use voluntary disclosures 
in TBL reports as legitimation tool. They include especially soft disclosures to conceal and 
dismiss their actual firm behavior
154
 which only has limited potential to add to the credibility, 
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transparency and accountability of voluntary disclosures. Such disclosures refer to cognitive 
legitimacy and may deceive stakeholders to bring public acceptance, yet at the risk of being 
discovered at any time which eventually does more harm than good. 
Voluntary disclosure theory suggests that firms have incentives to disclose information volun-
tarily to reduce adverse selection problems.
155
 Firms which provide of mainly favorable in-
formation, i. e. the benefits outweigh the costs of disclosing unfavorable information, may 
have an interest to gain or maintain public acceptance by truthfully increasing the level of 
voluntary disclosures. They include not only favorable, but also unfavorable information as 
long as the benefits resulting from an improved corporate image and reduced resource costs 
outweigh the costs of disclosures. Such disclosures are made to acquiesce or comply with 
stakeholder demands
156
 and can add to the credibility, transparency and accountability of vol-
untary disclosures
157
. In contrast, firms which have substantial unfavorable information, i. e. 
the costs outweigh the benefits of disclosing unfavorable information, might have an interest 
to maintain public perception by improving the marketing strategy and maintaining or reduc-
ing the disclosure level in the event of unfavorable information. Hence, they only include 
some unfavorable information for which the benefits outweigh the costs of disclosures. As 
with legitimacy theory such disclosures refer to cognitive legitimacy and only have a limited 
potential to add to the credibility, transparency and accountability of voluntary disclosures. 
Apart from the general disclosure strategy, i. e. legitimation vs. managerial/ commercial strat-
egy, the most evident difference between legitimacy theory and voluntary disclosure theory is 
the focus of analysis. Voluntary disclosure theory considers the general level of disclosures, 
whereas legitimacy theory additionally aims at analyzing the extent of disclosures. The phar-
maceutical/ biotechnology industry is typically considered to have strong impacts on sustain-
able development
158
 which suggests that the industry faces strong public pressure and thus 
support the arguments of legitimacy theory. But the SWOT analysis in chapter 3 indicates that 
the sample corporations perceive only limited societal controversies compared to the green 
biotechnology industry. Moreover, the red biotechnology corporations often stay silent in pub-
lic debates
159
 and communicate the advantages of biotechnology without discussing the 
risks
160
. The latter two arguments support the secrecy strategy of voluntary disclosure theory. 
Thus, this work helps to shed light into these contrasting theoretical and empirical views.  
Basing on the above considerations the research questions for this work are as follows: 
1. Do the considered corporations increase, maintain or reduce the level of guidance ap-
plied for setting boundaries and adopting external assurance for their TBL reports? 
2. What are the firm and industry specific factors which motivate voluntary disclosures 
in terms of guidance, boundary-setting and external assurance of TBL reports? 
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3. Do the considered corporations increase the extent of guidance applied for setting 
boundaries and adopting external assurance of their TBL reports as a legitimating 
strategy to respond to stakeholder pressure, as implied by legitimacy theory?  
4. Do the considered corporations maintain or reduce the level of guidance applied for 
setting boundaries and adopting external assurance of their TBL reports as managerial 
and commercial strategy to conceal unfavorable information, as implied by voluntary 
disclosure theory? 
5. Do the voluntary disclosures add to the credibility of TBL reporting? Do they have a 
legitimating effect? 
Figure 7 illustrates a preliminary model of the legitimacy of TBL reporting which includes the 
constructs discussed above that have been derived from previous literature.  
 
Figure 5: Preliminary model of the legitimacy of TBL reporting 
(Own illustration.) 
The purpose of this work is to get a clue of whether there is a positive or negative relationship 
between these constructs. It will be examined if voluntary disclosures on guidance, boundary-
setting and external assurance are indeed adding to the credibility of corporate TBL reporting. 
If so, reporting might make corporations democratically accountable to their stakeholders and 
bring within-game legitimacy for taking the political role discussed in subchapter 2.1. 
4.2 Research Methods 
In the previous chapter the purpose and research questions have been presented. The aim is to 
refine the model that explains the legitimacy of voluntary disclosures. To develop empirically 
grounded theory and propositions for future research, an inductive case study approach is 
chosen
161
 and the research questions are derived from the theoretical considerations in chap-
ter 2
162
. For such theory-building research samples should be selected theoretically
163
 and dif-
ferent data sources and methodologies should be combined
164
. To ensure broad and deep ac-
cumulation of data, time-series data from 2000 to 2009 is collected for multiple, intra-industry 
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cases
165
 (nine global red biotechnology corporations) and from multiple sources (TBL reports, 
annual reports and relevant information on corporate websites). The research also focuses 
both on stated motivations (risk factors identified in annual reports and disclosure motivations 
identified in TBL reports) as well as observable disclosures (on TBL guidance, boundary-
setting and assurance) to increase the reliability of findings. To increase the validity and gen-
eralizability of the data rival theoretical propositions are contrasted to find out if they replicate 
in different groups of cases and over time as well as in conflicting and similar literature.
166
 In 
an explanatory, multiple case study approach the collected data is constantly and iteratively 
coded and compared to find similarities, differences and conflicts and to fit them to the cate-
gories of this work which as well increases internal validity.
167
 This iterative process includes 
within-case as well as cross-case pattern search to continuingly refine the constructs and cate-
gories as well as confirm or disconfirm proposed links between constructs.
168
 By revisiting 
the research questions and propositions by preliminary literature as well as reducing theory 
through generalization, construct valid theory can inductively be constructed.
169
 Closure can 
occur when only little marginal improvement can be obtained, i. e. the differences between 
the developed theory and collected data are small.
170
 The case study is conducted using con-
tent analysis technique which can handle large volumes of unstructured information to infer 
replicable and valid data from texts.
171
 Certain corporate disclosures are analyzed by codify-
ing information into categories which are theoretically derived. To facilitate and ascertain the 
reliability of the qualitative data analysis process the computer-assisted text analysis software 
MAXQDA 10 is used which is a powerful coding tool to systematically analyze and interpret 
texts in order to develop theories.
172
 This tool documents the complete coding process, more-
over annotations, tabular materials and narratives can easily be extracted for documentation 
and further analysis. The following sub-chapters specify the sampling method, data sources 
and data analysis methods applied. 
4.2.1 Sampling and data sources 
It is important to specify population, sample size and sampling to control for extraneous var-
iation. As recommended for theory-building, the sample of this work is theoretically derived 
to reflect multiple and polar cases to compare polar results.
173
 On this account time-series data 
is drawn for nine multiple, intra-industry cases
174
 between 2000 and 2009. The red biotech-
nology industry promises interesting insights as it is characterized by strong risk factors (see 
chapter 3) and its biggest corporations are among the most active Fortune Global 250 corpora-
tions in TBL reporting
175
. 
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In the first selection process, 16 pharmaceutical corporations are identified that included in 
2009 a red biotechnology segment according to the Carbon Disclosure Project
176
, Corporate 
Register
177
, Datamonitor
178
 and the GRI
179
 (see table 13 in the Annex). Then the corporations 
are sorted by the number of TBL reports available for 2000 to 2009 and applying the GRI 
standards
180
 (see also table 13 in the Annex). By this number they are grouped in categories. 
Within every group the three corporations with the highest industry profits according to 
Forbes Magazine
181
 are selected for the sample (see table 6 below).  
In this work only TBL reports are considered from corporations which were willing to align 
their TBL reporting to the GRI reporting standards. To reduce such limitations or distortions, 
only the biggest red biotechnology corporations are considered. In this way, size effects can 
be controlled for. A bias remains towards GRI reporters, yet such “best” reporting practice is 
useful to confirm whether the use of TBL reporting guidance is helpful for preparing volun-
tary disclosures. Further variations from environmental effects are reduced by referring only 
to corporations within one industry. As the considered corporations do business on a global 
level, no control for regional effects is taken into account. 
Table 6: Sampling 
                                     Control for size 
Number of  
available GRI reports 
Highest industry profits  
(basis for sample) 
Lowest industry profits  
(not included in sample) 
High (8 to 10 TBL reports applying the 
GRI standards) 
Baxter 
Novozymes 
GlaxoSmithKline 
 
Medium (4 to 7 TBL reports applying 
the GRI standards) 
Novartis International AG 
Bristol-MyersSquibb 
Sanofi-Aventis Group 
Straumann 
Wyeth 
Esteve 
Low (1 to 3 TBL reports applying the 
GRI standards) 
AstraZeneca 
Roche Holding Ltd. 
Pfizer Inc. 
Millipore Corporation 
Coloplast 
Merck KGaA 
CSL Limited 
(Own illustration.) 
For reasons of comparability only group level reports are considered. To ensure broad and 
deep accumulation of data, data is collected from multiple sources.
182
 Voluntary disclosures 
on TBL guidance, boundary-setting and assurance are derived from the respective sections in 
integrated reports which include disclosures on the economic (financial), ecologic and social 
dimensions of business, separate TBL reports and equivalent disclosures on corporate web-
sites (generally only available for 2009, but not for previous years). Besides, the annual re-
ports are considered for disclosures on economic guidance, boundary-setting and assurance. 
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Publications by KPMG
183
 and Datamonitor
184
 are taken into account for the determination of 
motivations and underlying factors. Table 14 in the Annex gives an overview of the reports 
that are available for analysis. Moreover it details the report types and explains decisions 
made for excluding some reports from analysis. 
Three corporations prepare integrated reports throughout the reporting period, a fourth corpo-
rations shifted to integrated reporting within the second half of the considered time period. 
Except for one of those corporations in addition separate TBL reports were published for 
some years. The TBL reports were labeled inconsistently, ranging from Corporate (Social) 
Responsibility Report, Environment, (Health) and Safety Report to Sustainability Report, 
Sustainability Website Contents or GRI Report. In general, the reporting period covers the 
calendar year. In some instances, a longer reporting period, covering several years, is chosen. 
Is this the case, then the reports are carefully considered to include information only for the 
specific year in which it occurred. In this way, every item is coded only once. Only substantial 
changes or efforts over time are coded also for subsequent years.  
4.2.2 Data Analysis 
As initially mentioned in this chapter, a multiple case study and content analysis approach is 
applied to examine if voluntary disclosures on the constructs guidance, boundary-setting and 
external assurance can add to the credibility of corporate TBL reporting. For this purpose, this 
subchapter details the set of constructs of this work. These constructs provide the main cate-
gories of the content analysis category system (see table 15 in the Annex). To provide valid 
constructs preliminary literature and guidelines are considered and further adaptions are made 
during the own empirical research process. Moreover, the firm and industry factors identified 
in chapter 3 are considered to find some evidence for the existence of pressure or adverse se-
lection problems. Table 15 in the Annex also includes information on the number of codes that 
are included in each sub-category, the dimensions covered, the weights that are applied to cal-
culate the index score and the maximal points that can be achieved for each dimension and 
sub-category. The categories and codes are refined and operationalized by specifying the min-
imum and maximum sections to be coded (coding and context units), the order of analysis and 
search cycles.
185
 Typically, a nominal scale with binary response type and a standard weight 
of one is applied. The information is gathered and refined by applying lexical search within 
typical report sections and the table of contents. The data is recoded at the end with the final 
codes. The coding rules applied for content analysis are summarized in table 16 in the Annex. 
To define the main categories for operational boundaries and assurance the author draws on 
elements of preliminary literature.
186
 Moreover, all categories refer strongly to the GRI report-
ing guidelines
187
. Further guidelines are taken into account for operational boundary setting
188
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and assurance
189
. The initiatives which provide these guidelines are among the leading organ-
izations worldwide to provide solutions in terms of corporate responsibility and sustainable 
development. The GRI is a multi-stakeholder network-based organization that a framework 
for measuring and reporting TBL performance against which reported 10 firms in 1999 and 
already 1548 firms in 2010.
190
 While the GRI includes assurance guidance within its reporting 
framework, AccountAbility provides a widely-used stand-alone assurance standard accompa-
nied by a principles standard.
191
 FEE represents the European accounting profession and 
guides assurance of TBL reports by publishing various discussion papers on this subject.
192
 
The guidance content analysis index, which includes the guidance for preparing reports and 
assurance statements as well as for certifying corporate products and processes, is derived 
from content analysis and will be presented more detailed within the results section. It must 
be noted that guidelines should at least be adopted, but membership does not necessarily have 
to be involved, to be coded within TBL guidance. Both, traditional annual reports and TBL 
reports are content analyzed to compare the results between guidance for financial reporting 
and TBL reporting. 
In contrast to previous literature
193
, performance indicators are not used to analyze boundary 
setting, as they are part of TBL performance (compare section 2.2.3). Instead, the report sec-
tions that state the boundary of the report are considered concerning the categories boundaries 
of report, boundary changes, entities excluded and basis for reporting.  
The boundaries of TBL reporting can include scope 1, scope 2 and scope 3 entities. In line 
with the scopes for measuring greenhouse gas (GHG) emissions, scope 1 entities are those en-
tities which are directly owned or controlled by the company. First, it is considered if report-
ing includes regional or global entities. Second, the included entities are analyzed (i. e. parent 
company and divisions/ operations/ segments; subsidiaries of parent companies or joint ven-
tures/ associated companies with more than 50 % control; R&D and formulation sites; sales 
and distribution offices or headquarters; leased facilities). Scope 2 and scope 3 entities include 
indirect entities which are not owned or controlled by the company. Scope 2 entities encom-
pass the entities which generate purchased electricity while scope 3 entities include supply 
chain entities that extract, produce or transport purchased materials and fuels (i. e. suppliers, 
contractors, outsourced operations) or use sold products/ services (i. e. customers).
194
 
Boundary changes within the reporting period include significant changes in size, structure, 
ownership or inclusions of new reporting entities. Changes are only coded when they are 
named for the first time. Repetitions in subsequent years without substantial changes, e. g. 
past acquisitions, are not considered. The reporting boundary may be limited due to excluded 
entities, again the distinction of scope 1 (direct), scope 2 (indirect) and scope 3 (indirect) enti-
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ties is applied. Lastly, the basis for reporting is coded to find evidence how the boundary is set 
according to influence/ control and impact.
195
 
An external assurance engagement aims at evaluating and concluding on the nature, extent 
and quality of information disclosed on a subject against certain criteria to increase confi-
dence.
196
 For the purpose of this work, external assurance statements for financial reports 
(named “financial assurance statements”) and for TBL reports (named “TBL assurance state-
ments”) are distinguished. External assurance comprises the categories format, qualification, 
scope and opinions/ conclusions. Assurance format includes if an external assurance is em-
ployed, what the title of the assurance statement is like, what dimensions are included in the 
assurance process, who the assurance provider and the intended users of the assurance state-
ment are. It must be noted that some corporations are stating within their reports that external 
assurance is performed but no statement is enclosed within the report. In these particular cas-
es, the author only codes “assurance without available statement” and does not consider any 
statements made by the reporter. Moreover, disclosures on planned assurance engagements 
are not coded. The category qualification covers the interests in the information an assuror 
provides to show his assurance competence, his independence and impartiality towards the 
reporter and stakeholders as well as the respective responsibilities of the assuror and the re-
porter. Both, AccountAbility and the GRI, call for an inclusion of competency information in 
the assurance statements.
197
 AA1000AS go beyond and claim the assurors to provide infor-
mation on assurance guidelines, assurance oversight mechanisms, assurance principles, as-
suror registration, infrastructure/ systems, understanding of legal aspects, stakeholder compe-
tency and the sustainability subject competency covered.
198
 Yet for the purpose of this analy-
sis, assurance guidelines and assurance principles are grouped in the category scope. The 
qualification aspects are considered to positively affect the quality and credibility of assur-
ance.
199
 To determine the scope and extent of assurance it is considered which guidelines are 
referred to for assurance, what level of assurance is aimed, what is covered in and excluded 
from the assurance process, if a boundary is set for assurance, which criteria are used to ex-
amine the evidence and come to a conclusion, and if methodologies or assessments are per-
formed. If the scope and extent of assurance are presented in a reasonable and balanced man-
ner, the assurance process can increase the comparability and reliability of TBL reporting
200
. 
Finally, the opinions/ conclusions of assurance are analyzed by determining if the assurance 
statement includes sections in terms of findings/ observations, progress, commentary, opinion/ 
conclusions, and recommendations. Both, AccountAbility and GRI agree that findings/ obser-
vations, opinion/ conclusions shall be available within the assurance statement, while reports 
on progress and recommendations for improvement are only encouraged by Accountability.
201
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198  Cf. ACCOUNTABILITY (2008), p. 15. 
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These aspects are as well considered to positively affect the credibility of assurance as they 
can help to ascertain that sustainability reporting is more than mere public relation.
202
 
Now that the theoretical and methodological foundations have been laid and the characteris-
tics of the red biotechnology industry have been presented, the way is paved to begin with the 
analysis of the data.  
                                                 
202  Cf. GLOBAL REPORTING INITIATIVE (2006), p. 22; FÉDÉRATION DES EXPERTS COMPTABLES EU-
ROPÉENS (2006), p. 20. 
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5 Results 
The present chapter contains the main results of this work. First, a general overview is given 
on the temporal trend of TBL guidance, boundary-setting and external assurance. The follow-
ing subchapters compare the results of this study to the results of preliminary studies which 
are summarized in table 17 in the Annex. Subchapter 5.1 presents the empirical results with 
reference to the use of guidance when preparing TBL reports and assurance statements. In the 
subchapters 5.2 and 5.3 the case study results involving the use of guidance when deciding on 
boundary-setting and external assurance are given. 
Figures 8 to 10 (see also tables 18 to 23 in the Annex) help to find some hints whether the use 
of TBL guidance and the disclosures on boundary-setting and assurance increased over time. 
The bars indicate the percentage of the index score achieved for each aspect in the first and 
last year of reporting, usually 2000 and 2009 (see table 14 in the Annex). A light grey bar 
symbolizes increasing scores, dark grey decreasing scores. The lines indicate the minimum 
and maximum scores achieved during the considered period, if there is no line then the mini-
mum or maximum score is identical to either the first or last reporting year.  
 
Figure 8: TBL guidance index scores 
(Own illustration.) 
Note:  The bars show the index score percentage in the first and last year of reporting. A light grey bar symbolizes increas-
ing scores, a dark grey bar decreasing scores and lines the minimum and maximum scores. 
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Figure 9: TBL boundary index scores 
(Own illustration.) 
Note:  The bars show the index score percentage in the first and last year of reporting. A light grey bar symbolizes increas-
ing scores, a dark grey bar decreasing scores and lines the minimum and maximum scores. 
 
Figure 10: TBL assurance index scores  
(Own illustration.) 
Note:  The bars show the index score percentage in the first and last year of reporting. A light grey bar symbolizes increas-
ing scores, a dark grey bar decreasing scores and lines the minimum and maximum scores. 
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It can be stated that the TBL guidance index scores increase over time for all the corporations. 
For 2/3 of the corporations the TBL guidance index scores reach their maximum between 
2005 and 2009, yet for 1/3 the scores decrease after having reached their maximum between 
2004 and 2006. In contrast to the relative stable economic boundary index scores (see ta-
bles 24 and 25 in the Annex) overall boundary-setting for TBL reporting increases over the 
first half of the considered reporting period, but generally stagnate on the achieved level. TBL 
boundary-setting index scores were maximal for 2/3 of the corporations generally within the 
second half of the considered period. The remaining three corporations have higher scores un-
til 2004 and two of them, AstraZeneca and Roche Holding, did not disclose information on 
the boundaries set throughout the considered period. As to external assurance, the economic 
assurance index scores are also relatively stable over time with minor changes (see tables 26 
and 27 in the Annex), whereas overall external assurance for TBL reporting generally increas-
es or at least remains stable over time. Five of the considered corporations reach their maxi-
mum TBL assurance index scores in 2009. The remaining three corporations achieve their 
maximum scores between 2004 and 2007 and when not considering the years for which ex-
ternal assurance is provided but not available (indicated by a score of one) their scores remain 
relatively stable. 
5.1 Reporting Guidance 
In the following, the results within the categories reporting guidelines, certification/ accredita-
tion and assurance guidelines are presented for the economic and other TBL dimensions of 
traditional annual and TBL reporting. 
Table 28 in the Annex shows the reporting standards applied by the nine red biotechnology 
corporations. In terms of economic reporting standards, since 2000 some of the corporations 
refer to US generally accepted accounting principles (US GAAP) or United Kingdom (UK) 
generally accepted accounting practice (UK GAAP) and since 2002 increasingly International 
Financial Reporting Standards (IFRS). The US GAAP are national accounting standards that 
are established by the Financial Accounting Standards Board (FASB) and monitored by the 
Securities and Exchange Commission (SEC).
203
 The UK GAAP includes not only national ac-
counting standards but also company law.
204
 IFRS are internationally accepted and uniforms 
standards on accounting which are published by the International Accounting Standards 
Board (IASB).
205
 Many countries around the world require or permit annual reporting in line 
with the IFRS. For instance, with Regulation (EC) No 1606/2002, the European Union (EU) 
adopted certain international accounting standards, including the IFRS issued by the IASB, 
and since 2005 all EU listed companies are required to follow this regulation.
206
 UK compa-
nies are required to report under IFRS either by the IASB or the EU.
207
 While the number of 
economic reporting standards is limited, a great variety of TBL reporting standards is used, 
covering either environmental, social or all TBL dimensions. Separate environmental guid-
                                                 
203  Cf. FINANCIAL ACCOUNTING STANDARDS BOARD (2011), w/o p; U.S. SECURITIES & EXCHANGE COM-
MISSION (2011), w/o p. 
204  Cf. HM REVENUE & CUSTOMS (2011), w/o p. 
205  Cf. IFRS FOUNDATION (2011), w/o p. 
206  Cf. EUROPEAN PARLIAMENT AND OF THE COUNCIL (2002), p. 3. 
207  Cf. THE NATIONAL ARCHIVES (2010), w/o p. 
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ance, for instance by the Kyoto protocol
208
, United Nations Global Compact (UNGC)/ United 
Nations Environment Programme (UNEP) Caring for Climate
209
 or United Nations (UN) 
Convention on Biological Biodiversity
210
, are taken into account only by some of the corpora-
tions. Social guidelines, on the contrary, are considered to a greater extent. Guidance on cor-
porate practice and business ethics was applied first by Baxter in 2000, most commonly re-
ferred to are good marketing practices by the International Federation of Pharmaceutical 
Manufacturers Associations
211
, good clinical practices by International Conference on Har-
monisation
212
, good commercial practices by European Federation of Pharmaceutical Indus-
tries and Associations
213
 as well as the Pharmaceutical Industry Principles for Responsible 
Supply Chain Management set by the Pharmaceutical Supply Chain Initiative
214
. Guidance on 
human rights was first mentioned by Novozymes in 2001, in most cases the UN Universal 
Declaration of Human Rights
215
 and in some rare cases the Business Leaders Initiative on 
Human Rights
216
 are referred to. Labor condition standards were considered first in 2002 by 
GlaxoSmithKline, most commonly the Tripartite Declaration Concerning Multinational En-
terprises and Social Policy and to a lesser extent the Guidelines for Occupational Health Man-
agement Systems, both of which were set out by the International Labour Organization.
217
 
Over the years the number of corporations using such guidance increased significantly and in 
2009 a vast majority of the corporations referred to at least one of these social standards. In 
addition to the existing environmental and social guidelines, increasingly integrated TBL re-
porting standards were applied. The GRI standard
218
 is referred to most, followed by the UN 
Global Compact Communicating Progress guidelines
219
, industry specific standards (Business 
Charter for Sustainable Development developed by the International Chamber of Commerce 
and the World Health Organization
220
, Responsible Care Health, Safety and Environmental 
reporting guidelines published by the European Chemical Industry Council (CEFIC)
221
) or 
other standards (including the guidelines for Multinational Enterprises developed by the Or-
ganisation for Economic Co-operation and Development
 
(OECD)
222
, the Ceres Principles
223
 
and the AA1000 guidance
224
). Since 2007 all the corporations for which a TBL report was 
available for the respective year referred to either one of the mentioned sustainability stand-
ards. 
With respect to economic certification and accreditation of corporate products and programs 
(see table 29 in the Annex), some corporations make effort to obtain Supplementary Protec-
                                                 
208  Cf. UNITED NATIONS (1998), pp. 1ff. 
209  Cf. UNGC/UNEP (2010), pp. 1ff. 
210  Cf. UNITED NATIONS (1992), pp. 1ff. 
211  Cf. INTERNATIONAL FEDERATION OF PHARMACEUTICAL MANUFACTURERS ASSOCIATIONS (2006), 
p. 1ff. 
212  Cf. INTERNATIONAL CONFERENCE ON HARMONISATION (1996), pp. 1ff. 
213  Cf. EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS (2007), pp. 1ff. 
214  Cf. PHARMACEUTICAL SUPPLY CHAIN INITIATIVE (2011), w/o p. 
215  Cf. UNITED NATIONS (2011), w/o p. 
216  Cf. BUSINESS & HUMAN RIGHTS (2011), w/o p. 
217  Cf. INTERNATIONAL LABOUR OFFICE (2006), pp. 1ff; INTERNATIONAL LABOUR OFFICE (2001), pp. 1ff. 
218  Cf. GLOBAL REPORTING INITIATIVE (2002), pp. 1ff; GLOBAL REPORTING INITIATIVE (2006), pp. 1ff. 
219  Cf. UNGC (2010), w/o p. 
220  Cf. INTERNATIONAL INSTITUTE FOR SUSTAINABLE DEVELOPMENT (2011), w/o p. 
221  Cf. THE EUROPEAN CHEMICAL INDUSTRY COUNCIL (2011), w/o p. 
222  Cf. ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT (2008), pp. 1ff. 
223  Cf. CERES (2011), w/o p. 
224  Cf. ACCOUNTABILITY (2003), pp. 1ff; ACCOUNTABILITY (2008), pp. 1ff. 
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tion Certificates for the European market
225
 or Patent Term Extensions for instance for the US 
market
226
 to enhance patent protection. In their TBL reporting, some corporations state for 
some years that they have an ISO 9000 series quality management system in place.
227
 Over 
time, environmental management systems in line with EMAS or ISO 14000 series
228
 and oc-
cupational health and safety standards in line with OHSAS 18001
229
 are increasingly men-
tioned. Other certifications are obtained for example for renewable energy use, buildings, pa-
per use and wildlife habitat, which in fact does not refer to the core business of the corpora-
tions; the value of such certifications, however, is questionable. 
As table 30 in the Annex demonstrates, the considered corporations broadly apply assurance 
guidelines. Most common for the economic assurance statements are the auditing standards by 
the Public Company Accounting Oversights Board
230
, International Standards on Assurance 
Engagements 3000 (ISAE 3000)
231
 and other international auditing standards. Apart from the 
occasional application of the ethical standards by the Auditing Practices Board
232
, other sus-
tainability standards are not considered to guide the financial assurance process. In TBL 
statements auditing standards are referred to most. Most commonly used is the auditing stand-
ard ISAE 3000, followed by the AA1000 Auditing Standard (AA1000AS)
233
. While 
ISAE 3000 requires the assurors to comply with quality control standards and the Code of 
Ethics developed by the International Ethics Standards Board for Accounting
234
, including in-
dependence, the AA1000AS suggest the use of codes of practice to ensure independence, but 
does not provide a clear definition of the assurance engagement.
235
 Separate ethical guidelines 
are not referred to. However, integrated sustainability guidelines, for instance by the GRI and 
CEFIC, are applied in 2009 by half of the corporations which published a TBL report for that 
year. The case study findings support preliminary results (see table 17 in the Annex) which 
found that within the first half of the considered period assurance standards were applied in 
half or even less than 30 % of the considered firms, while in the second half of the period 
such were adhered to already by more than 60 % of the firms.
236
  
                                                 
225  Cf. THE COUNCIL OF THE EUROPEAN COMMUNITIES (2011), w/o p. 
226  Cf. UNITED STATES PATENT AND TRADEMARK OFFICE (2010), w/o p. 
227  Cf. INTERNATIONAL ORGANIZATION FOR STANDARDIZATION (2011a), w/o p. 
228  Cf. INTERNATIONAL ORGANIZATION FOR STANDARDIZATION (2011b), w/o p; EMAS (2011), w/o p. 
229  Cf. THE OCCUPATIONAL HEALTH & SAFETY GROUP (2007); w/o p. 
230  Cf. PUBLIC COMPANY ACCOUNTING OVERSIGHT BOARD (2011), w/o p. 
231  Cf. INTERNATIONAL FEDERATION OF ACCOUNTANTS (2005), w/o p. 
232  Cf. THE AUDITING PRACTICES BOARD (2011), w/o p. 
233  Cf. ACCOUNTABILITY (2003), pp. 1ff; ACCOUNTABILITY (2008), pp. 1ff. 
234  Cf. INTERNATIONAL ETHICS STANDARDS BOARD FOR ACCOUNTANTS (2011), w/o p. 
235  Cf. FÉDÉRATION DES EXPERTS COMPTABLES EUROPÉENS (2004), pp. 19f; ACCOUNTABILITY (2008), p. 14. 
236  Cf. KPMG SUSTAINABILITY SERVICES (2008), p. 65; O'DWYER, B.; OWEN, D. L. (2005), pp. 217f; DEEGAN, C. 
(2006a), p. 13; DEEGAN, C. (2006b), p. 353. 
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5.2 Report Boundary 
In the following, the results within the categories scope 1 to scope 3 boundaries, boundary 
changes, exclusions as well as influence/ control and impact as reporting basis are presented, 
both for the economic and other TBL dimensions of traditional annual and TBL reporting. Ta-
ble 31 in the Annex summarizes these results. 
Concerning the economic dimension all the corporations for which a report is available define 
their boundaries globally for their parent company and divisions as well as subsidiaries as re-
quired by International Accounting Standard (IAS) / IFRS Standards
237
 to which corporations 
operating in Europe are obliged to refer to in compliance with EU regulation 1606/2002
238
 
from 2005 on. In 2000, only two corporations decided to report on joint ventures, while in 
2009 six corporations did so. The other scope 1 to 3 entities are not stated to be included in 
boundary-setting. The number of corporations setting reporting boundaries on their scope 1 
entities increased over the first half of the considered reporting period, but generally stagnated 
on the achieved level. Generally, information is disclosed globally on parent companies and 
divisions. Subsidiaries, joint ventures or associated companies, R&D and formulation sites as 
well as sales and distribution offices and headquarters are included to a lesser extent. Leased 
facilities are only mentioned by Bristol-Myers Squibb. Two corporations, GlaxoSmithKline 
and Sanofi-Aventis distinguish boundaries for their social and environmental information. 
While Sanofi-Aventis sets the boundaries above for both dimensions, GlaxoSmithKline occa-
sionally provides information only for one of the two dimensions. Boundaries set once are not 
necessarily kept for the following years, for instance GlaxoSmithKline includes R&D and 
formulation sites only for some, not even successive years. Scope 2 purchased energy sites are 
only stated to be included in boundary-setting by Novartis within the second half of the con-
sidered period, while scope 3 entities are mentioned to be included in one rare case by Glax-
oSmithKline for their social dimension. 
In traditional annual reports little information is provided on boundary changes due to acqui-
sitions, closures, divestments, business combinations, the exclusion of intercompany transac-
tions or R&D investments in segment reporting. Typically, the corporations state control or in-
fluence as reporting basis in their available annual reports, i. e. entities on which they have fi-
nancial control in terms of the majority of the voting rights or other control, for instance on 
subsidiaries and joint ventures. This is in line with the IAS/ IFRS Standards
239
. There is no ev-
idence that the impact of entities is taken into account for the reporting basis. In TBL report-
ing, boundary changes and exclusions as well as the reporting basis are specified only in a 
limited number of cases. Evidence is found with respect to acquisitions, closures, divestments, 
business combinations and intercompany transactions due to mergers and joint ventures. 
Since 2001, information is increasingly provided on excluded entities, such as sales/ distribu-
tion/ offices/ headquarters, R&D and formulation sites as well as manufacturers. As depicted 
in table 7, scope 1 entities are often excluded basing on minor impacts, but mainly without 
providing appropriate definitions and methodologies to determine boundaries. 
                                                 
237  Cf. EUROPEAN COMMISSION (2009), p. 2. 
238  Cf. EUROPEAN PARLIAMENT AND OF THE COUNCIL (2002), p. L243/3. 
239  Cf. EUROPEAN COMMISSION (2009), p. 2. 
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Table 7: Evidence of excluded entities in TBL reports 
Type Exemplary quotes Corporations 
Different scope of 
environmental & so-
cial data 
“The scope of Baxter’s health and safety data is different than the scope of Bax-
ter’s environmental data because Baxter’s occupational injury and illness account-
ing includes smaller facilities that are not material to Baxter’s overall environmen-
tal performance.” 
Baxter 2009 
Exclusion of scope 1 
entities 
“all sites with relevant HSE impacts, including all production, formulation, re-
search and development sites, as well as major headquarter offices” 
Novartis 2005 – 
2009 
“Sites with activities considered not to have a significant impact are not included. 
Such sites comprise sales offices, R&D labs and sites with limited blending and 
storage of products.” 
Novozymes 
2008 - 2009 
“Environmental data are collected from all 81 of our Pharmaceutical, Consumer 
Healthcare and Nutritionals manufacturing sites, 11 of the 14 vaccines sites (three 
are not yet in operation), 20 of 26 pharmaceutical and Consumer Healthcare re-
search and development sites (six are too small to warrant collection of environ-
mental data), all three major offices and ten smaller offices and distribution cen-
tres. Injury and illness data are collected from all 81 of our Pharmaceutical, Con-
sumer Healthcare and Nutritionals manufacturing sites, 11 of the 14 vaccines sites 
(three are not yet in operation), all 26 pharmaceutical and Consumer Healthcare 
research and development sites, all three major offices, all eight main sales 
groups, all ten offices with more than one million hours worked and 46 of the 
smaller offices and distribution centres.” 
GlaxoSmith 
Kline 2007 (in-
creasingly im-
proved since 
2001) 
Exclusion of scope 3 
entities 
“The scope of this report does not include sustainability performance data from 
external organizations or activities over which the company has limited control or 
influence (e.g., suppliers, contractors, and customers). 
Bristol-Myers 
Squibb 2003 - 
2008 
“We do not monitor environmental impacts from the manufacture and delivery of 
purchased goods and services, nor the use of resources and other related emissions 
for activities outside company boundaries (Scope 3), such as GHG emissions from 
transportation by third parties.” 
Novartis 2009 
(similar in earli-
er years) 
(Own illustration.) 
Moreover, while for instance Novartis considers R&D sites as relevant enough to include 
them in their boundary, Novozymes has a contrary view. Some information is available on ex-
cluded scope 2 and scope 3 entities. The reporting basis is specified by less than half of the 
corporations, both in terms of control/ influence and impact.  
In line with VELEVA, V. et al. (2003) and ARCHEL, P. (2008) (see table 17 in the Annex) it 
can be shown that the corporations do not define broad boundaries for their reports to improve 
reporting practices and legitimacy. When comparing the boundaries set for financial and TBL 
reporting, it can be seen that in the absence of a binding standard in TBL reporting less sub-
sidiaries and joint ventures/ associated companies are included in the boundary than in finan-
cial reporting. With respect to scope 2 and scope 3 entities, only GlaxoSmithKline and Novar-
tis provide some information. Moreover, the boundary index scores vary substantially, which 
does not suggest that boundary setting improves over time. Thus, a lot of room for improve-
ment remains. 
5.3 Report Assurance 
Within this section, the results within the categories assurance format, assuror qualification, 
nature and scope of assurance as well as opinions/ conclusions are presented, both for tradi-
tional annual and TBL reporting.  
While financial assurance statements are generally provided, assurance in TBL reporting is 
still in its infancy and of a highly voluntary nature. In 1999, Accountability published the 
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AA1000 Framework Standard, which was replaced in 2004 and extended in 2008 by the 
AA1000 Assurance Standard, the first TBL assurance standard worldwide. Therefore, the 
number of external TBL statements is lower than in financial reporting. Nevertheless, it can 
be stated that the corporations opt increasingly for external assurance over time. While be-
tween 2000 and 2004 for about half of the corporations an external TBL assurance statement 
is available, from 2004 on all but two corporations include such a statement (see table 32 in 
the Annex.) Pfizer is the only corporation which does not disclose any assurance statement, 
whereas AstraZeneca, Bristol-Myers Squibb and Baxter inform on the adoption of external as-
surance in some years without enclosing the original assurance statement. Baxter disclosed a 
statement to the TBL report only in 2001 and 2002, for the remaining years they referred the 
reader to the corporate website, but there only the most previous version for 2009 can be ob-
tained. External TBL statements are available for Bristol-Myers Squibb since 2000, but it 
must be stated that assurance is given on an irregular and varying basis. Moreover, they also 
enclosed statements from previous periods if an actual assurance was not undertaken which in 
the view of the author do not increase transparency but confusion. The results confirm the 
general increase in external assurance engagements found by KPMG indicating that 40 % of 
the companies which issued a TBL report enclosed such a statement in 2008.
240
 In particular 
the pharmaceuticals industry is with 50 % assurance among the five leading industries in the 
Fortune Global 250 index (see table 1 in subchapter 2.2.3).
241
 The 2009 results of this work 
suggest a higher level which can be explained by the positive bias towards GRI reporters in 
this study (see subchapter 4.2.1). This is consistent with preliminary results for 2002, also fo-
cusing on “best” reporting practice and indicating a higher number of assurance statements 
(see table 17 in the Annex).
242
 However, this work aims at identifying “best” practices in TBL 
reporting, not at generalizing. 
With only slight variances the financial assurance statements are labeled with auditor’s reports 
or independent accountants’ reports. In most cases, however, the titles include the word “in-
dependent”. Consistent with preliminary literature
243
, the terminology for TBL statements var-
ies enormously over corporations and over time (see table 33 in the Annex). The term “verifi-
cation” was partly used until 2005 by three corporations, but all shifted to the “assurance” 
terminology. The corporation for which the statement was labeled as auditor’s review report 
in early years, included the term “statutory” from 2005 on to add weight to the assurance. 
Terminologies which include “assurance” are used most, since 2004 increasingly accompa-
nied by “independent”. In other studies titles including “verification” predominate titles in-
cluding “assurance” (see table 17 in the Annex). The main point of criticism is the varying 
terminology for principally similar assurance scopes.
244 
  
While the financial assurance statements do not include any environmental or social dimen-
sions, the TBL assurance statements included social and environmental dimensions and in two 
rare cases also economic dimensions (AstraZeneca for 2006 and 2009, Baxter for 2009). The 
                                                 
240  Cf. KPMG GLOBAL SUSTAINABILITY SERVICES (2002), p. 18; KPMG SUSTAINABILITY SERVICES (2008), 
p. 56. 
241  Cf. KPMG GLOBAL SUSTAINABILITY SERVICES (2002), p. 19; KPMG SUSTAINABILITY SERVICES (2008), 
p. 59. 
242  Cf. O'DWYER, B.; OWEN, D. L. (2005), p. 213. 
243  Cf. O'DWYER, B.; OWEN, D. L. (2005), p. 215; DEEGAN, C. (2006a), p. 7; DEEGAN, C. (2006b), pp. 337ff. 
244  Cf. O'DWYER, B.; OWEN, D. L. (2005), p. 215; DEEGAN, C. (2006a), p. 7; DEEGAN, C. (2006b), pp. 337ff. 
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financial assurance statements are provided in all cases by one of the major accountants, i. e. 
PricewaterhouseCoopers (PWC), KPMG, Ernst & Young and Deloitte & Touche. The TBL 
counterparts, however, are not solely provided by accountants, but also by publicly registered 
certifiers or consultants (see table 34 in the Annex). While in 2000 only one corporation con-
tracted an accountant, until 2009 about half of the corporations opted for such an assuror. The 
number of certification bodies contracted increased slightly, whereas, consultants were only 
contracted until 2006. Interestingly, four corporations changed their assurance provider over 
time, from consultant to accountant (Novartis), consultant to certifier (Baxter, Glax-
oSmithKline) or between different consultants (Bristol-Myers Squibb). Contrary to a KPMG 
survey according to which 27 % of the Fortune Global 250 firms included other types of 
third-party commentary or combined both assurance forms in 7 % of the cases
245
, this study 
does not find any case for such an involvement. The GRI explicitly encourages involvement 
in assurance, for instance of industry associations, stakeholder panels or other stakeholders.
246
 
Preliminary research points to mixed results (see table 17 in the Annex), in some instances 
consultants were contracted more often than accountants
247
. KPMG found preference for ac-
countants for the Fortune Global 250, whereas certification bodies, technical experts and spe-
cialist assurance providers were chosen to a much lesser extent
248
. First, these results point to 
different terminologies for different types of assurance providers. Moreover, country and in-
dustry specific factors influence the choice of an assurance provider.
249
 These results do not 
point to preliminary literature results which suggested that assurance quality may be positive-
ly affected by the selection of an accountant as assurance provider.
250
 
However, different intended users are addressed in financial and TBL assurance, including es-
pecially internal stakeholders (see table 35 in the Annex). In the financial assurance statement 
the board of directors, the general meeting and/ or members of the company are increasingly 
referred to by all the corporations. Stockholders or shareholders are addressed together with 
the board of directors. In the TBL assurance statements, internal stakeholders are addressed in 
a few instances, the audit and compliance committee, corporate sustainability committee or 
corporate management. External stakeholders in general are only addressed by AstraZeneca 
and GlaxoSmithKline in 2009. These poor TBL assurance results are consistent with prelimi-
nary literature (see table 17 in the Annex) and point to a need for clear regulation and guid-
ance.
251
 
With respect to the information the assurance providers enclose to affirm their competency in 
financial assurance statements, most recently, Roche Holding (since 2008) and Novartis (since 
2009) state that they meet legal requirements. In no financial assurance statement reference is 
made to assurance oversight mechanism, assuror registration, availability of infrastructure or 
systems, stakeholder competence and subject competence. In TBL statements, remarks on 
competency are made in some instances for assuror registration and subject competency. 
                                                 
245  Cf. KPMG SUSTAINABILITY SERVICES (2008), p. 60. 
246  Note: Suggested e. g. by GLOBAL REPORTING INITIATIVE (2006), p. 38. 
247  Cf. DEEGAN, C. (2006a), pp. 5ff; DEEGAN, C. (2006b), pp. 336ff. 
248  Cf. KPMG GLOBAL SUSTAINABILITY SERVICES (2002), p. 21; KPMG SUSTAINABILITY SERVICES (2008), 
p. 63. 
249  Cf. DEEGAN, C. (2006a), pp. 5ff; DEEGAN, C. (2006b), p. 336ff. 
250  Cf. PEREGO, P. (2009), pp. 418ff. 
251  Cf. O'DWYER, B.; OWEN, D. L. (2005), p. 215; DEEGAN, C. (2006a), pp. 7f; DEEGAN, C. (2006b), pp. 339ff. 
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Since 2006, SGS informs in assurance statements for GlaxoSmithKline that auditors and as-
surors are registered with the International Register of Certificated Auditors
252
, Institute of 
Environmental Management and Assessment
253
 as well as EMAS Verifiers. Subject compe-
tency is stated by some consultants since 2004 and auditors/ certifiers since 2006. As table 8 
shows, AstraZeneca, Bristol-Myers Squibb, Baxter, GlaxoSmithKline and Novozymes pro-
vide information for some, but not necessarily consecutive years. AstraZeneca and Glax-
oSmithKline, however, are most continuous. In all cases the assurors express their past expe-
rience with sustainability issues. Sometimes they also emphasize this by including their annu-
al turnover or information on their global operations. In no TBL statement reference is made 
to assurance oversight mechanism, availability of infrastructure or systems, understanding of 
legal aspects and stakeholder competence. These case study insights support preliminary re-
sults (see table 17 in the Annex) which indicate that consultants are more likely to disclose in-
formation on their past experience and subject experience than accountants.
254
 
Table 8: Evidence of subject competency in TBL assurance statements 
Type Exemplary quotes Corporations 
Experience 
Bureau Veritas: “Our assurance team has over20 years combined experience in conduct-
ing assurance over environmental, social, ethical and health and safety information, sys-
tems and processes in accordance with best practice.” 
AstraZeneca 
2004 - 2006 
 
SGS: “The assurance team was assembled based on their knowledge, experience and 
qualifications for this assignment”. 
GlaxoSmith 
Kline 2009 
 
PWC: “Our team of experts has competencies within performing assurance of environ-
mental and social data and within assessing such data and information. In addition, our 
team is highly experienced in sustainability management as well as in handling social 
and environmental related issues.” 
Novozymes 
2009 
Experience 
and turnover 
Bureau Veritas: “Bureau Veritas is an independent professional services company that 
specializes in quality, environmental, health, safety and social accountability with [] 
years history in providing independent assurance services, and an annual turnover in [] of 
[]. 
AstraZeneca and 
Baxter 2009, 
GlaxoSmith 
Kline 07 and 09 
 
Bureau Veritas: “Our assurance team has extensive experience in conducting assurance 
over environmental, social, ethical and health and safety information, systems and pro-
cesses in accordance with best practice.” 
AstraZeneca and 
GlaxoSmith 
Kline 2009 
Experience 
and global 
operations 
Haley & Aldrich: “Haley & Aldrich, Inc. applied relevant experience, processes, and 
people to conduct this work. The company has 50 years of experience providing strategic 
management, engineering, environmental and sustainability services. Haley & Aldrich 
has 18 offices across the United States and is headquartered in Boston, Massachusetts.” 
Bristol-Myers 
Squibb 2005 
 
SGS: “The SGS Group of companies is the world leader in inspection, testing and 
verification, operating in more than 140 countries and providing services including man-
agement systems and service certification; quality, environmental, social and ethical au-
diting and training; environmental, social and sustainability report assurance.” 
GlaxoSmith 
Kline 2006 - 
2008 
(Own illustration.) 
As demonstrated in table 36 in the Annex, there is also little evidence in financial assurance 
statements on the independence and impartiality of the assuror from the reporter and no evi-
dence on the impartiality towards their stakeholders. In contrast, TBL assurance statements 
include some more evidence on the independence and impartiality of the assuror towards the 
reporter from 2004 on and even some rare evidence towards stakeholders from 2006 on. The 
certifiers Bureau Veritas and SGS are the only assurors which inform that they apply a code of 
                                                 
252  Cf. INTERNATIONAL REGISTER OF CERTIFICATED AUDITORS (2009), w/o p. 
253  Cf. INSTITUTE OF ENVIRONMENTAL MANAGEMENT AND ASSESSMENT (2011), w/o p. 
254  Cf. O'DWYER, B.; OWEN, D. L. (2005), pp. 214f. 
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ethics (for AstraZeneca, Baxter, and GlaxoSmithKline) as the following examples will show. 
They confirm that they are free from conflicts of interests with the organization and its subsid-
iaries (for Baxter, GlaxoSmithKline) or that they are not involved in other projects with the 
corporation (AstraZeneca). Independence in line with the Code of Ethics for professional ac-
countants published by the International Federation of Accountants
255
 as required by the In-
ternational Standards on Assurance Engagements 2000 (ISAE 2000) and ISAE 3000 is pro-
vided by PWC for Roche Holding since 2003, Novozymes since 2004 and Novartis in 2009 
and by Bureau Veritas for Baxter and GlaxoSmithKline in 2009. SGS is the only assuror to 
confirm that they are free from conflicts of interest with stakeholders in assurance statements 
for Glaxo-SmithKline’s sustainability reports since 2006. The results of this study seem con-
sistent with a preliminary study that considered in general if a commentary on independence 
was provided
 
and the author shares the view that by simple labeling assurance statements with 
the word “independent” independence remains to be questioned.
256
  
The responsibilities of assurors and reporters, however, are increasingly stated in financial and 
TBL assurance (see table 37 in the Annex). As to financial assurance, since 2007 all the avail-
able assurance statements provide information on respective responsibilities. In the TBL as-
surance statements the responsibilities are reported to a lesser extent. These case study find-
ings are not consistent with preliminary literature (see table 17 in the Annex) which found for 
the period of 2000 to 2003 that more than 36 % of the TBL assurance statements included in-
formation on the respective responsibilities.
257
 During that period such information is dis-
closed only in some instances. From 2004 on, however, the responsibility disclosure increases 
significantly for TBL assurance. In 2009, Bristol-Myers Squibb is the only corporation for 
which an assurance statement is available that does not define the assurors’ and reporters’ re-
sponsibilities. 
In traditional assurance standards reasonable and limited assurance levels are distinguished. 
Reasonable assurance aims at reducing the risk of the assurance engagement to a low level 
which can be accepted under the conditions of the engagement as a basis for a positive ex-
pression of the conclusion; limited assurance encompasses the objective to reduce the risk to 
an acceptable level under the conditions of the engagement as a basis for a negative expres-
sion of the conclusion.
258
 Moreover, the AA1000 distinguishes high and moderate assurance 
levels. High assurance can be provided if assurors can be highly confident in disclosures with 
unrestricted evidence and statements for principles and performance information whereas 
moderate assurance enhances confidence in disclosures with less extensive evidence and 
statements for principles and performance information.
259
 While in the financial assurance 
statements the assurors generally provide a reasonable assurance level, in the TBL counterpart 
the assurance level is pointed out to a lesser extent and at a greater variance (see table 38 in 
the Annex). Reasonable and/ or limited assurance is only provided for four corporations. For 
two of these corporations both, reasonable and limited assurance is provided for some years. 
Moderate assurance is increasingly provided. High assurance is obtained only once in 2009. 
                                                 
255  Cf. INTERNATIONAL FEDERATION OF ACCOUNTANTS (2010), p. 1ff. 
256  Cf. O'DWYER, B.; OWEN, D. L. (2005), pp. 216f. 
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In the absence of the assurance level definitions in earlier years, AstraZeneca indicated as 
well as defines basic-level and positive assurance in 2004 (see table 9). For the first half of the 
considered period the case study findings do not support preliminary results (see table 17 in 
the Annex) indicating that in 2002 about 40 % of the assurance statements included infor-
mation on the assurance level.
260
 While KPMG found that 51 % of the assurance statements 
obtained limited assurance, 30 % reasonable assurance and 14 % a combination of both for 
the Fortune Global 250 companies, this was the case to a far lesser extent in this study. Only 
one corporation obtains limited assurance and two corporations reasonable assurance in 2009. 
This may suggest that red biotechnology corporations are less prepared than other industries 
to ask for assurance in line with these assurance levels. 
Little information is provided in terms of the scope of engagement (see table 39 in the An-
nex). With respect to economic assurance, assurors generally start in 2009 to state that they 
consider data/ information, systems/ procedures and/ or policies/ principles/ estimates. How-
ever, substantial information is provided for TBL assurance, especially with respect to data/ 
information as well as systems/ procedures. It can be stated that over time some assurors are 
more concrete on what part of the data/ information process they are actually referring to, i. e. 
they focus on the preparation/ collection, consolidation/ verification  or accuracy/ consistency 
of the data/ information. Policies/ principles/ estimates, the application level of guidelines and 
principles as well as the governance structure are included into the assurance scope to a far 
lesser extent. The case study results are in line with preliminary literatures’ findings that in 
general information on the assurance scope is provided, though there is strong variability and 
inclusion selectivity.
261
  
While in financial assurance statements no information is provided in terms of scope limita-
tions, some TBL counterparts include at least some information (see table 40 in the Annex) 
which is consistent with preliminary literature that found restrictions in less than 40 % of the 
cases
262
 or even in no cases at all
263
. This might suggest that limitations have not been consid-
ered increasingly over time. In the financial assurance statements the assurors broadly provide 
information that in general the group level is considered, whereas in the TBL assurance state-
ment the boundary is indicated to a lesser extent (see table 41 in the Annex). Thus, the bound-
ary of assurance is considered with only slight increases over time. 
                                                 
260  Cf. O'DWYER, B.; OWEN, D. L. (2005), p. 217. 
261  Cf. O'DWYER, B.; OWEN, D. L. (2005), pp. 217f; DEEGAN, C. (2006a), p. 10; DEEGAN, C. (2006b), pp. 344ff. 
262  Cf. O'DWYER, B.; OWEN, D. L. (2005), p. 217. 
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Table 9: Evidence of the assurance level in TBL assurance statements 
Type Exemplary quotes Corporations 
Basic level 
“The scope of our work was determined through discussions with AstraZeneca and can 
be summarised as follows: To provide a basic level of assurance [] over information in-
cluded in the Report.” 
“Basic = During the course of our review nothing came to our attention to indicate that 
there was any material error, omission or misstatement 
This is a minimum level of assurance over all the information and related systems in the 
compilation of the corporate, economic and social performance information in the Re-
port.  
We have reviewed the reported information, interviewed key personnel within the busi-
ness and conducted a review of available documentary evidence.  
Our approach was based on sampling of information and data to obtain evidence to 
support claims made in the Report. We have ensured that the data have been accurately 
transposed into the Report.” 
AstraZeneca 
2004 
Positive 
“The scope of our work was determined through discussions with AstraZeneca and can 
be summarised as follows: [] To provide positive assurance over safety, health and en-
vironmental (SHE) information within the Report.” 
“Positive = The reported information is supported by underlying evidence and systems 
and no material errors or omissions were identified. 
We have carried out all of the activities as for the Basic level assurance, above.  
In addition we increased our sampling and level of interrogation to provide a more rig-
orous level of assurance over all SHE information, associated evidence and related sys-
tems.  
We conducted site visits to AstraZeneca’s UK offices in Alderley and Brixham as part 
of our review.” 
AstraZeneca 
2004 
High level 
“The level of assurance offered is high as defined by AA1000AS (2008). As such, our 
work obtained sufficient evidence to support the statement that the risk of our conclu-
sion being in error is reduced to very low but not zero.” 
AstraZeneca 
2009 
Moderate 
“The standards require that we plan and perform the verification to obtain moderate, ra-
ther than absolute, assurance on the 2000 data. A verification provides less assurance 
than an audit. We have not performed an audit in accordance with International Stand-
ards on Auditing and accordingly, we do not express an audit opinion.” 
Roche 2000 - 
2002 
Moderate 
“We have planned and performed our work based on AA1000AS (2008), using the cri-
teria in the standard to perform a Type 2 engagement and to obtain a moderate level of 
assurance (review) as to Novozymes’ adherence to the AA1000 AccountAbility princi-
ples of inclusivity, materiality and responsiveness.” 
Novozymes 2009 
 
“This report has been assured at a moderate level of scrutiny using our protocols for 
evaluation of content veracity.” 
GlaxoSmith 
Kline 2009 
Reasona-ble 
“The work was planned and carried out to provide reasonable, rather than absolute as-
surance and we believe it provides a reasonable basis for our conclusions.” 
Baxter and Glax-
oSmith Kline 
2009 
 
“We planned and performed our work based on the aa1000 assurance standard and in 
accordance with the International standard on assurance engagements (Isae) 3000, “as-
surance engagements other than audits or reviews of Historical financial Information 
(revised)”, to obtain reasonable assurance that the environmental and social responsibil-
ity reporting in the annual report is free from material misstatements and that the infor-
mation has been presented in accordance with the accounting policies applied.” 
Novozymes 2008 
 
“We have been engaged to obtain moderate assurance (review) as to whether Novo-
zymes adheres to the AA1000 AccountAbility principles and to obtain reasonable as-
surance (audit) as to the statement of the Board of Directors and Executive Manage-
ment, Management’s review, accounting policies and the quantitative environmental 
and social data in Novozymes A/S’ Annual Report for the financial year 2009.” 
Novozymes 2009 
Reasona-ble 
and limited 
(ISAE 3000) 
“We planned and performed our evidence-gathering procedures to obtain a basis for our 
conclusions in accordance with an ISAE 3000 limited and reasonable assurance en-
gagement. We have not performed an audit according to International Standards on Au-
diting. Accordingly, we do not express such an audit opinion.” 
Roche 2006 – 
2007 (similar for 
2003) 
Limited 
“We have performed assurance procedures to provide limited assurance on the follow-
ing aspects of the [] Corporate Citizenship (CC) reporting of Novartis.” 
Novartis  
2008 - 2009 
(Own illustration.) 
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With respect to the criteria used in financial assurance, only Novozymes’ assuror commented 
in 2009 on ethical compliance. TBL assurance statements, however, show a significant in-
crease, but great variety of the criteria used in the assurance process (see table 42 in the An-
nex). In 2006, for six of the corporations criteria were stated, until 2009 the number increased 
to seven. AccountAbility requires the application of the principles of materiality, complete-
ness and stakeholder responsiveness in order to achieve so-called type-1 engagement, whereas 
the GRI focuses on the principles of materiality, completeness, stakeholder inclusivity and 
sustainability context.
264
 In 2009, no assuror applied all AA1000 criteria or GRI principles. 
Materiality is applied increasingly since 2004. Completeness and stakeholder responsiveness 
are referred to over the whole reporting period. Stakeholder inclusivity is mentioned in two 
instances since 2009. No reference is made to the sustainability context. Other criteria stated 
are, for instance, accuracy, balance or consistency. To perform an AA1000 type-2 engagement 
assurors are required to refer to the above AA1000 principles and name suitable criteria that 
are relevant, complete, reliable, neutral and understandable, to evaluate specific performance 
information.
265
 For Sanofi-Aventis such a type-2 engagement was aimed, yet rather than de-
termining suitable criteria, they simply refer to the suitable criteria’s criteria and do not men-
tion the basic principles of materiality, completeness and stakeholder responsiveness. The 
case study results support preliminary findings which indicated that criteria were identified in 
41 % of the cases
266
, yet other findings suggested that such criteria were only rarely speci-
fied
267
. Again there is strong variability and inclusion selectivity. 
The available financial and TBL assurance statements include information on the methodolo-
gies or assessments undertaken except for some years (see table 43 in the Annex). As to TBL 
assurance the GRI recommends to assess processes systematically and basing on evidence and 
defined procedures.
268
 Yet, there is rarely information provided to this extent. Typically, as-
surors undertake their work on a sample basis. In 2009, for instance, interviews were per-
formed with management, involved departments and/ or external stakeholders. Moreover, 
corporate documents and databases were reviewed or sites visited. The case study results are 
in line with preliminary literatures’ findings that in general information on the assurance 
methodology is provided, though there is strong variability and inclusion selectivity.
269
 
Table 44 in the Annex demonstrates the opinions/ conclusions etc. provided in the financial 
and TBL assurance statements over time. To conclude the financial assurance statements, all 
the assurors form a final opinion/ conclusion, yet only for some corporations a few commen-
taries, recommendations and only once information on progress are made. No statement is 
given in terms of findings/ observations. As to the TBL assurance statements, the assurors 
provide conclusions etc. to a lesser extent. Most assurors include opinions/ conclusions, find-
ings/ observations or recommendations. Information on progress is given only sporadically 
for four corporations, while commentaries are even rarer. Yet, in 2009, only four out of seven 
assurance statements include an opinion/ conclusion or findings/ observations and in further 
                                                 
264  Cf. ACCOUNTABILITY (2008), p. 13; GLOBAL REPORTING INITIATIVE (2006), pp. 7ff. 
265  Cf. ACCOUNTABILITY (2008), p. 13. 
266  Cf. O'DWYER, B.; OWEN, D. L. (2005), pp. 217ff. 
267  Cf. DEEGAN, C. (2006a), pp. 10f; DEEGAN, C. (2006b), pp. 347ff. 
268  Cf. GLOBAL REPORTING INITIATIVE (2006), p. 38. 
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three statements recommendations are given. As table 10 shows opinions and conclusions 
vary significantly and even if they are provided by the same assuror. The case study results 
are not conforming preliminary findings that indicated higher occurrence of recommenda-
tions.
270
  
After the results have been presented this work continues to discuss some underlying factors 
of TBL reporting. 
Table 10: Evidence of opinions/ conclusions etc. in TBL assurance statements 
Type Exemplary quotes Corporations 
General and 
brief 
“Based on our work described in this report and the assessment of criteria, nothing 
has come to our attention that causes us to believe that the data and information 
mentioned in the subject matter and disclosed with the Corporate Citizenship report-
ing does not give a fair picture of Novartis performance. Additionally, nothing has 
come to our attention that causes us to believe that the management and reporting 
processes as defined under the subject matter above are not functioning as designed, 
in all material respects.” 
Novartis 2009 
 
“Nothing has come to our attention causing us to believe that Novozymes does not 
adhere to the AA1000 AccountAbility principles. In our opinion, the environmental 
and social data in the Annual Report 2009 have been stated in accordance with the 
criteria mentioned.” 
Novozymes 2009 
 
“Based on our review, nothing has come to our attention that causes us to believe: 
That the selected information is not consistent with the collected supporting docu-
mentation; 
That the selected data has not, in all material respects, been prepared in accordance 
with the Group’s reporting procedures applicable during the 2009 fiscal year.” 
Sanofi-Aventis 
2009 
More specific 
and detailed 
“In Bureau Veritas’ opinion, based on the work carried out, the content of the ‘Re-
sponsibility’ website and CR content in the Annual Report, Form 20F: 
provides factual information that can be considered to be accurate and reliable and is 
reported in a clear and accessible manner; 
presents Key Performance Indicator (KPI) data that accurately reflects information 
collected at site level and collated by AstraZeneca at corporate level; 
AstraZeneca meets the GRI requirements at the B+ application level; 
AstraZeneca has CR policies and CR reporting procedures in place to comply with 
the AA1000 (2008) accountability principles of inclusivity, materiality and respon-
siveness.” 
AstraZeneca 2009 
 
“In our opinion 
The internal corporate responsibility reporting guidelines are being applied properly; 
The internal reporting system to collect and aggregate SHE and people key figures is 
functioning as designed and provides an appropriate basis for its disclosure; and 
The Roche Group SpeakUp Line systems and processes are designed following good 
practice procedures with regard todata privacy and anonymity. 
Based on our work described in this report and the assessmentof criteria, nothing has 
come to our attention that causes us tobelieve that the data and information men-
tioned in the subjectmatter and disclosed with the Sustainability Reporting inthe 
Roche Annual Report 2009, excluding ethical incident datadoes not give a fair pic-
ture of Roche’s performance.” 
Roche 2009 
 
“On the basis of the methodology described and the verification work performed, we 
are satisfied that the Environmental, Health and Safety data contained within the 
GlaxoSmithKline Corporate Responsibility Report 2009 is reliable and provides a 
fair and balanced representation of GlaxoSmithKline's Environmental, Health and 
Safety activitiesin 2009. The assurance team is of the opinion that the Report can be 
used by the Reporting Organisation's Stakeholders.” 
GlaxoSmith Kline 
2009 
(Own illustration.)  
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6 Discussion 
This chapter takes up the research questions elaborated in subchapter 4.1. First, the focus is 
set at discussing and ranking the index scores obtained. In a next step, some firm specific fac-
tors are considered to examine the relationship between these factors and TBL reporting. Fi-
nally, the industry specific risk factors identified in chapter 3 are related to the results to find 
some evidence for either or both of the disclosure arguments of legitimacy theory or voluntary 
disclosure theory. The aim is to determine whether TBL reporting indeed increases the corpo-
rations’ legitimacy by increasing the credibility of guidance, boundary-setting and assurance. 
6.1 Development of the TBL Guidance, Boundary-Setting and Assurance Levels 
First the research question (see subchapter 4.1) that is related to the development of the dis-
closure levels is discussed: 
Do the considered corporations increase, maintain or reduce the level of guidance applied 
for setting boundaries and adopting external assurance for their TBL reports? 
The case study findings suggest on the one hand that the TBL guidance index scores altogeth-
er increased over time and the TBL assurance index scores generally increased or at least re-
mained stable over time. On the other hand, the TBL boundary-index scores only increased 
over the first half of the considered reporting period, but generally stagnated on the achieved 
level. Obviously, the focus of preliminary studies on guidance and assurance has sensitized 
reporters and assurors to increase their attention to these aspects, whereas the lack of focus on 
boundary-setting seems to be underlined by the present varying reporting behavior. To com-
pare the corporate results for either of the aspects of TBL guidance, boundary-setting and as-
surance the maximum TBL index scores (see tables 18 to 23 in the Annex) are listed in ta-
ble 11 in descending order and grouped within three clusters, i. e. the corporations with the 
three highest scores are ranked as good, the medium rank includes the three middle scores and 
the three lowest scores are ranked as poor.  
Table 11: Maximum index scores 
TBL guidance 
GlaxoSmithKline 
Novartis 
Roche Holding 
Sanofi-Aventis 
AstraZeneca 
Bristol-Myers Squibb 
Pfizer 
Baxter 
Novozymes 
TBL boundary-setting 
Novartis 
Bristol-Myers Squibb 
Sanofi-Aventis 
GlaxoSmithKline 
Baxter 
Novozymes 
AstraZeneca 
Pfizer 
Roche Holding 
TBL assurance 
GlaxoSmithKline 
AstraZeneca 
Novozymes 
Roche Holding 
Baxter 
Novartis 
Sanofi-Aventis 
Bristol-Myers Squibb 
Pfizer 
 Good Medium Poor 
(Own illustration.)  
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In a further step, figure 11 visualizes how many different clusters each company covers with 
the three index scores. Pfizer is the only corporation which obtains poor results compared to 
the other corporations in all the three aspects considered. Baxter obtains medium and poor 
scores, whereas GlaxoSmithKline and Novartis obtain good and medium scores. The remain-
ing corporations are ranked differently for each aspect. A high guidance score does not neces-
sarily encompass high scores for boundary-setting or assurance, it is rather the exception. Nei-
ther does a poor boundary index score involve necessarily a poor assurance index score.  
 
Figure 11: Comparison of the maximum index scores 
(Own illustration.) 
These results suggest that there is a great variance in the corporate reporting behavior. In par-
ticular, the increase in guidance applied seems to mirror only partially in an increase of assur-
ance adopted, but not in the boundaries set. Hence, it cannot be derived that the increased ap-
plication of TBL guidance helped to improve the boundary-setting and assurance of TBL re-
ports. As long as the TBL reporting remains as voluntary as it is nowadays there is little incen-
tive to broadly align reporting boundaries and assurance formats to generally accepted crite-
ria. 
6.2 Firm and Industry Specific Factors 
Basing on the considerations of subchapter 6.1 it is suitable to discuss the following research 
question to find reasons why some of the considered red biotechnology corporations are clas-
sified as poor and medium performers while others achieved higher index scores: 
What are the firm and industry specific factors which motivate voluntary disclosures in 
terms of guidance, boundary-setting and external assurance of TBL reports? 
good & 
medium 
 
GSK, NA 
poor 
 
PF 
good, medium 
& poor 
 
AZ, BMS, NO, 
RH, SA 
medium & poor 
 
BX 
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Table 45 in the Annex summarizes the results. The corporations are grouped according to the 
clusters in figure 11. To start with, both criteria according to which the sample corporations 
were selected, i. e. the number of available TBL reports aligned to the GRI reporting standard 
between 2000 and 2009 and the net profits in 2009 are considered. Moreover, the extent of the 
value chain, the number of product types in the portfolio and the carbon performance are tak-
en into account. As to GRI adoption, there is no apparent relation between the number of 
available TBL reports and the overall evaluation of the index scores. For instance, Baxter is 
the only corporation which applies the GRI criteria for all ten reports, yet the corporation only 
obtains medium and poor index scores, whereas Novartis aligns only six reports to GRI, but is 
among the best two corporations. Interestingly, the results of this work are not confirming the 
results of a preliminary study on TBL reporting which also considered five of the present 
sample corporations.
271
 Although the focus of their work was on the use of environmental per-
formance indicators in TBL reports, the authors parted their sample in GRI pilots and non-
GRI-pilots and found higher environmental performance scores for the GRI pilots than for the 
non-pilots. Hence, when comparing the results of their study to this work, it cannot be con-
firmed that early application of guidance is mirrored in better boundaries set and assurance 
adopted. 
Similarly to GRI adoption, the corporate net profits, extent of the value chain, number of 
product types in the portfolio and the carbon performance are not apparently related to the 
overall evaluation of the index scores. While Baxter obtains low net profits and also poor and 
medium index scores, Novozymes has even lower net profits but ranks among the corpora-
tions that achieve good, medium and poor scores. There is also variety in terms of the extent 
of the value chain and the number of product types in the portfolio when comparing the 
ranked corporations. This is consistent with preliminary findings on external assurance.
272
 
These findings might point to the dynamic environment of red biotechnology corporations in 
which TBL reporting varies significantly depending on the current threats and weaknesses and 
their resulting corporate strategies. Moreover, the industry is typically considered to have 
strong impacts on sustainable development
273
 which may suggest that the industry faces 
strong public pressure. 
Second, the country of origin and the degrees of internationalization are taken into considera-
tion. As discussed in subchapter 2.2.1 the survival of a firm can be threatened by a legitima-
tion crisis resulting from increased institutional pressures. Such demands may be exerted from 
governments, legislators and regulators, consumers, employees and the management, inves-
tors and analysts, competitors and business partners, the society or the media.
274
 In particular, 
legislatory and regulatory drivers can motivate innovation and progress, reduce the costs of 
operation and enhance the corporate strategies for TBL performance and thus increase the in-
dustry’s competition.
275
 The descriptive analysis shows that except for Bristol-Myers Squibb 
especially corporations with head offices in Europe provide higher index scores than their US 
                                                 
271  Cf. VELEVA, V. et al. (2003), p. 107ff. 
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counter parts. This confirms findings of preliminary studies on external assurance.
276
 The EU 
legislation and government strongly encourages voluntary disclosures beyond mere compli-
ance, whereas the US disclosure strategy is explained by their compliance-orientated litigious 
tradition.
277
  
To consider the degree of internationalization this work compares the distribution of employ-
ees, investors and markets between the Americas (mainly the US), Europe and the rest of the 
world. The cluster of these global regions results from content analyzing the most recent an-
nual reports. Unfortunately, in a number of reports the regions cannot be further differentiated. 
In particular, the American as well as the Asian and African regions cannot be distinguished. 
However, for the American region it can be stated, that the US have the main share. There is 
no apparent relation between the number of employees per corporation and the overall evalua-
tion of the index scores. But it can be stated that especially corporations whose employees are 
mainly located in Europe obtain better index scores while corporations with solely poor and 
mediums have most of their employees in the Americas. Although only some information has 
been provided for the location of investors there might be the same trend. As to the location of 
main markets it can only be derived that they generally are in the Americas and Europe. 
Hence, public pressure originating from employees and investors seems to be stronger in Eu-
rope than in the Americas. In Europe, on the one hand, stronger social collective control is 
present which might drive public awareness concerning critical issues; on the other hand, in 
the Americas the individual responsibility is emphasized which might induce less public pres-
sure.
278
 Some corporations explain that their voluntary disclosures serve to report on the per-
formance and progress made in either of the TBL dimensions. Preliminary research suggests 
that the main addressees of TBL reports are investors, employees, NGOs representing cus-
tomers and society as well as governments which might suggest that the public pressure from 
each stakeholder group mentioned above is a major driver for TBL reporting.
279
  
Finally, the risk factors that have been identified in the SWOT analysis in chapter 3 (see ta-
bles 4 and 12) are compared between the corporations. In short, it can be stated that the num-
ber of risk factors merely varies among good, medium and poor reporters and for all corpora-
tions strengths and opportunities as well as weaknesses and threats are identified. Hence, there 
is no evident relation between these factors and the corporate reporting behavior. To get a bet-
ter understanding of other drivers for the enhancement of TBL reporting, in the following par-
agraphs the risk factors are related to the constructs considered in this work. The existence of 
specific drivers may point to either or both of the disclosure arguments of legitimacy theory or 
voluntary disclosure theory.  
Reporting and assurance standards as well as certifications refer to risk factors identified by 
the corporations which can be mainly traced to public pressure. Although the risks of ac-
ceptance by customers and human relations as well as reputation management and competi-
tion are rarely identified in the corporate annual reports, they might have a positive influence 
on the corporate decisions to adopt reporting and assurance standards as well as certifications 
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and accreditations. Besides, investors and analysts might urge the corporations to adopt such 
reporting and assurance standards and certifications. Legislation/ regulation, litigation/ inves-
tigation and product control, in terms of prices, safety and efficacy or marketing and sales 
practices, maybe is related to the adoption of reporting standards and certifications, too. The 
social reporting principles include, for example, the adoption of human rights initiatives and 
labor standards. In their 2008 and 2009 reports, Novartis informed that they signed the CEO 
Letter on the UN Convention against Corruption (maybe to reduce legal and regulatory risks). 
To a much greater extent good clinical and laboratory (including animal tests), manufacturing, 
commercial, marketing and/ or distribution practices are introduced to reduce product devel-
opment risks and beyond that improve the competitive position and the acceptance by cus-
tomers and human relations as well as reputation. The corporations, their management sys-
tems or products are certified with respect to quality, environment, organizational as well as 
consumer health and safety. Hence, such pressures from legislation/ regulation and product 
control might motivate innovation and progress
280
 in terms of enhanced corporate strategies 
for TBL performance. The case study findings indicate pressure from legal/ regulatory and fi-
nancial stakeholders and to a lesser extent influence by customers and employees which sup-
ports the arguments of legitimacy theory. 
The low results and great variance of the boundary index score suggest a negative relation be-
tween TBL boundary-setting and the corporate aim to gain, maintain or repair credibility by 
improving the quality, comparability and reliability of reporting. Although there is consensus 
among the investor and analyst community on the necessity of boundary-setting in TBL re-
porting to understand and inform on strategic risks and opportunities
281
, the case study results 
hardly suggest that these are taken into account adequately due to a number of risk factors. 
First, the pharmaceuticals industry faces high competition and strong efforts to develop new, 
innovative solutions
282
 which is why R&D and patent protection are of particular importance 
to keep market exclusivity as long as possible. Yet, the public perception and acceptance of 
for instance genetically modified products and related sustainability issues
283
 and side ef-
fects
284
 can threaten marketability and result in high accountability and reporting demands
285
. 
Second, the pharmaceuticals industry is characterized also by continuous M&A, restructuring, 
outsourcing and diversification at a global level. Such an environment consists of varying po-
litical, legal and social structures. Moreover, different standards, procedures and maybe even 
values occur between different entities in the value chain, ranging from wholly to partially 
owned.
286
 For these reasons, corporations are faced with a challenging task of integration. In 
order to take responsibility for subsidiaries and also other parts of the value chain, corpora-
tions have to make substantial efforts to control and thus to enhance the proper implementa-
tion of management systems in their global operations. Such improvements are time-
consuming, continuous processes. Besides, while the pressure from regulators, investors and 
analysts might be strong enough in Europe and the US to improve the clinical and laboratory, 
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manufacturing, commercial, marketing and/ or distribution practices and to ensure fair prices 
as well as efficacy, quality and safety this is not the case in developing or emerging markets.  
While the general increase of the TBL assurance index scores over time suggests a positive re-
lation between TBL assurance and the corporate aim to gain, maintain or repair credibility, the 
following discussion will raise question marks in terms of the credibility, comparability and 
reliability of such assurance. The decision to opt for external assurance might be related to the 
risk factors product control, value chain, customer acceptance, reputation and competitors. 
Some corporations state in very general terms that they have an interest in improving the qual-
ity, credibility, reliability or accuracy of reporting to respond to stakeholder demands of en-
hanced transparency, accountability and legitimacy. For instance, Baxter and Roche Holding 
choose external assurance to enhance the control of their global quality and risk management 
which points to product control and value chain risk factors. GlaxoSmithKline include “access 
to medicine” in the assurance process to face and address this strongly criticized issue which 
points to pressure-related risk factors, i. e. investors/ analysts, customer acceptance, product 
control. AstraZeneca identifies the issues addressed in the assurance process to accompany in-
ternal restructuring and industry challenges met which points to value chain, competition and 
reputation risk factors. Hence, the case study findings indicate risk factors relating to both, 
pressure-related or managerial/ commercial-related motivations. Yet, the present work cannot 
identify the dominance of pressure over managerial/ commercial interests or vice versa. Legit-
imacy theory suggests that firms with high public pressure (i. e. “poor” performers) increase 
the level and extent of their voluntary disclosures over time including especially soft disclo-
sures. Voluntary disclosure theory, however, suggests that only firms that have an interest to 
differentiate from their competitors (i. e. “good” performers) increase the level of voluntary 
disclosures over time. Hence, the increase of external assurance of TBL reports points to ei-
ther “good” or “poor” performers, depending on the theory considered valid. The following 
discussion aims at identifying patterns in the assurance statements which may allow deriving 
if the red biotechnology corporations are “good” or “poor” performers. 
The simple fact that the corporations increasingly decide to have their TBL reports externally 
assured suggests that they are interested to improve their reporting credibility. Yet, even the 
basic assurance format characteristics show significant differences between the corporations. 
Despite the terminology shift towards some kind of “assurance” these results contrast the 
more uniform labeling of financial assurance statements. Besides, simply labeling a statement 
with “independent” is not sufficient to add to the credibility of external assurance state-
ments
287
. The title should reflect the assurance type or methodology as well as the assurance 
level to guide the reader properly. Although the assurance statements typically include social 
as well as environmental dimensions, the above discussion of the boundaries set shows clear 
discrepancies as to the completeness of TBL reporting. Although traditional assurance stand-
ards as well as TBL assurance standards recommend the assurors to include an addressee in 
the assurance statement
288
, the results of TBL assurance are poor compared to financial assur-
ance and in general comprise solely internal stakeholders.  
                                                 
287  Cf. O'DWYER, B.; OWEN, D. L. (2005), pp. 216f. 
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Different views about who should be able to qualify as a competent, independent and respon-
sible assuror exist.
289
 Public statutory auditors can bring in their financial assurance compe-
tency, but they might not be independent from the reporting corporation if they already gain 
substantial earnings by assuring their financial statements, which may be the case for Novar-
tis, Novozymes and Sanofi-Aventis.
290
 Consultants and certifiers, however, may obtain earn-
ings from the reporter by providing consultancy services, for instance in order to implement 
an environmental management system.
291
 While in financial reporting it has become unac-
ceptable to be involved both in the design or implementation of a system as well as the prepa-
ration and audit of a financial report TBL assurance still lacks consensus and binding obliga-
tions.
292
 Moreover, there is no evidence that the red biotechnology corporations include third-
party commentaries or a combination of commentaries with formal assurance. To conclude, in 
the present work the disclosures on competence and independence of the assurors are sparse. 
Some reporters disclose more details at least most recently between 2006 and 2009, whereas 
the respective responsibilities of the reporter and assuror are stated in line with the recom-
mendations of assurance standards
293
. 
As with the above assurance categories, the nature and scope of assurance as well as the opin-
ions/ conclusions are subject to substantial variability and inclusion selectivity
294
.The bounda-
ries set for TBL assurance comprise the same limitations as described above for the bounda-
ries of TBL reporting. With respect to the latter category, in about half of the cases the as-
surors followed assurance guidelines which suggest that an opinion/ conclusion should be ex-
pressed and that findings/ observations and recommendations can be included based on the 
significance to the addressees’ needs.
295
 To conclude, the level of external TBL assurance 
statements generally improved compared to preliminary literature findings for the years 2000 
to 2003
296
. Yet, the assurance statements are characterized by strong variability and inclusion 
selectivity.  
To summarize the above considerations, a relation between the number of available TBL re-
ports and the overall evaluation of the index scores can be supported in particular for corpora-
tions which have their main head offices, employees and maybe investors in Europe. The re-
maining discussed factors do not suggest the existence of a relationship. 
6.3 Support for the Theories on Voluntary Disclosures 
The above discussion helps to determine different drivers of voluntary disclosures. This sub-
chapter aims at finding some evidence for either or both of the following arguments of legiti-
macy theory or voluntary disclosure theory: 
                                                 
289  Cf. DEEGAN, C. (2006b), pp. 336f. 
290  Cf. FÉDÉRATION DES EXPERTS COMPTABLES EUROPÉENS (2002), p. 23. 
291  Cf. FÉDÉRATION DES EXPERTS COMPTABLES EUROPÉENS (2002), p. 23. 
292  Cf. DEEGAN, C. (2006b), pp. 336f. 
293  Cf. INTERNATIONAL FEDERATION OF ACCOUNTANTS (2005), p. 1057; ACCOUNTABILITY (2008), p. 21. 
294  Cf. O'DWYER, B.; OWEN, D. L. (2005), pp. 217f; DEEGAN, C. (2006a), p. 10; DEEGAN, C. (2006b), pp. 344ff. 
295  Cf. INTERNATIONAL FEDERATION OF ACCOUNTANTS (2005), pp. 1060f. 
296  Cf. O'DWYER, B.; OWEN, D. L. (2005), pp. 205ff; DEEGAN, C. (2006b), pp. 329ff. 
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Do the considered red biotechnology corporations increase the extent of guidance applied 
for setting boundaries and adopting external assurance of their TBL reports as a legitimat-
ing strategy to respond to stakeholder pressure, as implied by legitimacy theory?  
Do the considered red biotechnology corporations maintain or reduce the level of guid-
ance applied for setting boundaries and adopting external assurance of their TBL reports 
as managerial and commercial strategy to conceal unfavorable information, as implied by 
voluntary disclosure theory? 
First, it can be stated that the motivations are related in particular to public pressure and se-
crecy strategies. As to the boundaries set, some risk factors support the secrecy arguments of 
voluntary disclosure theory, which include product portfolio, product development, manage-
ment of the value chain and reputation. Other risk factors support the public pressure argu-
ment of legitimacy theory, which encompass product control by legislators/ regulators and ac-
ceptance by customers and employees. Yet, when considering the frequency of mentioned risk 
factors, corporations identify substantial risks related to product development whereas the ac-
ceptance from customers and employees and the corporate reputation are stated only in some 
instances. On this account, there is more support for the secrecy argument of voluntary disclo-
sure theory than for the pressure argument of legitimacy theory. As to the assurance adopted, 
the pressure arguments of legitimacy theory seem to capture the drivers of external assurance 
in a better way than voluntary disclosure theory does. This notion is intensified when taking 
into account that the red biotechnology/ pharmaceutical industry generally is considered as 
having strong impacts on sustainable development and thus facing strong public awareness 
and pressure.
297
  
Hence, both theories can help to explain that the red biotechnology corporations generally are 
poor TBL performers who tend to conceal or dismiss information that is less favorable for the 
economic success of the corporation. The pressure arguments of legitimacy theory contribute 
to the understanding of why corporations choose to disclose information, whereas the secrecy 
arguments of voluntary disclosure theory explain why they do not choose to disclose. The 
findings show that economic motivations resulting in particular from a dynamic industry with 
strong M&A, R&D and patenting can incentivize to adopt a secrecy strategy to maintain mar-
ket exclusivity. This adds an additional notion to the existence of unfavorable information as a 
barrier to voluntary disclosures. While this work focuses solely on the explanation of market 
exclusivity, another study examined the relation of unfavorable information to voluntary dis-
closures and press releases by investigating media attention. The study revealed that negative 
media attention increases the level of environmental press releases but not environmental dis-
closures in annual reports.
298
 This supports the secrecy strategy due to unfavorable infor-
mation for annual report disclosures but not for press releases. To sum up, unfavorable infor-
mation not solely includes negative information with respect to the corporate TBL perfor-
mance but also information that has a value to maintain market exclusivity. 
The arguments of legitimacy theory and voluntary disclosure theory are not necessarily con-
tradictory but rather can complement each other. Voluntary disclosure theory can serve to pro-
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vide economic motivations, while legitimacy theory is helpful to provide a legitimating moti-
vation. Good performers disclose both, hard and soft information, whereas poor performers 
disclose mainly soft information to conceal and dismiss other information which they prefer 
to keep a secret.
299
 Depending on the relationship of the aspect considered and the related risk 
factors, either of the theory can provide the appropriate arguments. For instance, voluntary 
disclosure theory might provide a more robust explanation why the corporations set their 
boundaries for their TBL reports quite poorly. Legitimacy theory might predict better why and 
to what extent the corporations opt for external assurance.  
Preliminary literature discusses in particular the economics-based motivations of voluntary 
disclosures (adverse selection, secrecy) in relation to the levels of disclosures, whereas legiti-
macy theorists find a relationship between public pressure and the extent of the disclosures. 
However, the findings of this work point to a reverse relation of causes and effects. Results 
suggest that a corporation that faces strong public pressure is incentivized to increase disclo-
sure levels to satisfy stakeholder demands superficially by maintaining conceal and dismissal 
strategies. Besides, a corporation operating in a dynamic industry with strong M&A, R&D 
and patenting is interested in disclosing soft information that does not undermine the econom-
ic interest of the business. In such an environment a corporation conceals and dismisses hard 
information that is of strategic importance to maintain market exclusivity. Following this ar-
gumentation the above economics-based factors are better predictors for the secrecy strategy 
of providing mainly soft disclosures, while the increase of disclosure levels may be felt suffi-
cient to respond to public pressure. Hence, it is useful to consider both theories as comple-
mentary, not contradictory. 
Responding to the research questions it can be summarized that the corporations increase the 
level of guidance applied and in general also the level of assurance adopted to respond to pub-
lic pressure, as implied by stakeholder theory. However, the levels of boundaries set increase 
only over the first half of the period and then stagnate on the achieved level which supports 
the secrecy arguments of voluntary disclosure theory to conceal and dismiss information un-
favorable to the economic success. Besides, while public pressure might have motivated the 
increased application of TBL guidance, criticism remains that the disclosure extents remain 
heterogeneous
300
 and do not reflect appropriately the standards the corporations refer to. This 
is reflected by the great variance and inclusion selectivity of boundary-setting and external as-
surance which is also implied by voluntary disclosure theory.  
This chapter concludes by discussing the following normative research questions: 
Do the voluntary disclosures add to the credibility of TBL reporting?  
Do they have a legitimating effect? 
On the one hand, normative researchers claim that corporations nowadays need democratic 
accountability because of their sub-political role in the global community (see subchap-
ter 2.1.22.1.2). Hence, they are required to become legitimized by the way they behave in the 
usual course of business. On the other hand, the empirical findings of this case study suggest 
that current TBL guidance, boundary-setting and assurance for TBL reports are not sufficient 
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to increase the credibility, comparability and reliability of TBL reporting. Hence, it cannot be 
derived that current TBL reporting can add to corporate legitimacy. It seems that there is not 
only a corporate legitimation gap but also a gap between normative and empirical research on 
the drivers and implications of corporate legitimacy. The author reckons that normative re-
search should tests their legitimacy argument more properly with descriptive and instrumental 
works on legitimacy and vice versa. 
As long as TBL reporting remains voluntary in nature or there is no consent as to how volun-
tary disclosures should be made, the influence of guidance on TBL reporting remains limited. 
Nevertheless, the author’s opinion is that the analyzed corporations are not necessarily using 
boundary setting and external assurance solely strategically to conceal non-disclosure and 
dismiss their indirect impacts
301
. They rather might have an interest to improve their global 
TBL practice which might be why they are willing to report on the boundaries set and assur-
ance adopted. Yet, the difficulties described above help to explain why they might choose to 
exclude entities that are e. g. difficult to control. This signals an urgent need of binding stand-
ards for management systems and corporate practices as well as TBL reporting. Such stand-
ards will have to make reporting more transparent and comparable by providing binding, ex-
plicit definitions and explanations of how the materiality, impact or influence of an entity are 
to be determined in order to decide on its inclusion or exclusion. 
After presenting and discussing the results this work concludes with some final remarks on 
the legitimacy of TBL reporting and the different theoretical and empirical considerations. 
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7 Conclusion 
This work examines the extent to which corporations apply guidance for setting boundaries 
and adopting external assurance for TBL reports. A set of country and industry specific factors 
are discussed that are expected to significantly predict the level and extent of corporate TBL 
reports. The sample comprises nine US and EU red biotechnology corporations which align 
their TBL reporting to the GRI reporting standards in at least part of the TBL reports pub-
lished between 2000 and 2009. A model depicting the legitimating effect of voluntary disclo-
sures in TBL reports is provided in figure 12. The box at the bottom of the figure depicts the 
constructs analyzed and their expected relationships. A dotted arrow illustrates a postulated re-
lationship, a solid arrow an empirically verified relationship. The sign above the arrow im-
plies the direction of the relationship, “+” for a positive relationship and “-“a negative rela-
tionship. The propositions 1 to 3 summarize the expected influence of the constructs on the 
credibility of TBL reporting. Proposition 4 refers to the research question whether TBL re-
porting can have a legitimating effect. At the top of the figure the arguments of the discussed 
voluntary disclosure theories are summarized. The ellipses on the left side of the figure show 
the risk factors that are supposed to be mainly related to the public pressure argument, where-
as those on the ride side show the factors that are supposed to be mainly related to the secrecy 
argument. The propositions 5 and 6 summarize the expected relationships between the moti-
vations and the voluntary disclosures in terms of guidance applied, boundaries set and assur-
ance adopted. The aim is to help guide future research in the verification of the propositions 
presented below. 
The case study findings suggest that TBL guidance, including reporting standards, certifica-
tions and assurance standards, is increasingly adopted over time. Compared to economic 
guidance, there exists a greater variety of TBL guidance. The findings support mainly the 
public pressure argument of legitimacy theory. The industry specific factors related to TBL 
guidance indicate public pressure mainly from legal/ regulatory and financial stakeholders and 
to a lesser extent influence by customers and employees which might support the arguments 
of legitimacy theory. To respond to stakeholder demands TBL guidance is applied, but only 
selectively in order to conceal unfavorable information or such information that constitutes a 
competitive advantage. These relationships can be expressed as follows: 
Proposition 1: TBL guidance is applied selectively for setting boundaries and adopting 
assurance and therefore has limited potential to improve the credibility of TBL reporting. 
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Figure 12: Advanced model of the legitimacy of TBL reporting 
(Own illustration.) 
Note:  The box at the bottom of the figure depicts the constructs analyzed and their expected relationships. A dotted arrow il-
lustrates a postulated relationship, a solid arrow an empirically verified relationship. The sign above the arrow im-
plies the direction of the relationship, “+” for a positive relationship and “-“a negative relationship. At the top of the 
figure the arguments of the discussed voluntary disclosure theories are summarized. The ellipses on the left side of the 
figure show the risk factors that are supposed to be mainly related to the public pressure argument, whereas those on 
the ride side show the factors that are supposed to be mainly related to the secrecy argument. 
 
T
h
e
 r
e
la
ti
o
n
 b
e
tw
e
e
n
 T
B
L
 r
e
p
o
rt
in
g
 a
n
d
 l
e
g
it
im
a
c
y
T
B
L
 r
ep
o
rt
in
g
L
eg
it
im
at
io
n
B
o
u
n
d
ar
y
 s
et
ti
n
g
E
x
te
rn
al
 a
ss
u
ra
n
ce
T
B
L
 g
u
id
el
in
es
, 
st
an
d
ar
d
s,
 
p
ri
n
ci
p
le
s,
 
ce
rt
if
ic
at
io
n
s
C
re
d
it
ib
il
it
y
, 
co
m
p
ar
ab
il
it
y
, 
 
re
li
ab
il
it
y
-
-
-
-
-
-
P
ro
d
u
ct
 c
o
n
tr
o
l,
 l
eg
is
la
ti
o
n
, 
re
g
u
la
ti
o
n
, 
li
ti
g
at
io
n
, 
in
v
es
ti
g
at
io
n
B
ro
ad
 p
ro
d
u
ct
 p
o
rt
fo
li
o
, 
d
iv
er
si
fi
ca
ti
o
n
, 
re
se
ar
ch
 a
n
d
 
d
ev
el
o
p
m
en
t,
 p
at
en
ti
n
g
A
cc
ep
ta
n
ce
 b
y
 
em
p
lo
y
ee
s,
 c
u
st
o
m
er
s,
 
in
v
es
to
rs
, 
an
al
y
st
s 
(a
n
d
 
so
ci
et
y
 i
n
 g
en
er
al
)
R
es
tr
u
ct
u
ri
n
g
, 
o
u
ts
o
u
rc
in
g
, 
v
al
u
e 
ch
ai
n
 d
ep
en
d
en
ce
, 
fi
n
an
ci
al
 r
es
o
u
rc
es
A
d
v
an
ce
d
 m
o
d
el
 o
f 
v
o
lu
n
ta
ry
 d
is
cl
o
su
re
P
u
b
li
c 
p
re
ss
u
re
 a
rg
u
m
en
t
S
ec
re
cy
 a
rg
u
m
en
t
M
ai
n
ta
in
 o
r 
re
p
ai
r 
p
u
b
li
c 
ac
ce
p
ta
n
ce
In
cr
ea
se
 s
o
ft
 T
B
L
 d
is
cl
o
su
re
s
C
o
g
n
it
iv
e 
le
g
it
im
ac
y
In
cr
ea
se
 d
is
cl
o
su
re
 l
ev
el
s,
 m
ai
n
ta
in
/r
ed
u
ce
 t
o
 s
o
ft
 d
is
cl
o
su
re
s 
an
d
 c
o
n
ce
al
 n
o
n
-d
is
cl
o
su
re
s
L
im
it
ed
 c
re
d
ib
il
it
y
In
cr
ea
se
 o
f 
T
B
L
 d
is
cl
o
su
re
 l
ev
el
s
V
ar
ia
b
il
it
y
 a
n
d
 i
n
cl
u
si
o
n
 s
el
ec
ti
v
it
y
D
y
n
am
ic
 i
n
d
u
st
ry
, 
co
m
p
et
it
io
n
, 
m
er
g
er
s 
&
 
ac
q
u
is
it
io
n
s
S
am
p
le
: 
 G
lo
b
al
 r
ed
 b
io
te
ch
n
o
lo
g
y
 c
o
rp
o
ra
ti
o
n
s 
fr
o
m
 t
h
e 
U
S
 a
n
d
 E
U
 
  
  
  
  
  
  
  
 w
it
h
 s
ig
n
if
ic
an
t 
im
p
ac
ts
 o
n
 s
u
st
ai
n
ab
le
 d
ev
el
o
p
m
en
t
M
et
h
o
d
: 
C
as
e 
st
u
d
y
 a
n
al
y
si
s 
o
f 
th
e 
co
rp
o
ra
te
 T
B
L
 r
ep
o
rt
s 
fo
r 
2
0
0
0
 t
o
 2
0
0
9
62 Sustainable Business through Voluntary Disclosures: 
Motivations for Adopting Reporting Guidance, Boundaries and Assurance 
Operational boundaries are central to determine the extent of entities, also from the upstream 
and downstream value chain, that should be included in TBL reporting subject to significant 
impacts on sustainable development and/ or financial respectively operational control.
 302
 Fig-
ures suggest that boundary-setting improved over the first half of the considered period, but 
generally stagnated on the achieved level. Corporate entities are included in the reporting 
boundary quite differently and selectively without providing a clear basis for setting the 
boundaries, whereas upstream and downstream entities are included only sparely. The indus-
try specific factors related to boundary-setting indicate mainly economics-based risks. This 
might point to the secrecy strategy in order to conceal unfavorable information or such infor-
mation that constitutes a competitive advantage. On this account, the findings may lend sup-
port to voluntary disclosure theory and can be summarized as follows: 
Proposition 2: Due to strong variety and inclusion selectivity the boundaries set in TBL 
reports have limited potential to improve the credibility of TBL reporting. 
Third-party assurance is considered as a central means to bring credibility to effective TBL 
reporting by evaluating and concluding on the nature, extent and quality of information dis-
closed on a subject against certain criteria.
303
 Figures suggest that TBL reports were increas-
ingly assured by external parties. Yet, the level and extent of external assurance is character-
ized by strong variability and inclusion selectivity among the corporations and within corpo-
rations even between years. The industry specific factors relate to external assurance support 
in particular the public pressure argument of legitimacy theory and the findings can be ex-
pressed as follows: 
Proposition 3: Due to strong variety and inclusion selectivity the external assurance 
adopted in TBL reports has limited potential to improve the credibility of TBL reporting. 
This work is guided by the normative argument that corporations nowadays need democratic 
accountability because of their sub-political role in the global community (see subchap-
ter 2.1.2). Hence, corporations are required to become legitimized by the way they behave in 
the usual course of business. However, the empirical findings of this case study suggest that 
current TBL guidance, boundary-setting and assurance for TBL reports are not sufficient to 
increase the credibility, comparability and reliability of TBL reporting. It seems that there is 
not only a corporate legitimation gap but also a gap between normative and empirical research 
on the drivers and implications of legitimacy. The author reckons that normative research 
should tests their legitimacy argument more properly with descriptive and instrumental works 
on legitimacy and vice versa. The above considerations can be summarized as follows: 
Proposition 4: Building on the propositions 1 to 3 TBL reporting has a limited legitimat-
ing effect. 
This work analyzes conditions that evoke different drivers of voluntary disclosure, i. e. public 
pressure and/ or secrecy strategies. Voluntary disclosure theory can serve to provide economic 
motivations, while legitimacy theory is helpful to provide a legitimating motivation. Interest-
ing patterns can be found when grouping the risk factors by economics-based and pressure-
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based drivers (see figure 12). In a dynamic industry, corporations are faced with the need to 
adapt the product portfolio continuously, in particular by intense R&D, patenting and M&A. 
These characteristics might induce corporations to include mainly soft disclosures in TBL re-
ports and conceal certain disclosures to keep market exclusivity. As discussed in chapter 6.2, 
political and societal acceptance is dependent on the country of origin and the degree of inter-
nationalization. Hence, pressure typically increases with the public awareness of undesirable 
developments. Corporations may increase the level of voluntary disclosures without feeling 
the need to improve the extent of disclosures. Not without a good reason the legitimation tools 
are interchanged in figure 12. The findings suggest that the above economics-based factors 
explain better the secrecy strategy of providing mainly soft disclosures. The increase of dis-
closure levels, however, may be felt sufficient to respond to public pressure. This extension of 
the model suggests that both arguments are not necessarily contradictory but rather comple-
ment each other. In one context the dominance of pressure factors may be identified, in anoth-
er the dominance of secrecy factors. Future research is certainly useful to shed light into the 
pressure-based and economics-based drivers of voluntary disclosures and develop robust 
measures for these drivers. The above considerations lead to the following propositions:  
Proposition 5: Public pressure and the level of voluntary disclosures in terms of guid-
ance applied, boundaries set and assurance adopted are positively associated. 
Proposition 6: Secrecy and the extent of voluntary disclosures in terms of guidance ap-
plied, boundaries set and assurance adopted are negatively associated. 
This work aims at examining if the calls for improving the quality, comparability and verifia-
bility of TBL reporting to enhance transparency and accountability
304
 are taken into account in 
praxis in recent years. On this account, this work adds to the limited prior descriptive evi-
dence for boundaries set
305
 and external assurance adopted
306
 in TBL reports. However, ex-
cept for KOLK, A. (2010) these empirical works are not connecting the empirical results to 
theory. For this reason, this work investigates the credibility of TBL reporting by contrasting 
the two competing predictions of legitimacy theory and voluntary disclosure theory on volun-
tary disclosures. An initial attempt is made to systematically connect the motivations of the 
competing theories to develop the model of voluntary disclosures. The case study findings 
suggest that the arguments of both theories are not necessarily contradictory but rather can 
complement each other and help to explain different drivers for voluntary disclosure. 
In addition to the prepositions derived above further directions of research in the areas of 
guidance, boundary-setting and assurance are suggested. An inductive case study approach 
over a period of ten years was chosen to enhance the understanding of the drivers of voluntary 
disclosures. While this research design allows discovering new insights and relationships, no 
robust conclusions can be drawn. First, further descriptive research on the extent rather than 
the mere adoption of TBL guidance, boundary-setting and external assurance is useful to in-
centivize higher adoption levels of existing standards. Next, future research could instrumen-
tally test the robustness of the constructs and their relationships with larger samples to gener-
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64 Sustainable Business through Voluntary Disclosures: 
Motivations for Adopting Reporting Guidance, Boundaries and Assurance 
alize the theoretical framework for other industries with similar characteristics and impacts or 
to adapt it to quite different industries. Such research is useful to shed further light into the re-
lationship of TBL guidance, boundary-setting as well as external assurance to the different 
disclosure strategies of pressure, adverse selection and secrecy. In particular, it would be in-
teresting to examine the motivations for adopting the secrecy strategy. This work finds that in-
formation may be kept secret to maintain market exclusivity by analyzing corporate risk fac-
tors. The argument of unfavorable information can be examined also by relating voluntary 
disclosures and press releases with media attention. A study on this relationship revealed that 
negative media attention increases the level of environmental press releases but not environ-
mental disclosures in annual reports.
307
 This supports the secrecy argument of voluntary dis-
closure theory for annual report disclosures but not for press releases. Hence, the theoretical 
framework can be refined by other patterns relevant in this context. 
Moreover, the research sample is positively biased on purpose and includes only corporations 
from Europe and the US. Further research could replicate the constructs and relationships to 
generalize and adapt the theoretical framework to other regions to investigate the influence of 
different stakeholder demands on the corporate voluntary disclosures. Another constraint to 
this study was the partial unavailability of data to extend the investigation to other underlying 
factors. For instance when determining the degrees of internationalization, information was 
rare for the localization of investors and markets. 
It would be also interesting to empirically examine the relation of guidance, boundary-setting 
as well as external assurance to TBL performance. This work deliberately focuses on the di-
rect information provided in TBL reports for boundary-setting and not on the indirect reflec-
tion in terms of the TBL performance indicators as proposed by ARCHEL, P. (2008). Building 
on both approaches clearly has the potential to compare words and deeds. Further research is 
needed to better understand how different stakeholders react to the corporate boundary-setting 
and assurance-provision and if they perceive a legitimating effect of such voluntary disclo-
sures. Finally, it is worth to focus on external as well as internal corporate governance mecha-
nisms to see if processes have changed in favor of credibility, comparability and stakeholder 
inclusion into corporate decision-making.
308
 
This work is an attempt to advance the understanding of why firms adopt a certain level of 
voluntary disclosures. A rich model of voluntary disclosures requires considering the drivers 
and underlying factors. This work aims at informing the normative and empirical literature on 
legitimacy by developing theory that helps to explain and predict voluntary disclosures in 
corporate TBL reports.  
                                                 
307  Cf. AERTS, W.; CORMIER, D. (2009), pp. 1ff. 
308  Cf. OWEN, D. L. (2000), p. 95. 
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Annex 
Table 12: Firm-level SWOT analysis 
 Strength/ opportunity Weakness/ threat 
AZ 
Significant financial strength & cost control, diversifi-
cation, late stage R&D pipeline with potential block-
buster 
Generics competition, recent pipeline failures, patent 
case, overdependence on a segment 
BMS 
Drug exclusivity until November 2011, strong in bio-
logics, cost-saving initiative, strong financial position 
US patent expiry, key drug development programs sub-
ject to regulatory setbacks 
BX Sustained bioscience growth, acquisitions & alliances 
Reduced product reimbursement, high competition, 
manufacturing failures / product recalls 
GSK n/a n/a 
NA 
Robust revenue growth rate due to diverse portfolio & 
strong R&D between 2002 - 2008 and future (among 
global diversity leaders) 
Patent expiry, generics competition, reduced financial 
& strategic flexibility due to acquisition 
NO n/a n/a 
PF 
Largest global biopharmaceutical, leading in sales & 
marketing infrastructure, M&A cost cutting 
Generics competition, M&A dilutes own R&D and in-
novation 
RH 
Leading in global research and oncology, exclusive ac-
cess to product, minimal patent expiry exposure, robust 
financial position 
Biosimilars competition, overreliance on oncology, ad-
juvant trial failure 
SA 
Globally leading vaccine manufacturer, balanced global 
presence reduces dependence on US market 
Generics competition, claims of product linked to can-
cer risk, late stage R&D pipeline attrition 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Derived from: DATAMONITOR (2010a), DATAMONITOR (2010b), DATAMONITOR (2010c), DATAMONITOR (2010d), 
DATAMONITOR (2010f), DATAMONITOR (2010g), DATAMONITOR (2010i), pp. 5ff.) 
Table 13: Global red biotechnology corporations 
Red biotechnology corpo-
rations 
Carbon Disclosure 
Project 
Corporate Reg-
ister 
Data-
monitor 
GRI 
Number of 
GRI reports 
Profits 2009 
($bil) 
AstraZeneca 1 1 1 1 3 6 
Baxter International 1 
  
1 10 5 
Bristol-Myers Squibb 1 1 
 
1 6 10 
Coloplast 
   
1 1 1 
CSL Limited 1 1 1 1 1 4 
ESTEVE 
 
1 
 
1 4 1 
GlaxoSmithKline 1 
  
1 8 9 
Merck KGaA 
 
1 
 
1 3 3 
Millipore Corporation 1 
 
1 1 2 1 
Novartis International AG 1 1 
 
1 6 7 
Novozymes 
 
1 
 
1 9 2 
Pfizer Inc 1 1 1 1 2 8 
Roche Holding Ltd 
 
1 1 1 4 6 
Sanofi-Aventis Group 1 1 
 
1 4 6 
Straumann 
   
1 4 1 
Wyeth 1 1 
 
1 4 1 
(Derived from: PRICEWATERHOUSECOOPERS (2010), pp. 62ff; CORPORATE REGISTER (2010h), without (w/o) p; 
DATAMONITOR (2010h), w/o p; GLOBAL REPORTING INITIATIVE (2010), w/o p; FORBES MAGAZINE (2010), w/o p.) 
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Table 14: Overview of the availability and report types of corporate reports 
  Report 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Note 
AZ Annual 1 1 1 1 1 1 1 - - - Shift to integrated re-
porting in 2009, for 
2009 website contents 
for TBL available 
  TBL 1 1 1 1 1 1 1 - - 1 
  Integrated - - - - - - - 1 1 1 
BMS Annual 1 1 - 1 1 1 1 1 1 1 No annual report for 
2002 found, hence TBL 
report excluded from 
analysis, too; TBL re-
ports usually covered 
3 subsequent years  
  TBL 1 1 (1) 1 1 1 1 1 1 1 
  Integrated - - - - - - - - - - 
BX Annual 1 1 1 1 1 1 1 1 1 1 
 
  TBL 1 1 1 1 1 1 1 1 1 1 
  Integrated - - - - - - - - - - 
GSK Annual 1 1 1 1 1 1 1 1 1 1 
 
  TBL 1 1 1 1 1 1 1 1 1 1 
  Integrated - - - - - - - - - - 
NA Annual - - - - - - - - - - 
No integrated report for 
2000 found; integrated 
reports found for 2001 
and 2001 included only 
corporate responsibility 
section, hence no infor-
mation available for 
some categories consid-
ered 
  TBL (1) 1 - - - 1 1 1 1 1 
  Integrated - 1 1 1 1 1 1 1 1 1 
NO Annual - - - - - - - - - - 
No integrated report for 
2000 found 
  TBL  - - - - - - - - - - 
  Integrated - 1 1 1 1 1 1 1 1 1 
PF Annual 1 (1) (1) (1) 1 (1) 1 1 1 (1) 
TBL reports published 
irregularly, which is 
why 
for 2001 – 03, 2005 and 
2009 no information 
was available, hence 
annual reports excluded 
from analysis for these 
years, too 
  TBL  1 - - - 1 - 1 1 1 - 
  Integrated - - - - - - - - - - 
RH Annual - - - - - - - - - - 
Integrated reporting 
throughout the period, 
but until 2004 additional 
TBL report published 
  TBL  1 1 1 1 1 - - - - - 
  Integrated 1 1 1 1 1 1 1 1 1 1 
SA Annual - - - - 1 1 1 1 1 1 
Merger of Sanofi-
Synthélabo and Aventis 
in January 2004, reports 
of preliminary periods 
not included for statisti-
cal reasons 
  TBL  - - - - 1 1 1 1 1 1 
  Integrated - - - - - - - - - - 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), Novartis Internation-
al AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
1 implies that a report is available, (1) implies that an available report is not examined, - implies that no report is available. 
(Own illustration.) 
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Table 15: Category system 
Main  
categories 
Categories Sub-categories 
Number of 
codes 
Dimensions Weight 
Max 
points 
Econ 
Max 
points 
TBL 
Max 
points 
ALL 
Guidelines 
     
6 20 26 
 
Reports/ poli-
cies  
Economic 2 Economic 1 2 - 2 
  
Environmental  3 TBL 1 - 3 3 
  
Social 3 TBL 1 - 3 3 
  
TBL 4 TBL 1 - 4 4 
 
Certifications Economic  1 
Economic, 
TBL 
1 1 1 2 
  
Environmental  3 TBL 1 - 3 3 
  
Social 2 TBL 1 - 2 2 
  
TBL 1 TBL 1 - 1 1 
 
Assurance Audit 1 
Economic, 
TBL 
1 1 1 2 
  
Ethics 1 
Economic, 
TBL 
1 1 1 2 
  
TBL 1 
Economic, 
TBL 
1 1 1 2 
Boundaries  
     
14 14 28 
 
Boundaries Scope 1 7 
Economic, 
TBL 
1 7 7 14 
  
Scope 2 1 
Economic, 
TBL 
1 1 1 2 
  
Scope 3 2 
Economic, 
TBL 
1 2 2 4 
 
Changes Changes 1 
Economic, 
TBL 
1 1 1 2 
 
Exclusions Exclusions 1 
Economic, 
TBL 
1 1 1 2 
 
Report  
basis 
Influence/control 1 
Economic, 
TBL 
1 1 1 2 
  
Impact 1 
Economic, 
TBL 
1 1 1 2 
External As-
surance      
24 24 48 
 
Format Statement 1 
Economic, 
TBL 
1 1 1 2 
  
Title 1 
Economic, 
TBL 
0 0 0 0 
  
Dimensions 3 
Economic, 
TBL 
0 0 0 0 
  
Assuror 1 
Economic, 
TBL 
0 0 0 0 
  
Addressee 2 
Economic, 
TBL 
1 2 2 4 
 
Qualification Competence 6 
Economic, 
TBL 
1 6 6 12 
  
Independence 2 
Economic, 
TBL 
1 2 2 4 
  
Responsibility 2 
Economic, 
TBL 
1 2 2 4 
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Main  
categories 
Categories Sub-categories 
Number of 
codes 
Dimensions Weight 
Max 
points 
Econ 
Max 
points 
TBL 
Max 
points 
ALL 
 
Nature & scope Level 1 
Economic, 
TBL 
1 1 1 2 
  
Coverage 1 
Economic, 
TBL 
1 1 1 2 
  
Limitations 1 
Economic, 
TBL 
1 1 1 2 
  
Boundary 1 
Economic, 
TBL 
1 1 1 2 
  
Criteria 1 
Economic, 
TBL 
1 1 1 2 
  
Methodology 1 
Economic, 
TBL 
1 1 1 2 
 
Opinions/ con-
clusions 
Opinions/ conclu-
sions 
1 
Economic, 
TBL 
1 1 1 2 
  
Findings/ observa-
tions 
1 
Economic, 
TBL 
1 1 1 2 
  
Recommendations 1 
Economic, 
TBL 
1 1 1 2 
  
Progress 1 
Economic, 
TBL 
1 1 1 2 
  
Commentary 1 
Economic, 
TBL 
1 1 1 2 
(Own illustration.) 
Table 16: Coding rules 
 
Coding rules Specification 
1 
Code only items which are within the 
considered period. 
The reporting period must cover more than 6 months of the present year 
(e.g. January to August) 
2 
Boundary changes are coded when they are named the first time (e.g. acqui-
sitions), repetitions without improvement in future reports are not coded. 
3 Disclosures on planned assurance engagements are not coded. 
4 
Code reports covering more than one 
year separately for every single year. 
Code carefully to consider information only for the specific year. 
5 Code every item only once. 
6 Code for subsequent years only if substantial changes occurred. 
7 
Long-term oriented items are only coded if substantial effort can be proven 
for the period. 
8 
Code adoption of, not necessarily 
membership, with reporting guidelines. 
TBL reporting should at least be basing on a guideline, but does not neces-
sarily have to involve membership. 
9 Code only group level information. 
Code only reports that explicitly comprise group-level activity, not solely 
facility-activity. 
10 
Code assurance report only if a report is 
available. 
The simple statement that assurance was made is not sufficient. 
(Own illustration.) 
Sustainable Business through Voluntary Disclosures:  
Motivations for Adopting Reporting Guidance, Boundaries and Assurance 69 
Table 17: Time trends in preliminary and proper studies 
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(Own illustration.) 
Note:  With respect to the proper case study a number without brackets symbolizes the number of corporations which dis-
closed on all codes within a sub-category. A number in brackets symbolizes the number of corporations which dis-
closed on some codes within a sub-category. With respect to preliminary studies in general percentages are provided, 
the categories which were not considered is shown by n/a.   
Sustainable Business through Voluntary Disclosures:  
Motivations for Adopting Reporting Guidance, Boundaries and Assurance 71 
Table 18: TBL guidance index scores (absolute) 
 
AZ BX BMS GSK NA NO PF RH SA mean med min max se 
2000 0 5 4 0 - - 1 3 - 2.17 2.00 0.00 5.00 2.14 
2001 2 4 1 4 1 5 - 6 - 3.29 4.00 1.00 6.00 1.98 
2002 3 3 - 7 5 2 - 5 - 4.17 4.00 2.00 7.00 1.83 
2003 2 2 4 8 3 2 - 9 - 4.29 3.00 2.00 9.00 2.98 
2004 3 3 4 9 2 4 3 11 4 4.78 4.00 2.00 11.00 3.07 
2005 3 4 4 8 4 5 - 8 4 5.00 4.00 3.00 8.00 1.93 
2006 4 4 5 9 8 5 6 10 10 6.78 6.00 4.00 10.00 2.49 
2007 1 6 5 10 9 5 5 6 9 6.22 6.00 1.00 10.00 2.77 
2008 1 3 5 12 10 3 5 6 8 5.89 5.00 1.00 12.00 3.55 
2009 8 7 5 11 11 5 - 7 6 7.50 7.00 5.00 11.00 2.39 
mean 2.7 4.1 4.1 7.8 5.9 4 4 7.1 6.8 
     
med 2.5 4 4 8.5 5 5 5 6.5 7 
     
min 0 2 1 0 1 2 1 3 4 
     
max 8 7 5 12 11 5 6 11 10 
     
se 2.2 1.5 1.3 3.5 3.7 1.3 2 2.4 2.6 
     
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
median (med), minimum (min), maximum (max), standard deviation (se). 
“-“ implies that the TBL report was not available or excluded from analysis (see table 14 in the Annex).  
A zero score implies that no information was provided. 
(Own illustration.) 
Table 19: TBL guidance index scores (percentage) 
 
AZ BX BMS GSK NA NO PF RH SA mean med min max se 
2000 0% 25% 20% 0% - - 5% 15% - 11% 10% 0% 25% 11% 
2001 10% 20% 5% 20% 5% 25% - 30% - 16% 20% 5% 30% 10% 
2002 15% 15% - 35% 25% 10% - 25% - 21% 20% 10% 35% 9% 
2003 10% 10% 20% 40% 15% 10% - 45% - 21% 15% 10% 45% 15% 
2004 15% 15% 20% 45% 10% 20% 15% 55% 20% 24% 20% 10% 55% 15% 
2005 15% 20% 20% 40% 20% 25% - 40% 20% 25% 20% 15% 40% 10% 
2006 20% 20% 25% 45% 40% 25% 30% 50% 50% 34% 30% 20% 50% 12% 
2007 5% 30% 25% 50% 45% 25% 25% 30% 45% 31% 30% 5% 50% 14% 
2008 5% 15% 25% 60% 50% 15% 25% 30% 40% 29% 25% 5% 60% 18% 
2009 40% 35% 25% 55% 55% 25% - 35% 30% 38% 35% 25% 55% 12% 
mean 14% 21% 21% 39% 29% 20% 20% 36% 34%           
med 13% 20% 20% 43% 25% 25% 25% 33% 35%           
min 0% 10% 5% 0% 5% 10% 5% 15% 20%           
max 40% 35% 25% 60% 55% 25% 30% 55% 50%           
se 11% 8% 6% 18% 18% 7% 10% 12% 13%           
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
median (med), minimum (min), maximum (max), standard deviation (se). 
“-“ implies that the TBL report was not available or excluded from analysis (see table 14 in the Annex).  
A zero percentage implies that no information was provided. 
(Own illustration.) 
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Table 20: TBL boundary index scores (absolute) 
 
AZ BX BMS GSK NA NO PF RH SA mean med min max se 
2000 4.00 0.00 0.00 2.00 - - 1.00 4.00 - 1.83 1.50 0.00 4.00 1.83 
2001 4.00 0.00 0.00 6.00 7.00 0.00 - 4.00 - 3.00 4.00 0.00 7.00 3.00 
2002 0.00 - 0.00 3.00 0.00 4.00 - 4.00 - 1.83 1.50 0.00 4.00 2.04 
2003 0.00 9.00 0.00 6.50 6.00 4.00 - 4.00 - 4.21 4.00 0.00 9.00 3.34 
2004 0.00 9.00 0.00 5.00 6.00 4.00 0.00 4.00 8.00 4.00 4.00 0.00 9.00 3.43 
2005 0.00 9.00 3.00 5.50 10.00 4.00 - 2.00 8.00 5.19 4.75 0.00 10.00 3.57 
2006 0.00 9.00 5.00 3.00 10.00 4.00 3.00 0.00 8.00 4.67 4.00 0.00 10.00 3.67 
2007 0.00 9.00 5.00 4.50 8.00 5.00 4.00 0.00 8.00 4.83 5.00 0.00 9.00 3.26 
2008 0.00 9.00 5.00 0.00 8.00 6.00 4.00 0.00 7.50 4.39 5.00 0.00 9.00 3.62 
2009 2.00 6.00 6.00 0.00 8.00 5.00 - 0.00 7.50 4.31 5.50 0.00 8.00 3.22 
mean 1.00 6.67 2.40 3.55 7.00 4.00 2.40 2.20 7.83           
med 0.00 9.00 1.50 3.75 8.00 4.00 3.00 3.00 8.00           
min 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.50           
max 4.00 9.00 6.00 6.50 10.00 6.00 4.00 4.00 8.00           
se 1.70 3.91 2.63 2.35 3.00 1.66 1.82 1.99 0.26           
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
median (med), minimum (min), maximum (max), standard deviation (se). 
“-“ implies that the TBL report was not available or excluded from analysis (see table 14 in the Annex).  
A zero score implies that no information was provided. 
(Own illustration.) 
Table 21: TBL boundary index scores (percentage) 
 
AZ BX BMS GSK NA NO PF RH SA mean med min max se 
2000 29% 0% 0% 14% - - 7% 29% - 13% 11% 0% 29% 13% 
2001 29% 0% 0% 43% 50% 0% - 29% - 21% 29% 0% 50% 21% 
2002 0% - 0% 21% 0% 29% - 29% - 13% 11% 0% 29% 15% 
2003 0% 64% 0% 46% 43% 29% - 29% - 30% 29% 0% 64% 24% 
2004 0% 64% 0% 36% 43% 29% 0% 29% 57% 29% 29% 0% 64% 24% 
2005 0% 64% 21% 39% 71% 29% - 14% 57% 37% 34% 0% 71% 25% 
2006 0% 64% 36% 21% 71% 29% 21% 0% 57% 33% 29% 0% 71% 26% 
2007 0% 64% 36% 32% 57% 36% 29% 0% 57% 35% 36% 0% 64% 23% 
2008 0% 64% 36% 0% 57% 43% 29% 0% 54% 31% 36% 0% 64% 26% 
2009 14% 43% 43% 0% 57% 36% - 0% 54% 31% 39% 0% 57% 23% 
mean 7% 48% 17% 25% 50% 29% 17% 16% 56%           
med 0% 64% 11% 27% 57% 29% 21% 21% 57%           
min 0% 0% 0% 0% 0% 0% 0% 0% 54%           
max 29% 64% 43% 46% 71% 43% 29% 29% 57%           
se 12% 28% 19% 17% 21% 12% 13% 14% 2%           
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
median (med), minimum (min), maximum (max), standard deviation (se). 
“-“ implies that the TBL report was not available or excluded from analysis (see table 14 in the Annex).  
A zero percentage implies that no information was provided. 
(Own illustration.) 
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Table 22: TBL assurance index scores (absolute) 
 
AZ BX BMS GSK NA NO PF RH SA mean med min max se 
2000 0.00 5.00 1.00 5.00 11.00 - 0.00 9.00 - 4.43 5.00 0.00 11.00 4.39 
2001 0.00 1.00 4.00 6.00 6.00 0.00 - 9.00 - 3.71 4.00 0.00 9.00 3.50 
2002 0.00 - 4.00 7.00 8.00 9.00 - 8.00 - 6.00 7.50 0.00 9.00 3.41 
2003 0.00 1.00 0.00 7.00 0.00 10.00 - 8.00 - 3.71 1.00 0.00 10.00 4.42 
2004 15.00 5.00 0.00 7.00 10.00 8.00 0.00 10.00 8.00 7.00 8.00 0.00 15.00 4.82 
2005 14.00 6.00 1.00 8.00 10.00 6.00 - 9.00 8.00 7.75 8.00 1.00 14.00 3.73 
2006 13.00 5.00 1.00 12.00 11.00 10.00 0.00 12.00 8.00 8.00 10.00 0.00 13.00 4.90 
2007 1.00 0.00 1.00 13.00 11.00 10.00 0.00 12.00 8.00 6.22 8.00 0.00 13.00 5.61 
2008 1.00 1.00 1.00 12.00 11.00 10.00 0.00 11.00 8.00 6.11 8.00 0.00 12.00 5.21 
2009 14.00 0.00 11.00 17.00 11.00 13.00 - 11.00 9.00 10.75 11.00 0.00 17.00 4.98 
mean 5.80 2.67 2.40 9.40 8.90 8.44 0.00 9.90 8.17           
med 1.00 1.00 1.00 7.50 10.50 10.00 0.00 9.50 8.00           
min 0.00 0.00 0.00 5.00 0.00 0.00 0.00 8.00 8.00           
max 15.00 6.00 11.00 17.00 11.00 13.00 0.00 12.00 9.00           
se 7.08 2.50 3.34 3.86 3.54 3.68 0.00 1.52 0.41           
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
median (med), minimum (min), maximum (max), standard deviation (se). 
“-“ implies that the TBL report was not available or excluded from analysis (see table 14 in the Annex).  
A zero score implies that no information was provided, a score of one implies that assurance was adopted, but no statement 
was enclosed. 
(Own illustration.) 
Table 23: TBL assurance index scores (percentage) 
 
AZ BX BMS GSK NA NO PF RH SA mean med min max se 
2000 0% 21% 4% 21% - - 0% 38% - 14% 13% 0% 38% 15% 
2001 0% 4% 17% 25% 25% 0% - 38% - 15% 17% 0% 38% 15% 
2002 0% - 17% 29% 33% 38% - 33% - 25% 31% 0% 38% 14% 
2003 0% 4% 0% 29% 0% 42% - 33% - 15% 4% 0% 42% 18% 
2004 63% 21% 0% 29% 42% 33% 0% 42% 33% 29% 33% 0% 63% 20% 
2005 58% 25% 4% 33% 42% 25% - 38% 33% 32% 33% 4% 58% 16% 
2006 54% 21% 4% 50% 46% 42% 0% 50% 33% 33% 42% 0% 54% 20% 
2007 4% 0% 4% 54% 46% 42% 0% 50% 33% 26% 33% 0% 54% 23% 
2008 4% 4% 4% 50% 46% 42% 0% 46% 33% 25% 33% 0% 50% 22% 
2009 58% 0% 46% 71% 46% 54% - 46% 38% 45% 46% 0% 71% 21% 
mean 24% 11% 10% 39% 36% 35% 0% 41% 34%           
med 4% 4% 4% 31% 42% 42% 0% 40% 33%           
min 0% 0% 0% 21% 0% 0% 0% 33% 33%           
max 63% 25% 46% 71% 46% 54% 0% 50% 38%           
se 30% 10% 14% 16% 15% 15% 0% 6% 2%           
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
median (med), minimum (min), maximum (max), standard deviation (se). 
“-“ implies that the TBL report was not available or excluded from analysis (see table 14 in the Annex).  
A zero percentage implies that no information was provided, a percentage of four implies that assurance was adopted, but 
no statement was enclosed. 
(Own illustration.) 
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Table 24: Economic boundary index scores (absolute) 
 
AZ BX BMS GSK NA NO PF RH SA mean med min max se 
2000 5.00 4.00 3.00 3.00 - - 4.00 5.00 - 4.00 4.00 3.00 5.00 0.89 
2001 5.00 4.00 3.00 3.00 0.00 5.00 - 5.00 - 3.57 4.00 0.00 5.00 1.81 
2002 5.00 - 3.00 3.00 6.00 5.00 - 5.00 - 4.50 5.00 3.00 6.00 1.22 
2003 5.00 5.00 3.00 4.00 0.00 6.00 - 5.00 - 4.00 5.00 0.00 6.00 2.00 
2004 5.00 5.00 3.00 4.00 5.00 5.00 4.00 5.00 4.00 4.44 5.00 3.00 5.00 0.73 
2005 5.00 5.00 3.00 4.00 5.00 6.00 - 5.00 5.00 4.75 5.00 3.00 6.00 0.89 
2006 5.00 5.00 3.00 4.00 6.00 6.00 4.00 5.00 5.00 4.78 5.00 3.00 6.00 0.97 
2007 5.00 5.00 3.00 3.00 6.00 6.00 4.00 5.00 5.00 4.67 5.00 3.00 6.00 1.12 
2008 5.00 6.00 3.00 3.00 6.00 6.00 4.00 5.00 5.00 4.78 5.00 3.00 6.00 1.20 
2009 5.00 6.00 3.00 3.00 5.00 6.00 - 5.00 5.00 4.75 5.00 3.00 6.00 1.16 
mean 5.00 5.00 3.00 3.40 4.33 5.67 4.00 5.00 4.83           
med 5.00 5.00 3.00 3.00 5.00 6.00 4.00 5.00 5.00           
min 5.00 4.00 3.00 3.00 0.00 5.00 4.00 5.00 4.00           
max 5.00 6.00 3.00 4.00 6.00 6.00 4.00 5.00 5.00           
se 0.00 0.71 0.00 0.52 2.50 0.50 0.00 0.00 0.41           
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
median (med), minimum (min), maximum (max), standard deviation (se). 
“-“ implies that the TBL report was not available or excluded from analysis (see table 14 in the Annex).  
A zero score implies that no information was provided. 
(Own illustration.) 
Table 25: Economic boundary index scores (percentage) 
 
AZ BX BMS GSK NA NO PF RH SA mean med min max se 
2000 36% 29% 21% 21% - - 29% 36% - 29% 29% 21% 36% 6% 
2001 36% 29% 21% 21% 0% 36% - 36% - 26% 29% 0% 36% 13% 
2002 36% - 21% 21% 43% 36% - 36% - 32% 36% 21% 43% 9% 
2003 36% 36% 21% 29% 0% 43% - 36% - 29% 36% 0% 43% 14% 
2004 36% 36% 21% 29% 36% 36% 29% 36% 29% 32% 36% 21% 36% 5% 
2005 36% 36% 21% 29% 36% 43% - 36% 36% 34% 36% 21% 43% 6% 
2006 36% 36% 21% 29% 43% 43% 29% 36% 36% 34% 36% 21% 43% 7% 
2007 36% 36% 21% 21% 43% 43% 29% 36% 36% 33% 36% 21% 43% 8% 
2008 36% 43% 21% 21% 43% 43% 29% 36% 36% 34% 36% 21% 43% 9% 
2009 36% 43% 21% 21% 36% 43% - 36% 36% 34% 36% 21% 43% 8% 
mean 36% 36% 21% 24% 31% 40% 29% 36% 35%           
med 36% 36% 21% 21% 36% 43% 29% 36% 36%           
min 36% 29% 21% 21% 0% 36% 29% 36% 29%           
max 36% 43% 21% 29% 43% 43% 29% 36% 36%           
se 0% 5% 0% 4% 18% 4% 0% 0% 3%           
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
median (med), minimum (min), maximum (max), standard deviation (se). 
“-“ implies that the TBL report was not available or excluded from analysis (see table 14 in the Annex).  
A zero percentage implies that no information was provided. 
(Own illustration.) 
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Table 26: Economic assurance index scores (absolute) 
 
AZ BX BMS GSK NA NO PF RH SA mean med min max se 
2000 7.00 7.00 6.00 8.00 10.00 - 5.00 9.00 - 7.43 7.00 5.00 10.00 1.72 
2001 5.00 7.00 9.00 8.00 0.00 6.00 - 9.00 - 6.29 7.00 0.00 9.00 3.15 
2002 7.00 - 9.00 8.00 8.00 8.00 - 9.00 - 8.17 8.00 7.00 9.00 0.75 
2003 7.00 10.00 3.00 8.00 0.00 8.00 - 9.00 - 6.43 8.00 0.00 10.00 3.60 
2004 7.00 9.00 8.00 8.00 9.00 10.00 9.00 9.00 9.00 8.67 9.00 7.00 10.00 0.87 
2005 7.00 9.00 7.00 8.00 9.00 8.00 - 9.00 9.00 8.25 8.50 7.00 9.00 0.89 
2006 7.00 9.00 7.00 8.00 9.00 10.00 9.00 9.00 9.00 8.56 9.00 7.00 10.00 1.01 
2007 7.00 9.00 9.00 8.00 9.00 10.00 9.00 10.00 9.00 8.89 9.00 7.00 10.00 0.93 
2008 7.00 9.00 9.00 7.00 9.00 10.00 9.00 11.00 9.00 8.89 9.00 7.00 11.00 1.27 
2009 8.00 10.00 10.00 10.00 10.00 11.00 - 12.00 10.00 10.13 10.00 8.00 12.00 1.13 
mean 6.90 8.78 7.70 8.10 7.30 9.00 8.20 9.60 9.17           
med 7.00 9.00 8.50 8.00 9.00 10.00 9.00 9.00 9.00           
min 5.00 7.00 3.00 7.00 0.00 6.00 5.00 9.00 9.00           
max 8.00 10.00 10.00 10.00 10.00 11.00 9.00 12.00 10.00           
se 0.74 1.09 2.06 0.74 3.89 1.58 1.79 1.07 0.41           
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
median (med), minimum (min), maximum (max), standard deviation (se). 
“-“ implies that the TBL report was not available or excluded from analysis (see table 14 in the Annex).  
A zero score implies that no information was provided, a score of one implies that assurance was adopted, but no statement 
was enclosed. 
(Own illustration.) 
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Table 27: Economic assurance index scores (percentage) 
 
AZ BX BMS GSK NA NO PF RH SA mean med min max se 
2000 29% 29% 25% 33% 42% - 21% 38% - 31% 29% 21% 42% 7% 
2001 21% 29% 38% 33% 0% 25% - 38% - 26% 29% 0% 38% 13% 
2002 29% - 38% 33% 33% 33% - 38% - 34% 33% 29% 38% 3% 
2003 29% 42% 13% 33% 0% 33% - 38% - 27% 33% 0% 42% 15% 
2004 29% 38% 33% 33% 38% 42% 38% 38% 38% 36% 38% 29% 42% 4% 
2005 29% 38% 29% 33% 38% 33% - 38% 38% 34% 35% 29% 38% 4% 
2006 29% 38% 29% 33% 38% 42% 38% 38% 38% 36% 38% 29% 42% 4% 
2007 29% 38% 38% 33% 38% 42% 38% 42% 38% 37% 38% 29% 42% 4% 
2008 29% 38% 38% 29% 38% 42% 38% 46% 38% 37% 38% 29% 46% 5% 
2009 33% 42% 42% 42% 42% 46% - 50% 42% 42% 42% 33% 50% 5% 
mean 29% 37% 32% 34% 30% 38% 34% 40% 38%           
med 29% 38% 35% 33% 38% 42% 38% 38% 38%           
min 21% 29% 13% 29% 0% 25% 21% 38% 38%           
max 33% 42% 42% 42% 42% 46% 38% 50% 42%           
se 3% 5% 9% 3% 16% 7% 7% 4% 2%           
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
median (med), minimum (min), maximum (max), standard deviation (se). 
“-“ implies that the TBL report was not available or excluded from analysis (see table 14 in the Annex).  
A zero percentage implies that no information was provided, a percentage of four implies that assurance was adopted, but 
no statement was enclosed. 
(Own illustration.) 
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Table 28: Reporting guidelines applied 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic report-
ing 
                    
Economic guid-
ance 
                    
US GAAP & UK 
GAPP 
AZ, 
BX, 
GSK, 
PF 
AZ, 
BX, 
GSK, 
NO 
AZ, 
BX, 
GSK, 
NO 
AZ, 
BMS, 
GSK 
AZ, BX, 
BMS, 
GSK, 
PF 
AZ, BX, 
BMS, 
GSK 
AZ, BX, 
BMS, 
GSK, PF 
AZ, BX, 
BMS, 
GSK, PF 
AZ, BX, 
BMS, 
GSK, PF 
AZ, BX, 
BMS, 
GSK 
IFRS     RH RH 
NA, 
NO, RH 
AZ, 
GSK, 
NA, NO, 
RH, SA 
AZ, GSK, 
NA, NO, 
RH, SA 
AZ, GSK, 
NA, NO, 
RH, SA 
AZ, GSK, 
NA, NO, 
RH, SA 
AZ, 
GSK, 
NA, NO, 
RH, SA 
TBL reporting                     
Environmental 
guidance 
                    
Kyoto-Protocol   RH RH   SA RH, SA 
NA, RH, 
SA 
NA NA NA, SA 
UN programs   
GSK, 
NO 
GSK   GSK   NA, SA 
GSK, 
NA, SA 
GSK, 
NA, SA 
GSK, 
NA 
UNEP       RH RH           
Social guidance                     
Corporate prac-
tice and business 
ethics 
BX   AZ 
AZ, 
BMS, 
GSK, 
RH 
AZ, 
BMS, 
GSK, 
PF, RH, 
SA 
AZ, 
BMS, 
GSK, 
NA, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, PF, 
RH, SA 
BMS, 
BX, 
GSK, 
NA, PF, 
RH, SA 
AZ, 
BMS, 
GSK, 
NA, PF, 
RH, SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, RH, 
SA 
Human rights   NO 
AZ, 
GSK 
AZ, 
GSK, 
RH 
AZ, 
GSK, 
RH 
AZ, 
GSK 
AZ, GSK, 
RH, SA 
AZ, GSK, 
NA, SA 
AZ, GSK, 
NA, SA 
AZ, 
GSK, 
NA, SA 
Labour condi-
tions 
    GSK 
BMS, 
GSK, 
RH 
BMS, 
GSK, 
RH 
BMS, 
GSK 
BMS, 
GSK, SA 
BMS, 
GSK, 
NA, SA 
BMS, 
GSK, 
NA, SA 
BMS, 
GSK, 
NA, SA 
TBL guidance                     
GRI BX 
AZ, 
BX, 
NO 
AZ, 
BX, 
GSK, 
NO 
BMS, 
BX, 
GSK, 
NO 
BMS, 
BX, 
GSK, 
NA, NO 
BMS, 
BX, 
GSK, 
NA, NO 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, SA 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH, 
SA 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH, 
SA 
BMS, 
BX, 
GSK, 
NA, NO, 
RH, SA 
Industry specific 
BMS, 
RH 
NO, 
RH 
RH RH PF, RH RH NA, RH NA, RH NA, RH NA, RH 
UN   
NA, 
NO 
NA 
NA, 
RH 
NA, PF, 
RH, SA 
NA, NO, 
SA 
NA, NO, 
PF, SA 
GSK, 
NA, NO, 
SA 
GSK, 
NA, NO, 
SA 
AZ, 
GSK, 
NA, NO, 
SA 
Others BX 
BX, 
GSK 
BX, 
GSK 
GSK 
BX, 
GSK, 
RH 
BX, 
GSK 
BX, 
GSK, SA 
BX, 
GSK, SA 
GSK, 
NA, SA 
AZ, 
GSK, 
NA, SA 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
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Table 29: Certifications and accreditations applied 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic re-
porting 
                    
Economic                     
Patent protection 
AZ, 
GSK 
AZ AZ AZ 
AZ, 
BMS 
AZ, 
BMS, 
NA 
BMS, SA 
BMS, 
GSK, 
SA 
SA 
GSK, 
SA 
TBL reporting                     
Economic                     
Quality man-
agement system 
BMS, 
BX 
BMS, 
BX 
NA   NO NO NO NO GSK NO 
Environmental                     
GHG emissions         NO     NA BX, NA BX, NA 
Environmental 
management sys-
tem 
BMS, 
BX, 
PF, RH 
AZ, 
BX, 
GSK, 
RH 
BX, 
GSK, 
NA, 
RH 
BMS, 
BX, 
GSK, 
NA 
BMS, 
BX, 
GSK, 
SA 
BMS, 
BX, 
GSK, 
NO, RH, 
SA 
BMS, 
BX, GSK, 
NA, NO, 
PF, RH, 
SA 
BMS, 
BX, 
GSK, 
NO, PF, 
SA 
BMS,GSK, 
PF, SA 
AZ, 
BMS, 
BX, 
GSK, 
NO, SA 
Others       BMS BMS BMS AZ, BMS 
BMS, 
BX, PF, 
RH 
BMS, BX, 
NA, PF 
AZ, 
BMS, 
BX 
Social                     
Occupational 
health & safety 
  
GSK, 
RH 
GSK, 
NA 
GSK, 
NA 
GSK 
BX, 
GSK 
BMS, 
GSK, 
NA, PF 
BMS, 
BX, 
GSK, PF 
BMS, GSK, 
PF 
BMS, 
BX, 
GSK 
R&D and ani-
mals 
      
GSK, 
RH 
GSK, 
RH 
GSK, 
NA, RH 
GSK, RH, 
SA 
SA GSK 
GSK, 
RH 
TBL                     
Health, safety & 
environment 
        RH RH RH   RH RH 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
 
(Own illustration.) 
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Table 30: Assurance guidelines applied 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic assurance                     
Auditing                     
AA1000AS       NO NO NO NO NO NO   
Auditing Practices Board auditing 
standards 
AZ, 
GSK 
  AZ AZ AZ           
Auditing Standards Board         PF           
Danish Auditing Standard   NO NO NO NO NO NO NO NO NO 
international auditing standards  RH 
NO, 
RH 
NA, 
NO, 
RH 
NO, 
RH 
NO, 
RH 
AZ, 
NA, 
NO, 
RH 
AZ, 
NA, 
NO, 
RH 
AZ, 
NA, 
NO, 
RH 
AZ, 
NA, 
NO, 
RH 
AZ, 
NA, 
NO, 
RH 
ISAE 3000         NA NA NA 
NA, 
RH 
NA, 
RH 
NA, 
RH 
Public Company Accounting 
Oversights Board auditing stand-
ards 
        
BX, 
BMS, 
PF, 
SA 
BX, 
BMS, 
NA, 
SA 
BX, 
BMS, 
NA, 
PF, 
SA 
BX, 
BMS, 
NA, 
PF, 
SA 
BX, 
BMS, 
NA, 
PF, 
SA 
AZ, 
BX, 
BMS, 
NA, 
SA 
Swiss Auditing Standards RH RH 
NA, 
RH 
RH 
NA, 
RH 
NA, 
RH 
NA, 
RH 
NA, 
RH 
NA, 
RH 
NA, 
RH 
US GAAP 
BX, 
BMS, 
GSK 
BX, 
BMS, 
GSK 
BX, 
GSK 
BMS             
Ethical                     
Auditing Practices Board ethical 
standards 
                  
AZ, 
GSK 
TBL assurance                     
Auditing                     
AA1000AS     NO NO 
AZ, 
NO 
AZ, 
NO 
AZ, 
GSK, 
NO 
GSK, 
NO 
GSK, 
NO 
AZ, 
NO 
Environment, Health & Safety 
Auditing Roundtable 
BMS                   
FEE     NO               
International Federation of Ac-
countants 
  RH RH               
international auditing standards      
NA, 
NO 
NO             
ISAE 2000       RH             
ISAE 3000         
NO, 
RH 
NO, 
RH 
NO, 
RH 
NO, 
RH 
NO, 
RH 
BX, 
GSK, 
NA, 
NO, 
RH 
International Organization for 
Standardization Environmental 
Audit Guidelines 
BMS                   
US Department of Justice Guide-
lines 
BMS                   
US Environmental Protection 
Agency audit program criteria 
BMS                   
Ethical                     
-                     
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
TBL                     
CEFIC Responsible Care HSE re-
porting guidelines 
RH RH RH RH RH RH RH RH RH RH 
Good Environment, Health & 
Safety Reporting Principles 
  BX BX               
GRI criteria     NA   RH RH 
GSK, 
RH 
GSK, 
RH 
GSK, 
RH 
AZ, 
BX, 
GSK, 
RH 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
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Table 31: Reporting boundaries set 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic re-
porting 
                    
Parent compa-
ny & divisions 
AZ, 
BMS, 
BX, 
GSK, 
PF, RH 
AZ, 
BMS, 
BX, 
GSK, 
NO, 
RH 
AZ, 
BX, 
GSK, 
NA, 
NO, 
RH 
AZ, 
BMS, 
BX, 
GSK, 
NO, 
RH 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO,  
RH, SA 
AZ, BMS, 
BX, GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO,  
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
RH, SA 
Global opera-
tions 
AZ, 
BMS, 
BX, 
GSK, 
PF, RH 
AZ, 
BMS, 
BX, 
GSK, 
NO, 
RH 
AZ, 
BX, 
GSK, 
NA, 
NO, 
RH 
AZ, 
BMS, 
BX, 
GSK, 
NO, 
RH 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO,  
RH, SA 
AZ, BMS, 
BX, GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO,  
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
RH, SA 
Subsidiaries 
AZ, 
BMS, 
BX, 
GSK, 
PF, RH 
AZ, 
BMS, 
BX, 
GSK, 
NO, 
RH 
AZ, 
BX, 
GSK, 
NA, 
NO, 
RH 
AZ, 
BMS, 
BX, 
GSK, 
NO, 
RH 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
RH, SA 
AZ, BMS, 
BX, GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, NA, 
NO, RH, 
SA 
Joint ventures/ 
associated 
companies 
AZ, 
RH 
AZ, 
RH 
AZ, 
NA, 
RH 
AZ, 
GSK, 
NO, 
RH 
AZ, 
GSK, 
NO, RH 
AZ, 
GSK, 
NA, NO, 
RH, SA 
AZ, GSK, 
NA, NO, 
RH, SA 
AZ, NA, 
NO, RH, 
SA 
AZ, 
BMS, 
NA, NO, 
RH, SA 
AZ, 
BMS, 
NA, NO, 
RH, SA 
R&D and for-
mulation sites 
                    
Sales/ distribu-
tion/ offices/ 
headquarters 
                    
Leased facili-
ties 
                    
Purchased en-
ergy 
                    
Suppliers, con-
tractors, out-
sourced opera-
tions 
                    
Customers                     
Boundary 
changes 
  NO 
AZ, 
NA, 
NO 
NO NA NO NA, NO NA, NO NA, NO NO 
Facilities ex-
cluded 
      BMS BMS BMS BMS BMS BMS 
BMS, 
GSK 
Control/ influ-
ence as report-
ing basis 
AZ, 
BMS, 
PF, RH 
AZ, 
BMS, 
NO, 
RH 
AZ, 
NA, 
NO, 
RH 
AZ, 
BMS, 
NO, 
RH 
AZ, 
BMS, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
NA, NO, 
RH, SA 
AZ, BMS, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
NA, NO, 
RH, SA 
Impact as re-
porting basis 
                    
TBL report-
ing 
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Parent compa-
ny & divisions 
AZ, 
GSK, 
RH 
AZ, 
GSK, 
NA, 
RH 
GSK, 
NO, 
RH 
BMS, 
GSK, 
NA, 
NO, 
RH 
BMS, 
GSK, 
NA, NO, 
RH, SA 
BMS, 
BX, 
GSK, 
NA, NO, 
SA 
BMS, BX, 
GSK 
(env.), 
NA, NO, 
PF, SA 
BMS, 
BX, GSK, 
NA, NO, 
PF, SA 
BMS, 
BX, NA, 
NO, PF, 
SA 
AZ, 
BMS, 
BX, NA, 
NO, SA 
Global opera-
tions 
AZ, 
GSK, 
RH 
AZ, 
GSK, 
NA, 
RH 
GSK, 
NO, 
RH 
BMS, 
GSK, 
NO, 
RH 
BMS, 
GSK, 
NO, RH, 
SA 
BMS, 
BX, 
GSK, 
NA, NO, 
SA 
BMS, BX, 
GSK 
(env.), 
NA, NO, 
PF, SA 
BMS, 
BX, GSK 
(soc.), 
NA, NO, 
PF, SA 
BMS, 
BX, NA, 
NO, PF, 
SA 
AZ, 
BMS, 
BX, NA, 
NO, SA 
Subsidiaries AZ AZ NO 
BMS, 
NO 
BMS, 
NO, SA 
BMS, 
BX, NO, 
SA 
BMS, BX, 
NO, SA 
BMS, 
BX, NO, 
SA 
BMS, 
BX, NO, 
SA 
BMS, 
BX, NO, 
SA 
Joint ventures/ 
associated 
companies 
RH RH RH 
BMS, 
RH 
BMS, RH 
BMS, 
NA 
BMS, BX, 
NA 
BMS, BX BMS, BX 
BMS, 
BX 
R&D and for-
mulation sites 
  
GSK, 
NA 
  
BMS, 
GSK, 
NA 
BMS, 
GSK, 
NA, SA 
BMS, 
GSK, 
NA, SA 
BMS, 
GSK 
(env.), 
NA, SA 
BMS, 
GSK, 
NA, SA 
BMS, 
NA, SA 
(soc.) 
BMS, 
NA, SA 
(soc.) 
Sales/ distribu-
tion/ offices/ 
headquarters 
  GSK   
BMS, 
GSK 
(soc.) 
BMS, 
GSK, SA 
BMS, 
GSK, 
NA, SA 
BMS, 
GSK 
(env.), 
NA, SA 
BMS, 
GSK, 
NA, SA 
BMS, 
NA, SA 
NA, SA 
Leased facili-
ties 
      BMS BMS BMS BMS BMS BMS BMS 
Purchased en-
ergy 
          NA NA NA NA NA 
Suppliers, con-
tractors, out-
sourced opera-
tions 
          
GSK 
(soc.) 
        
Customers                     
Boundary 
changes 
AZ 
AZ, 
GSK, 
NA 
  
NA, 
RH 
NA, RH, 
SA 
NA, SA 
NA, PF, 
SA 
NA, PF, 
SA 
NA, PF, 
SA 
SA 
Facilities ex-
cluded 
  
GSK, 
NA 
GSK 
BMS, 
GSK, 
NA 
BMS, 
GSK, 
NA, SA 
BMS, 
GSK, 
NA, SA 
BMS, 
GSK, NA, 
SA 
BMS, 
GSK, 
NA, PF, 
SA 
BMS, 
NA, NO, 
PF, SA 
BX, NA, 
NO, SA 
Control/ influ-
ence as report-
ing basis 
RH 
NA, 
RH 
RH 
BMS, 
GSK, 
NA 
BMS, 
NA, SA 
BMS, 
NA, SA 
BMS, BX, 
NA, SA 
BMS, 
BX, NA, 
SA 
BMS, 
BX, NA, 
SA 
NA, SA 
Impact as re-
porting basis 
  NA NO 
GSK, 
NA, 
NO 
NA, NO NA, NO NA, NO NA, NO NA, NO 
BX, NA, 
NO, PF 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
environmental (env.) and social (soc.) 
(Own illustration.) 
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Table 32: Overview of the availability of assurance statements 
 
Report 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
AZ Economic  1 1 1 1 1 1 1 1 1 1 
 
TBL  0 0 0 0 1 1 1 0 0 1 
 
TBL n/a 0 0 0 0 0 0 0 1 1 0 
BMS Economic  1 1 - 1 1 1 1 1 1 1 
 
TBL  1 0 - 0 1 1 1 0 0 0 
 
TBL n/a 0 1 - 1 0 0 0 0 1 0 
BX Economic  1 1 1 1 1 1 1 1 1 1 
 
TBL  0 1 1 0 0 0 0 0 0 1 
 
TBL n/a 1 0 0 0 0 1 1 1 1 0 
GSK Economic  1 1 1 1 1 1 1 1 1 1 
 
TBL  1 1 1 1 1 1 1 1 1 1 
 
TBL n/a 0 0 0 0 0 0 0 0 0 0 
NA Economic  - 0 1 0 1 1 1 1 1 1 
 
TBL  - 1 1 0 1 1 1 1 1 1 
 
TBL n/a - 0 0 0 0 0 0 0 0 0 
NO Economic  - 1 1 1 1 1 1 1 1 1 
 TBL  - 0 1 1 1 1 1 1 1 1 
 TBL n/a - 0 0 0 0 0 0 0 0 0 
PF Economic  1 - - - 1 - 1 1 1 - 
 TBL  0 - - - 0 - 0 0 0 - 
 TBL n/a 0 - - - 0 - 0 0 0 - 
RH Economic  1 1 1 1 1 1 1 1 1 1 
 TBL  1 1 1 1 1 1 1 1 1 1 
 TBL n/a 0 0 0 0 0 0 0 0 0 0 
SA Economic  - - - - 1 1 1 1 1 1 
 TBL  - - - - 1 1 1 1 1 1 
 TBL n/a - - - - 0 0 0 0 0 0 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
- implies that no report is available/ examined (see table 14 in the Annex).  In the lines “Economic” and “TBL” 1 implies 
that an assurance statement is available, in line “TBL n/a” 1 implies that assurance was adopted, but no statement was en-
closed. 0 implies that no statement/ information on a statement was enclosed. 
(Own illustration.) 
84 Sustainable Business through Voluntary Disclosures: 
Motivations for Adopting Reporting Guidance, Boundaries and Assurance 
Table 33: Titles of the assurance statements 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic assurance                     
Auditor's Report                     
Auditor's report           NO         
Report by/ of the auditors GSK   NA   NA NA NA NA     
Report of the group auditors RH RH RH RH RH RH RH RH     
Report of the statutory audi-
tor 
                NA, RH 
NA, 
RH 
Independent auditor's report 
AZ, 
PF 
AZ, 
GSK 
AZ, 
GSK 
AZ, 
BX, 
GSK 
AZ, 
GSK 
AZ, 
GSK 
AZ, 
GSK, 
NO 
AZ, 
GSK, 
NO 
AZ, 
GSK, 
NO 
AZ, 
GSK, 
NO 
Independent accountants' re-
port 
                    
Report of independent ac-
countants 
BMS, 
BX 
BMS, 
BX 
BX BMS             
Report of the independent 
registered public accounting 
firm 
        
BMS, 
BX, PF, 
SA 
BMS, 
BX, 
SA 
BMS, 
BX, PF, 
SA 
BMS, 
BX, PF, 
SA 
BMS, 
BX, PF, 
SA 
BMS, 
BX, 
SA 
TBL assurance                     
Assurance                     
Assurance           BMS       RH 
Assurance report     NA RH             
Assurance statement                 GSK GSK 
External assurance statement               GSK     
Independent assurance report         
NA, 
NO, RH 
NA, 
NO, 
RH 
NA, 
NO, RH 
NA, RH 
NA, 
NO, RH 
NA, 
NO, 
RH 
Independent assurance state-
ment 
        AZ AZ AZ GSK   
AZ, 
BX 
Independent auditors TBL as-
surance report 
              NO     
Review                     
Auditor's review report         SA           
Statutory auditor's review re-
port 
          SA SA SA SA SA 
Verification                     
Auditors verification state-
ment 
  BX BX               
Statement of the verifiers   NA                 
Verification           GSK         
Verification report RH RH RH               
Verification statement     GSK GSK GSK           
Independent verification GSK                   
Other                     
Assessment BMS       BMS           
ERM statement   GSK                 
Evaluation program attesta-
tion 
            BMS       
Independent verifica-
tion/assurance statement 
            GSK       
Statement of the auditors     NO NO             
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Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
Table 34: Assurance providers 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic assurance                     
Accountants                     
Deloitte & Touche             BMS BMS BMS BMS 
KPMG 
AZ, 
PF 
AZ AZ AZ 
AZ, 
PF, 
RH 
AZ, 
RH 
AZ, 
PF, 
RH 
AZ, 
PF, 
RH 
AZ, 
PF, 
RH 
AZ, RH 
Ernst & Young RH 
NO, 
RH 
NO, 
RH 
NO, 
RH 
NO, 
SA 
SA SA SA SA SA 
PWC 
BX, 
BMS, 
GSK, 
RH 
BX, 
BMS, 
GSK, 
NO, 
RH 
BX, 
GSK, 
NA, 
NO, 
RH 
BX, 
BMS, 
GSK, 
NO, 
RH 
BX, 
BMS, 
GSK, 
NA, 
NO, 
SA 
BX, 
BMS, 
GSK, 
NA, 
NO, 
SA 
BX, 
GSK, 
NA, 
NO, 
SA 
BX, 
GSK, 
NA, 
NO, 
SA 
BX, 
GSK, 
NA, 
NO, 
SA 
BX, GSK, 
NA, NO, SA 
TBL assurance                     
Accountants                     
Ernst & Young         SA SA SA SA SA SA 
PWC RH RH 
NA, 
NO, 
RH 
NO, 
RH 
NA, 
NO, 
RH, 
SA 
NA, 
NO, 
RH, 
SA 
NA, 
NO, 
RH, 
SA 
NA, 
NO, 
RH, 
SA 
NA, 
NO, 
RH, 
SA 
NA, NO, 
RH, SA 
Certifier                     
Bureau Veritas         AZ AZ AZ GSK   
AZ, BX, 
GSK 
SGS             GSK GSK GSK GSK 
Consultants                     
Arthur D Little   NA                 
Cadmus             BMS       
Clayton Group Services         BMS           
ERM 
BMS, 
GSK 
BX, 
GSK 
BX, 
GSK 
GSK GSK GSK         
Haley & Aldrich           BMS         
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
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Table 35: Addressees of assurance statements 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic assurance                     
Board of directors and stockholders/ 
shareholders 
BX, 
BMS 
BX, 
BMS 
BX 
BX, 
BMS 
BX, 
BMS, 
PF, 
SA 
BX, 
BMS, 
SA 
BX, 
BMS, 
NO, 
PF, 
SA 
BX, 
BMS, 
NO, 
PF, 
SA 
BX, 
BMS, 
NO, 
PF, 
SA 
BX, 
BMS, 
NO, 
SA 
General meeting RH RH 
NA, 
RH 
RH 
NA, 
RH 
NA, 
RH 
NA, 
RH 
NA, 
RH 
NA, 
RH 
NA, 
RH 
Members of the company 
AZ, 
GSK 
AZ, 
GSK 
AZ, 
GSK 
AZ, 
GSK 
AZ, 
GSK 
AZ, 
GSK 
AZ, 
GSK 
AZ, 
GSK 
AZ, 
GSK 
AZ, 
GSK 
TBL assurance                     
Audit and compliance committee     NA   NA NA NA NA NA NA 
Corporate TBL committee           RH RH RH RH RH 
Management         AZ AZ       NO 
Stakeholders                   
AZ, 
GSK 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
Table 36: Information on the impartiality/ independence of assurors from reporters 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic assurance                     
towards company                     
Independence directly stated ac-
cording to Auditor Oversight Act 
                RH NA, RH 
Independence indirectly given ac-
cording to ISAE 3000 
        NA NA NA 
NA, 
RH 
NA, 
RH 
NA, RH 
TBL assurance                     
towards company                     
AA1000 definition                   NO 
code of ethics         AZ AZ AZ GSK   
AZ, BX, 
GSK 
free from conflicts of interests with 
the organization and subsidiaries 
            GSK GSK GSK BX, GSK 
no involvement with other projects 
with the corporation 
        AZ AZ AZ       
Independence indirectly given ac-
cording to ISAE 2000 
      RH             
Independence indirectly given ac-
cording to ISAE 3000 
        
NO, 
RH 
NO, 
RH 
NO, 
RH 
NO, 
RH 
NO, 
RH 
BX, GSK, 
NA, NO, RH 
towards stakeholders                     
free from conflicts of interests with 
the stakeholders 
            GSK GSK GSK GSK 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
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Table 37: Information on the respective responsibilities of assurors and reporters 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic 
assurance 
AZ, 
GSK, 
RH 
BX, 
GSK, 
NO, 
RH 
AZ, BX, 
GSK, 
NA, 
NO, RH 
AZ, 
BMS, 
GSK, 
NO, RH 
AZ, 
BMS, 
GSK, 
NA, NO, 
PF, RH,  
SA 
AZ, 
BMS, 
GSK, 
NA, NO, 
RH,  
SA 
AZ, 
BMS, 
GSK, 
NA, NO, 
PF, RH,  
SA 
AZ, BMS, 
BX, GSK, 
NA, NO, 
PF, RH,  
SA 
AZ, BMS, 
BX, GSK, 
NA, NO, 
PF, RH,  
SA 
AZ, 
BMS, 
BX, GSK, 
NA, NO, 
RH,  
SA 
TBL as-
surance 
RH RH 
NA, 
NO, RH 
NO 
AZ, NA, 
RH, SA, 
NO 
AZ, NA, 
RH, SA 
AZ, GSK, 
NA, NO, 
RH, SA 
GSK, NA, 
NO, RH, 
SA 
GSK, NA, 
NO, RH, 
SA 
AZ, BX, 
GSK, 
NA, NO, 
RH, SA 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
Table 38: Information on the assurance levels provided 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic 
assurance 
                    
Reasonable 
assurance 
BMS, 
BX, 
GSK, 
PF, RH 
BMS, 
BX, 
GSK, 
NO, RH 
BX, 
GSK, 
NA, 
NO, 
RH 
BMS, 
GSK, 
NO, 
RH 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH,  
SA 
BMS, 
BX, 
GSK, 
NA, NO, 
RH,  
SA 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH,  
SA 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH,  
SA 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH,  
SA 
BMS, 
BX, 
GSK, 
NA, NO, 
RH,  
SA 
TBL assur-
ance 
                    
Reasonable 
assurance 
    NO 
NO, 
RH 
NO NO NO, RH NO, RH NO 
BX, 
GSK, 
NO 
Limited as-
surance 
            NO, RH NO, RH NO NO 
High assur-
ance 
                  AZ 
Moderate as-
surance 
RH RH RH   SA SA SA SA SA 
GSK, 
NO, SA 
Basic-level 
assurance 
        AZ         BX 
Medium-
level assur-
ance 
                  BX 
Positive as-
surance 
        AZ           
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
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Table 39: Information on the assurance scopes 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic assurance                     
Directors' statement & 
management review/ 
commitment 
            NO NO NO   
Data & information     NO             
BX, RH, 
SA 
Performance, man-
agement & reporting 
systems, procedures 
                  
BX, GSK, 
NO, RH, 
SA 
Policies, principles & 
estimates 
    NO       NO NO NO 
BX, 
BMS, 
NO, SA 
TBL assurance                     
Directors' statement & 
management review/ 
commitment 
BMS                 NO 
Activities/ projects                   AZ, NA 
Application level GRI           BMS         
Assurance principles           NO NO NO NO NO 
Compliance infor-
mation 
                  RH 
Data/ information GSK   
GSK, 
NO 
NO 
NO, RH, 
SA 
NO, 
RH, SA 
NO, RH, 
SA 
GSK, 
NO, 
RH, SA 
GSK, 
NA, NO, 
RH, SA 
AZ, BX, 
NA, NO, 
RH, SA 
Data preparation/ col-
lection 
BMS, 
RH 
BX, 
RH 
BX RH RH     
GSK, 
RH 
  BX 
Data  consolidation/ 
verification 
            GSK GSK NA NA, RH 
Data accuracy/ con-
sistency 
                  
BX, GSK, 
RH, SA 
Governance structure         AZ AZ AZ     GSK 
Performance, man-
agement & reporting 
systems, procedures 
BMS, 
GSK 
GSK, 
NA 
GSK, 
NA, 
NO 
GSK, 
NO 
BMS, 
GSK, 
NA, RH 
AZ, 
GSK, 
NA, RH 
AZ, BMS, 
GSK, NA, 
NO, RH 
NA, 
NO, 
RH 
NA, NO, 
RH 
AZ, BX, 
GSK, 
NA, RH, 
SA 
Policies, principles & 
estimates 
    NA     AZ AZ   NA 
GSK, 
NA, NO, 
RH 
Resource application BMS                   
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
Table 40: Limitations of the assurance engagements 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
TBL assurance         AZ, RH AZ, RH 
AZ, GSK, 
RH 
RH RH 
AZ, BX, GSK, 
RH 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
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Table 41: Boundaries of the assurance engagements 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic 
assurance 
AZ, 
BMS, 
BX, 
GSK, 
PF, RH 
AZ, 
BMS, 
BX, 
GSK, 
RH 
AZ, 
BX, 
GSK, 
RH 
AZ, 
BMS, 
GSK, 
NO, RH 
AZ, 
BMS, 
BX, GSK, 
NO, PF, 
RH, SA 
AZ, 
BMS, 
BX, 
GSK, 
NO, RH, 
SA 
AZ, 
BMS, 
BX, GSK, 
NO, PF, 
RH, SA 
AZ, 
BMS, 
BX, GSK, 
NO, PF, 
RH, SA 
AZ, 
BMS, 
BX, GSK, 
NO, PF, 
RH, SA 
AZ, 
BMS, 
BX, 
GSK, 
NO, RH, 
SA 
TBL as-
surance 
RH RH RH RH 
AZ, NA, 
RH 
AZ, NA, 
RH 
AZ, NA, 
RH 
NA, RH NA, RH 
AZ, NA, 
RH, SA 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
Table 42: Criteria used for the assurance engagements 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic assur-
ance 
                    
Ethical compliance                   NO 
TBL assurance                     
Responsiveness         
AZ, 
GSK, 
NA, RH 
AZ, NO AZ, NO 
GSK, 
NO 
NO AZ, NO 
Completeness RH NA, RH NO, RH 
GSK, 
RH 
AZ, 
GSK, 
NA, RH 
AZ, GSK, 
NA, NO, 
RH 
AZ, 
NA, 
NO, RH 
GSK, 
NA, NO, 
RH 
NA, 
NO, 
RH 
NA, RH 
Materiality         AZ AZ, NO AZ, NO 
GSK, 
NO 
NO 
AZ, 
GSK, 
NO 
Neutrality         SA SA SA SA SA SA 
Relevance       GSK GSK, SA GSK, SA SA SA SA SA 
Reliability       NO NO, SA SA SA SA SA 
BX, 
GSK, SA 
Understandability         SA SA SA SA SA SA 
Stakeholder inclu-
sivity 
                  AZ, NO 
TBL context                     
Accessibility                   BX 
Accuracy RH 
GSK, 
NA, RH 
GSK, 
NO, RH 
GSK, 
NO, RH 
GSK, 
NA, NO, 
RH 
GSK, NA, 
RH 
NA, RH NA, RH 
NA, 
RH 
BX, 
GSK, 
NA, RH 
Adequacy                 RH RH 
Balance     NO NO NO         BX 
Clarity                   BX 
Comparability                   BX 
Consistency         SA SA SA SA SA RH, SA 
Objectivity                   GSK 
Timeliness                   BX 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
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Table 43: Methodologies used for the assurance engagements 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic 
assurance 
AZ, 
BMS, 
GSK, 
RH 
AZ, 
BMS, 
BX, 
GSK, 
NO, RH 
AZ, 
BX, 
GSK, 
NA, 
NO, RH 
AZ, 
BMS, 
GSK, 
NO, 
RH 
AZ, 
BMS, 
BX, GSK, 
NA, NO, 
PF RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
RH, SA 
AZ, 
BMS, 
BX, GSK, 
NA, NO, 
PF RH, 
SA 
AZ, 
BMS, 
BX, GSK, 
NA, NO, 
PF RH, 
SA 
AZ, 
BMS, 
BX, GSK, 
NA, NO, 
PF RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
RH, SA 
TBL as-
surance 
BMS, 
GSK, 
RH 
BX, 
GSK, 
RH 
BX, 
GSK, 
NA, 
NO RH 
GSK, 
NO, 
RH 
AZ, 
BMS, 
GSK, 
NA, NO, 
RH, SA 
AZ, 
BMS, 
GSK, 
NA, NO, 
RH, SA 
AZ, 
BMS, 
GSK, 
NA, NO, 
RH, SA 
GSK, 
NA, NO, 
RH, SA 
GSK, 
NA, NO, 
RH, SA 
AZ, BX, 
GSK, 
NA, NO, 
RH, SA 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
Table 44: Opinions, conclusions etc. formed in assurance statements 
 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Economic assur-
ance 
                    
Progress         NO           
Commentary     NO 
BMS, 
NO 
BX, NO NO NO NO NO 
AZ, 
GSK, 
NO 
Opinion & conclu-
sion 
AZ, 
BMS, 
BX, 
GSK, 
PF, RH 
AZ, 
BMS, 
BX, 
GSK, 
NO, 
RH 
AZ, 
BX, 
GSK, 
NA, 
NO, 
RH 
AZ, 
BMS, 
BX, 
GSK, 
NO, 
RH 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, 
NO, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, NO, 
PF, RH, 
SA 
AZ, 
BMS, 
BX, 
GSK, 
NA, 
NO, RH, 
SA 
Recommendations RH RH 
NA, 
RH 
RH NO, RH NA, RH NA, RH NA, RH NA, RH NA, RH 
TBL assurance                     
Findings & obser-
vations 
  NA     GSK 
BMS, 
GSK 
      
AZ, BX, 
GSK, 
NO 
Progress   NA GSK 
GSK, 
NO 
  
AZ, 
GSK 
AZ GSK GSK   
Commentary         AZ   NO NO NO   
Opinion & conclu-
sion 
BMS, 
RH 
RH RH 
NO, 
RH 
RH, SA RH, SA 
NO, RH, 
SA 
NO, RH, 
SA 
NA, NO, 
RH, SA 
NA, 
NO, RH, 
SA 
Recommendations 
BMS, 
GSK 
GSK 
GSK, 
NA, 
NO 
GSK, 
NO 
AZ, 
BMS, 
GSK, 
NA 
AZ, 
GSK, 
NA 
AZ, 
BMS, 
GSK, 
NA 
GSK, 
NA 
GSK, 
NA 
AZ, 
GSK, 
NO 
Note: 
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA). 
(Own illustration.) 
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Table 45: Identification of firm characteristics for 2009 data 
 
Num-
ber of 
GRI 
reports 
avail-
able 
Net 
prof
it ($ 
bil) 
Carbon 
perfor-
mance 
(for 
measure-
ment scale 
see note) 
Head of-
fice 
Number 
of em-
ployees 
Distribu-
tion of 
employ-
ees 
Distribu-
tion of 
investors 
Distribu-
tion of 
markets 
(by reve-
nue, 
sales or 
turnover) 
Number  
of  
pressure-
related 
vs. eco-
nomics-
related 
risk fac-
tors 
Extent of the 
value chain 
Num-
ber of 
prod-
uct 
types 
in the 
portfo-
lio 
good & medium scores 
GS
K 
8 
8.9
4 
43.80 ˡ + 4 UK 99913 
Europe,  
rest of 
the 
world, 
the 
Americas 
Mainly 
in the 
Americas 
The 
Ameri-
cas, Eu-
rope, rest 
of the 
world 
5 versus 
4 
R&D, manu-
facture, mar-
keting 
3 
NA 6 8.4 38.56 ˡ + 4 
Switzer-
land 
99834 n/a 
Europe, 
followed 
by the 
Americas 
Europe, 
the 
Ameri-
cas, rest 
of the 
world 
5 versus 
4 
R&D, manu-
facture, mar-
keting 
7 
good, medium & poor scores 
AZ 3 
7.5
2 
38.60 ˡ + ³ UK 62700 
Europe, 
the 
Ameri-
cas, rest 
of the 
world 
Mainly 
in the 
Americas 
Rest of 
the 
world, 
Europe, 
the 
Americas 
4 versus 
4 
R&D, manu-
facture, mar-
keting 
6 
BM
S 
6 
10.
61 
38.84 ˡ + 4 US 28000 n/a n/a 
The 
Ameri-
cas, rest 
of the 
world, 
Europe 
4 versus 
4 
Development,  
licensing,  
manufacture, 
marketing,  
commercializa-
tion, distribu-
tion 
7 
NO 9 
0.2
3 
n/a Denmark 5275 
Europe, 
rest of 
the 
world, 
the 
Americas 
Mainly 
in Eu-
rope 
Europe, 
the 
Ameri-
cas, rest 
of the 
world 
3 versus 
5 
Development, 
manufacture, 
marketing 
1 
RH 4 
7.5
1 
12.92 ² + ³ 
Switzer-
land 
81507 
Europe, 
the 
Ameri-
cas, rest 
of the 
world 
n/a 
The 
Ameri-
cas, Eu-
rope, rest 
of the 
world 
n/a 
Development, 
commercializa-
tion, distribu-
tion 
6 
SA 4 
7.5
4 
24.06 ˡ + 4 France 104867 
Europe,  
rest of 
the 
world, 
the 
Americas 
Europe, 
followed 
by the 
Americas 
Europe, 
the 
Ameri-
cas, rest 
of the 
world 
5 versus 
4 
R&D, manu-
facture, mar-
keting 
6 
medium & poor scores 
BX 10 
2.2
1 
59.76 ˡ + 4 US 49700 
The 
Ameri-
cas, Eu-
rope, rest 
of the 
world 
n/a 
The 
Ameri-
cas, Eu-
rope, rest 
of the 
world 
3 versus 
4 
Develop-ment, 
manufacture, 
marketing 
6 
92 Sustainable Business through Voluntary Disclosures: 
Motivations for Adopting Reporting Guidance, Boundaries and Assurance 
poor scores 
PF 2 
8.6
4 
n/a US 116500 
The 
Ameri-
cas, Eu-
rope, rest 
of the 
world 
n/a 
The 
Ameri-
cas, Eu-
rope, rest 
of the 
world 
6 versus 
4 
R&D, com-
mercialization, 
distribution 
5 
Note:  
The abbreviations stand for: Astra-Zeneca (AZ), Bristol-Myers Squibb (BMS), Baxter (BX), GlaxoSmith Kline (GSK), 
Novartis International AG (NA), Novozymes (NO), Pfizer Inc. (PF), Roche Holding Ltd (RH), Sanofi-Aventis Group (SA), 
thousand (T), million (mil.), carbon dioxide (CO²)  
The following superscripted numbers indicate: ˡ T CO²/ mil.$ turnover, ² T CO²/ Employee, ³ total emissions, 4 GHG scope 
1 + 2. 
(Derived from: GLOBAL REPORTING INITIATIVE (2010), w/o p; FORBES MAGAZINE (2010), w/o p; CORPORATE REG-
ISTER (2010a), CORPORATE REGISTER (2010b), CORPORATE REGISTER (2010c), CORPORATE REGISTER (2010d), 
CORPORATE REGISTER (2010e), CORPORATE REGISTER (2010f), CORPORATE REGISTER (2010g), w/o p; DATA-
MONITOR (2010a), DATAMONITOR (2010b), DATAMONITOR (2010c), DATAMONITOR (2010d), DATAMONITOR 
(2010f), DATAMONITOR (2010g), DATAMONITOR (2010i), pp. 5ff. and proper content analysis of corporate economic and 
TBL reports.) 
Table 46: Literature search 
Topic Subject terms Further limitation 
EBSCO 
Host 
EconBiz 
Internet-
quellen 
Else-
vier 
Science 
Direct 
Else-
vier 
Sco-
pus 
WISO Liter-
aturnachweise 
Google 
Scholar 
insg. 
verwen-
det 
B
io
te
ch
n
o
lo
g
y
 
"biotechnolog*"  50552  296982    0 
"biotechnolog*" 
AND "industry 
overview" 
 18 (16)  29 (0)    16 
"biotechnolog*" 
AND "sustain*" 
AND ("legitima-
cy" OR "disclo-
sure" OR "stake-
holder" OR "per-
formance")  
 68 (10)  14042  2 (0) 
19500 
(4) 
14 
as before 
Subject area: 
Business, Man-
agement and Ac-
counting 
  1856    0 
as before 
Journal: Research 
Policy; Techno-
logical Forecast-
ing and Social 
Change; Long 
Range Planning; 
Journal of Busi-
ness Venturing; 
Journal of Busi-
ness Research; 
Journal of Inter-
national Man-
agement; Journal 
of World Busi-
ness 
  
747 
(17) 
   17 
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Topic Subject terms Further limitation 
EBSCO 
Host 
EconBiz 
Internet-
quellen 
Else-
vier 
Science 
Direct 
Else-
vier 
Sco-
pus 
WISO Liter-
aturnachweise 
Google 
Scholar 
insg. 
verwen-
det 
B
u
si
n
es
s 
et
h
ic
s 
"review" AND 
"business ethics" 
 4393    628 (1) 868000 1 
"review" AND 
"business ethics" 
Publication: 
Journal of Busi-
ness Ethics, 
Business Ethics 
Quarterly 
695      0 
"review" AND 
"business ethics" 
as before plus 
subject: business 
ethics 
46 (2)      2 
"review" AND 
"business ethics" 
Publication Date: 
1990 - 2010 
     
99500 
(14) 
14 
"business ethics" 
AND "sustaina-
bility" 
 386 7   1761  0 
"business ethics" 
AND "sustaina-
bility" 
Publication: 
Journal of Busi-
ness Ethics, 
Business & Soci-
ety, Accounting 
Auditing Ac-
countability 
Journal 
125      0 
"business ethics" 
AND "sustaina-
bility" 
as before plus 
subject: method-
ology, sustainable 
development re-
porting 
16      0 
"business ethics" 
AND "sustaina-
bility" AND 
"methodology" 
 11 (0)    18 (0)  0 
"business ethics" 
AND "stake" 
 108 5 (2)   11 (0)  3 
"business ethics" 
AND "stake" 
Publication from 
2000 on: Journal 
of Business Eth-
ics, Business Eth-
ics Quarterly, 
Business & Soci-
ety 
27 (1)      1 
"business ethics" 
AND "stake" 
AND "case 
study" 
 6 (0)       
"business ethics" 
AND "responsi-
bility" 
 4980 14     0 
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Topic Subject terms Further limitation 
EBSCO 
Host 
EconBiz 
Internet-
quellen 
Else-
vier 
Science 
Direct 
Else-
vier 
Sco-
pus 
WISO Liter-
aturnachweise 
Google 
Scholar 
insg. 
verwen-
det 
 
"business ethics" 
AND "responsi-
bility" AND 
"content analy-
sis" 
Publication: Jour-
nal of Business 
Ethics, Business 
Ethics Quarterly, 
Business & So-
ciety 
18 (1)    93 (0)  1 
"business ethics" 
AND "corporate 
objective func-
tion" 
 1 (1)    16 (0)  1 
"business ethics" 
AND "purpose" 
AND "corpora-
tion" 
 187      0 
"business ethics" 
AND "purpose" 
AND "corpora-
tion" 
Publication from 
2000 on: Journal 
of Business Eth-
ics, Accounting 
Auditing Ac-
countability Jour-
nal, Business Eth-
ics Quarterly 
51 (9) 1 (0)   62 (0)  9 
"business ethics" 
AND "area" 
AND "public 
concern" 
 3 (1)    7 (0)  1 
         
"organisational 
ethics" OR "or-
ganizational eth-
ics" 
 187       
"organisational 
ethics" OR "or-
ganizational eth-
ics" 
Publications: 
Journal of Busi-
ness Ethics, Busi-
ness Ethics Quar-
terly 
61       
 
"organisational 
ethics" OR "or-
ganizational eth-
ics" 
Publications: 
Journal of Busi-
ness Ethics, Busi-
ness Ethics Quar-
terly AND 
Methodology 
4       
 corporate ethics  495       
 
corporate ethics 
Publications: 
Journal of Busi-
ness Ethics, Busi-
ness Ethics Quar-
terly 
70       
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Topic Subject terms Further limitation 
EBSCO 
Host 
EconBiz 
Internet-
quellen 
Else-
vier 
Science 
Direct 
Else-
vier 
Sco-
pus 
WISO Liter-
aturnachweise 
Google 
Scholar 
insg. 
verwen-
det 
C
o
rp
o
ra
te
 c
it
iz
en
sh
ip
 a
n
d
 c
o
rp
o
ra
te
 r
es
p
o
n
si
b
il
it
ie
s 
"review" 
AND"corporate 
citizenship" 
 152    235 (2) 190000 6 
"review" 
AND"corporate 
citizenship" 
Publication: 
Business & Soci-
ety Review, 
Journal of Corpo-
rate Citizenship, 
Journal of Busi-
ness Ethics, 
Academy of 
Management Re-
view, Business 
Ethics Quarterly, 
Harvard Business 
Review 
74 (9)      9 
"review" 
AND"corporate 
citizenship" 
Publication Date: 
2000 - 2010 
     
26400 
(11) 
11 
"review" AND 
"corporat*" 
AND "rights" 
 2105      0 
"review" AND 
"corporat*" 
AND "rights" 
Publication Date: 
2000 - 2010 
AND full text 
AND  
Source type: aca-
demic journals 
591      0 
"review" AND 
"corporat*" 
AND "rights" 
as before plus 
publication: Cor-
porate Gov-
ernace: An Inter-
national Review, 
Business & Soci-
ety Review, 
Journal of Busi-
ness Ethics, 
Academy of 
Management Re-
view 
68 (2)      2 
"review" AND 
"corporate" 
AND "responsi-
bility" 
 3161  27680  1343 1380000 4 
"review" AND 
"corporate" 
AND "responsi-
bility" 
Full text AND 
academic journal 
OR book 
1554    54 (0)  0 
"review" AND 
"corporate" 
AND "responsi-
bility" 
as before plus 
publication: 
Journal of Busi-
ness Ethics, 
Academy of 
Management Re-
view, Business 
Ethics Quarterly 
126      0 
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Topic Subject terms 
Further limita-
tion 
EBSCO 
Host 
EconBiz 
Internet-
quellen 
Else-
vier 
Science 
Direct 
Else-
vier 
Sco-
pus 
WISO Liter-
aturnachweise 
Google 
Scholar 
insg. 
verwen-
det 
C
o
rp
o
ra
te
 c
it
iz
en
sh
ip
 a
n
d
 c
o
rp
o
ra
te
 r
es
p
o
n
-
si
b
il
it
ie
s 
"review" 
AND"corporate 
citizenship" 
as before plus 
subject: litera-
ture review 
25 (2)      2 
"review" AND 
"corporate" AND 
"responsibility" 
Publication 
Date: 2000 - 
2010 
  15294  1278 (0) 
618000 
(8) 
8 
"review" AND 
"corporate" AND 
"responsibility" 
as before plus 
topic: corporate 
governance, sus-
tainable devel-
opment, envi-
ronmental man-
agement, ems, 
management 
system 
  287 (4)    4 
L
eg
it
im
ac
y
 t
h
eo
ry
 
"review" AND 
"legitimacy" 
      
426000 
(5) 
5 
legitimacy AND 
("environmental 
reporting" OR 
"social reporting") 
AND ("environ-
mental disclosure" 
OR "social disclo-
sure") 
       7 
legitimacy AND 
("environmental 
reporting" OR 
"social reporting") 
AND ("environ-
mental disclosure" 
OR "social disclo-
sure") 
Business, Man-
agement and 
Accounting 
7 (1)  145 (2)    3 
legitimacy AND 
("social perfor-
mance" OR "envi-
ronmental perfor-
mance") 
     20 (0) 
12900 
(9) 
9 
legitimacy AND 
("social perfor-
mance" OR "envi-
ronmental perfor-
mance") 
Business, Man-
agement and 
Accounting 
36 (4)  
363 
(15) 
   19 
R
ep
o
rt
in
g
 
(("reporting" OR 
"accouting" OR 
"audit") AND 
("guideline" OR 
"standard" OR 
"principle")) AND 
("content analy-
sis") 
Business, Man-
agement and 
Accounting 
11 (1)  189 (6)  17 (0) 
40400 
(0) 
7 
"GRI" AND "con-
tent analysis" 
 8 (1)  30 (2)  0 878 (2) 5 
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Topic Subject terms 
Further limita-
tion 
EBSCO 
Host 
EconBiz 
Internet-
quellen 
Else-
vier 
Science 
Direct 
Else-
vier 
Sco-
pus 
WISO Liter-
aturnachweise 
Google 
Scholar 
insg. 
verwen-
det 
S
ta
k
eh
o
ld
er
 t
h
eo
ry
 
"review" AND 
"stakeholder" 
AND "theory" 
 432    195 (0) 107000 2 
"review" AND 
"stakeholder" 
AND "theory" 
Publication: 
Journal of Busi-
ness Ethics, 
Harvard Busi-
ness Review, 
Academy of 
Management 
Review, Busi-
ness Ethics 
Quarterly 
97      0 
"review" AND 
"stakeholder" 
AND "theory" 
as before plus 
subject: stake-
holder theory 
46 (4)      4 
"review" AND 
"stakeholder" 
AND "theory" 
Publication 
Date: 1990 - 
2010 
     
49000 
(11) 
11 
"stake" AND 
"legitimacy" 
 51 (2)    4  2 
("stakeholder 
performance" 
OR "stakeholder 
engagement" 
OR "stakeholder 
management") 
AND ("dis-
clos*" OR "re-
port*") 
Publication 
Date: 2000 - 
2010 
74 (7)  338 (12)    19 
"stakeholder sa-
lience" AND 
"measure" 
 2 (0) 30 (1) 375 (1)  8 (0) 
21300 
(5) 
7 
S
u
st
ai
n
ab
le
 d
ev
el
o
p
m
en
t 
"review" AND 
"sustainabl*" 
AND "develop-
ment" 
 4470 4 (0)   994 (0) 
17800 
(4) 
10 
"review" AND 
"sustainabl*" 
AND "develop-
ment" 
Publication: 
Ecological Eco-
nomics, Journal 
of Environmen-
tal Planning and 
Management, 
Sustainable De-
velopment 
155      0 
"review" AND 
"sustainabl*" 
AND "develop-
ment" 
as before plus 
subject: sustain-
able develop-
ment 
62 (5)      5 
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Top-
ic 
Subject terms Further limitation 
EB-
SCO 
Host 
EconB
iz In-
ternet-
quellen 
Else-
vier 
Sci-
ence 
Direct 
Else-
vier 
Sco-
pus 
WISO Liter-
aturnachweise 
Googl
e 
Schol
ar 
insg. 
ver-
wendet 
M
et
h
o
d
o
lo
g
y
 
("review" OR "me-
ta*analy*") AND ("corpo-
rate citizen" OR "respon-
sibilit*" OR "sustain*" OR 
"stakeholder") AND 
"method*" 
 1505  410435 37175 65  0 
as before 
Publication Date: 
2000 - 2010; 
Publication: Journal 
of Business Ethics, 
Corporate Govern-
ance: The Interna-
tional Journal of Ef-
fective Board Per-
formance, Ecological 
Economics, Man-
agement Decision, 
Sustainable Devel-
opment 
68 (12)      12 
as before 
Arbeitswissenschaft-
liche Literatur, Bliss, 
Econis 
    33 (1)  1 
("überblick" OR "me-
ta*analy*") AND ("unter-
nehmen*bürger" OR "un-
terneh-
men*verantwortung" OR 
"nachhaltig*" OR "an-
spruch") AND "method*" 
 0  352 0   0 
as before 
Business, Manage-
ment and Account-
ing,Decision Scienc-
es,Social Sciences 
  45 (0)    0 
as before 
Arbeitswissenschaft-
liche Literatur, Bliss, 
Econis 
    9 (0)  0 
("review" OR "meta*analy*") AND "corporate 
citizen*" AND "method*" 
  592 798   0 
("review" OR "me-
ta*analy*") AND "corpo-
rate citizen*" AND 
"method*" 
Keyword: CR, CSR, 
SD, SR, sustainabil-
ity, sustainability re-
porting; 
Document type: Re-
view 
 
  55 (20) 
38 
(12) 
  32 
("review" OR "meta*analy*") AND "responsi-
bilit*" AND "method*" 
  154662    0 
("review" OR "me-
ta*analy*") AND "corpo-
rate responsibilit*" AND 
"method*" 
Keyword: CR, CSR, 
SD, SR, sustainabil-
ity, sustainability re-
porting 
 
  839    0 
("review" OR "me-
ta*analy*") AND "corpo-
rate responsibilit*" AND 
"method*" 
Keyword: CR, CSR, 
SD, SR, sustainabil-
ity, sustainability re-
porting 
Source Title: Ac-
counting, Organiza-
tions and Society; 
Business Horizons, 
Journal of Cleaner 
Production, Journal 
of Business Research 
  32 (5)    5 
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To
pic 
Subject 
terms 
Further limitation 
EB-
SCO 
Host 
Econ
Biz 
Inter
ter-
net-
quell
en 
Else
vier 
Sci-
ence 
Di-
rect 
Else
-
vier 
Sco
pus 
WISO Liter-
eratur-
atur-
nachweise 
Goo
gle 
Sch
olar 
insg. 
ver-
wende
t 
M
et
h
o
d
o
lo
g
y
 
("review" 
OR "me-
ta*analy*
") AND 
"respon-
sibilit*" 
AND 
"meth-
od*" 
Subject Area: Social Sciences; Business, Man-
agement and Accounting; 
Source Title: Journal of Business Ethics;  
Keyword: CSR; SR; 
Document Type: Review 
   
12 
(5) 
  5 
("review" 
OR "me-
ta*analy*
") AND 
"sustain*" 
AND 
"meth-
od*" 
 38  
2920
52 
208
336 
  0 
("review" 
OR "me-
ta*analy*
") AND 
"sustain*" 
AND 
"meth-
od*" 
Keyword: SD   
1791
3 
   0 
("review" 
OR "me-
ta*analy*
") AND 
"sustain-
able de-
velop-
ment" 
AND 
"meth-
od*" 
EXCLUDE(smi, 
"5905,6542,5885,6974,5855,5852,5908,5927,580
9,5713,5912","Tourism Manage-
ment,Government Information Quarter-
ly,Landscape and Urban Planning,Nurse Educa-
tion Today,Annals of Tourism Re-
search,Evaluation and Program Plan-
ning,International Journal of Project Manage-
ment,International Journal of Hospitality Man-
agement,Industrial Marketing Manage-
ment,Energy Policy,Land Use Policy") AND 
EXCLUDE(contenttype, 
"2,3,4,5",",Book,Reference Work")[All 
Sources(Business, Management and Account-
ing,Decision Sciences,Social Sciences)] 
  
65 
(8) 
   8 
("review" 
OR "me-
ta*analy*
") AND 
"sustain*" 
AND 
"meth-
od*" 
Document Type: Review; 
Subject Area: Environmental Science; Business, 
Management and Accounting; Social Sciences; 
Number of citations: more than 50 
   
35 
(8) 
  8 
("review" OR "meta*analy*") AND "stakeholder" AND 
"method*" 
33  
3061
8 
167
87 
  0 
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To
pic 
Subject 
terms 
Further limitation 
EB-
SCO 
Host 
Econ
Biz 
Inter
ter-
net-
quell
en 
Else
vier 
Sci-
ence 
Di-
rect 
Else
vier 
Sco-
pus 
WISO 
eratur-
atur-
nachweise 
Goo
gle 
Sch
olar 
insg. 
ver-
wende
t 
M
et
h
o
d
o
lo
g
y
 
("review" 
OR "me-
ta*analy*
") AND 
"stake-
holder" 
AND 
"meth-
od*" 
EXCLUDE(smi, 
"5905,6542,5885,6974,5855,5852,5908,5927,580
9,5713,5912","Tourism Manage-
ment,Government Information Quarter-
ly,Landscape and Urban Planning,Nurse Educa-
tion Today,Annals of Tourism Re-
search,Evaluation and Program Plan-
ning,International Journal of Project Manage-
ment,International Journal of Hospitality Man-
agement,Industrial Marketing Manage-
ment,Energy Policy,Land Use Policy") AND 
EXCLUDE(contenttype, 
"2,3,4,5",",Book,Reference Work")[All 
Sources(Business, Management and Account-
ing,Decision Sciences,Social Sciences)] 
  
32 
(4) 
   4 
("review" 
OR "me-
ta*analy*
") AND 
"stake-
holder" 
AND 
"meth-
od*" 
Document Type: Review; 
Subject Area: Environmental Science; Business, 
Management and Accounting; Social Sciences; 
Number of citations: more than 50 
   
39 
(3) 
  3 
("review" 
OR "me-
ta*analy*
") AND 
("legiti-
macy") 
AND 
"meth-
od*" 
 94  
1431
1 
229 9 (0)  0 
as before 
Subject Area: Business, Management and Ac-
counting; Social Sciences 
   
100 
(10) 
  10 
("review" 
OR "me-
ta*analy*
") AND 
("legiti-
macy" 
OR "ac-
count-
ab*") 
AND 
"meth-
od*" 
 441  
4502
7 
1324 18 (1)  1 
as before 
Subject Area: Business, Management and Ac-
counting; Social Sciences 
Citations: 10 or more 
   
84 
(3) 
  3 
as before 
Subject Area: Business, Management and Ac-
counting 
Years: 2000 - 2010 
  7517    0 
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Topic Subject terms 
Further limita-
tion 
EBSCO 
Host 
EconBiz 
Internet-
quellen 
Elsevier 
Science 
Direct 
Elsevier 
Scopus 
WISO Liter-
aturnachweise 
Google 
Scholar 
insg. ver-
wendet 
M
et
h
o
d
o
lo
g
y
 
as before AND 
NOT ("corpo-
rate citizen" OR 
"responsibilit*" 
OR "sustain*" 
OR "stakehold-
er") 
  261 (2) 1223   
89900 
(2) 
4 
as before 
Journal: Ac-
counting, Or-
ganizations 
and Society; 
Critical Per-
spectives on 
Accounting; 
Journal of 
Business Re-
search; Organ-
izational Be-
havior and 
Human Deci-
sion Processes  
  152 (1)    1 
("überblick" OR 
"meta*analy*") 
AND ("legit-
im*" OR "re-
chenschaft*") 
AND "method*" 
       0 
"content analy-
sis" AND ("cor-
porate citizen" 
OR "responsi-
bilit*" OR "sus-
tain*" OR 
"stakeholder") 
 268  8403 5282 0 
104200 
(7) 
7 
as before 
Publication 
Date: 2000 - 
2010; 
Publication: 
Journal of 
Business Eth-
ics, Public Re-
lations Re-
view, Man-
agement Deci-
sion, Corpo-
rate Social Re-
sponsibility & 
Environmental 
Management, 
Business 
Strategy & the 
Environment, 
Issues in So-
cial & Envi-
ronmental Ac-
counting 
50 (7)      7 
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Top
ic 
Subject 
terms 
Further limitation 
EB-
SCO 
Host 
Econ
Biz 
Inter-
net-
quelle
n 
Else-
vier 
Sci-
ence 
Di-
rect 
Else-
vier 
Sco-
pus 
WISO Liter-
aturnachweise 
Goog
le 
Scho
lar 
insg. 
ver-
wendet 
M
et
h
o
d
o
lo
g
y
 
as before 
Subject Area: Business, Management 
and Accounting; Economics, Econo-
metricss and Finance; Social Sciences, 
Environmental Science; 
Source Title: JBE, BSE, CSR & EM, 
AAAJ 
   
100 
(20) 
  20 
as before 
EXCLUDE(smi, 
"5905,6542,5855,5852,5908,5809,592
7","Tourism Management,Government 
Information Quarterly,Annals of Tour-
ism Research,Evaluation and Program 
Planning,International Journal of Pro-
ject Management,Industrial Marketing 
Management,International Journal of 
Hospitality Management") AND LIM-
IT-TO(topics, "environmental disclo-
sure,content analysis,corporate so-
cial,environmental performance,social 
responsibility,accounting,accounting 
standard,sustainable development") 
  
42 
(13) 
   13 
"inhaltsana-
lyse" 
     7 (0)  0 
"case 
study" 
AND "sus-
tain*" AND 
("disclo-
sure" OR 
"stakehold-
er" OR 
"perfor-
mance") 
  
278 
(10) 
4447
6 
  
1170
00 
(0) 
10 
as before 
Year: 2000 - 2010 
Source: Business, Management and 
Accounting 
  7278    0 
as before 
Publication Date: 2000 - 2010; 
Publication: Journal of Business Eth-
ics, Public Relations Review, Man-
agement Decision, Corporate Social 
Responsibility & Environmental Man-
agement, Business Strategy & the En-
vironment, Issues in Social & Envi-
ronmental Accounting 
50 
(7) 
     7 
as before 
Subject Area: Business, Management 
and Accounting; Economics, Econo-
metricss and Finance; Social Sciences, 
Environmental Science; 
Source Title: JBE, BSE, CSR & EM, 
AAAJ 
   
100 
(20) 
  20 
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Top
ic 
Subject 
terms 
Further limitation 
EB-
SCO 
Host 
Econ
Biz 
Inter-
net-
quelle
n 
Else-
vier 
Sci-
ence 
Di-
rect 
Else-
vier 
Sco-
pus 
WISO Liter-
aturnachweise 
Goog
le 
Scho
lar 
insg. 
ver-
wendet 
M
et
h
o
d
o
lo
g
y
 
as before 
EXCLUDE(smi, 
"5905,6542,5855,5852,5908,5809,592
7","Tourism Management,Government 
Information Quarterly,Annals of Tour-
ism Research,Evaluation and Program 
Planning,International Journal of Pro-
ject Management,Industrial Marketing 
Management,International Journal of 
Hospitality Management") AND LIM-
IT-TO(topics, "environmental disclo-
sure,content analysis,corporate so-
cial,environmental performance,social 
responsibility,accounting,accounting 
standard,sustainable development") 
  
42 
(13) 
   13 
"inhaltsana-
lyse" 
     7 (0)  0 
"case 
study" 
AND "sus-
tain*" AND 
("disclo-
sure" OR 
"stakehold-
er" OR 
"perfor-
mance") 
  
278 
(10) 
4447
6 
  
1170
00 
(0) 
10 
as before 
Year: 2000 - 2010 
Source: Business, Management and 
Accounting 
  7278    0 
as before 
Journal: Research Policy; Technologi-
cal Forecasting and Social Change; 
Long Range Planning; Journal of Op-
erations Management; Journal of Busi-
ness Research; Accounting, Organiza-
tions and Society; Critical Perspectives 
on Accounting 
  
1205 
(13) 
   13 
"case 
study" 
AND "dis-
closure" 
      
7360
0 (4) 
4 
"case 
study" 
AND "sus-
tain*" AND 
"stakehold-
er" 
      
6290
0 (3) 
3 
"case 
study" 
AND "sus-
tain*" AND 
"perfor-
mance" 
      
1100
00 
(0) 
0 
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Topic Subject terms 
Further limita-
tion 
EBSCO 
Host 
EconBiz 
Internet-
quellen 
Elsevier 
Science 
Direct 
Elsevier 
Scopus 
WISO Liter-
aturnachweise 
Google 
Scholar 
insg. ver-
wendet 
M
et
h
o
d
o
lo
g
y
 
"content analy-
sis" AND ("le-
gitimacy" OR 
"accountab*")  
 85 (2)  2109 158 (6) 1 (0) 20300 6 
"content analy-
sis" AND (("le-
gitimacy" OR 
"accountab*") 
AND ("respon-
sibilit*" OR 
"stakeholder" 
OR "sustain-
ab*")) 
   519 34 (0)  
3200 
(12) 
12 
as before 
Year: 2000 - 
2010 
Source: Busi-
ness, Manage-
ment and Ac-
counting 
  477    0 
as before 
Journal: Ac-
counting, Or-
ganizations 
and Society; 
Critical Per-
spectives on 
Accounting; 
The Leader-
ship Quarterly; 
Journal of 
Business Re-
search  
  72 (3)    4 
"case study" 
AND ("legiti-
macy" OR "ac-
countab*") 
 749  17989  17 (1) 
130000 
(2) 
3 
as before 
Journal: Jour-
nal of Business 
Ethics; Acad-
emy of Man-
agement Pro-
ceedings; Ac-
counting, Au-
diting & Ac-
countability 
Journal; Jour-
nal of the In-
ternational 
Academy for 
Case Studies; 
Public Admin-
istration Re-
view 
 109 (6)     6 
as before 
Year: 2000 - 
2010 
Source: Busi-
ness, Man-
agement and 
Accounting 
  4137    0 
 
Sustainable Business through Voluntary Disclosures:  
Motivations for Adopting Reporting Guidance, Boundaries and Assurance 105 
Topic Subject terms 
Further limita-
tion 
EBSCO 
Host 
EconBiz 
Internet-
quellen 
Elsevier 
Science 
Direct 
Elsevier 
Scopus 
WISO Liter-
aturnachweise 
Google 
Scholar 
insg. ver-
wendet 
M
et
h
o
d
o
lo
g
y
 
"content anal-
ysis" AND 
("legitimacy" 
OR "account-
ab*")  
Journal:  Criti-
cal Perspectives 
on Accounting; 
Accounting, 
Organizations 
and Society; 
Management 
Accounting Re-
search 
  
451 
(10) 
   10 
(Own illustration.) 
Note:  From the EBSCO Host search template the research databases Business Source Complete and Econlit were selected. 
From the WISO Literaturnachweise search template the databases Arbeitswissenschaftliche Literatur, Bliss and Eco-
nis were selected. 
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Abstract 
This paper explores the extent to which corporations currently increase the voluntary disclo-
sures in triple bottom line (TBL) reports. Although research already has provided substantial 
contributions as to why and how firms apply TBL reporting, there remains limited under-
standing of the motivations for and against making voluntary disclosures. Drawing from liter-
ature in environmental management and accounting as well as international auditing, this 
work focuses on guidance, boundary-setting and external assurance for TBL reports. An in-
ductive case study approach is applied to investigate the credibility of TBL reporting by con-
trasting the competing predictions from legitimacy theory and voluntary disclosure theory on 
voluntary disclosures. A set of firm and industry specific factors are identified that are ex-
pected to determine a firm’s level and extent of reporting. The sample comprises nine US and 
EU red biotechnology corporations which aligned their TBL reporting to the GRI reporting 
standards in at least part of their TBL reports that were published between 2000 and 2009. An 
initial attempt is made to systematically investigate the credibility of TBL reporting to devel-
op the model of voluntary disclosures. The empirical findings of this case study suggest that 
current guidance, boundary-setting and assurance for TBL reports are not sufficient to in-
crease the credibility, comparability and reliability of reporting. Voluntary disclosure theory 
can serve to provide economic motivations, while legitimacy theory is helpful to provide a le-
gitimating motivation. The findings support the notion that the economics-based factors better 
explain the secrecy strategy of providing mainly soft disclosures. The increase of disclosure 
levels maybe is considered sufficient to respond to public pressure. This work concludes by 
suggesting some directions of research in the areas of boundary-setting and assurance that 
have academic and practical implications. 
 
Keywords:  legitimacy; voluntary disclosure; reporting; boundary; assurance; triple bottom 
line; sustainable development; red biotechnology industry 
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